
<html lang="en"     class="pb-page"  data-request-id="959fb4e1-6ffc-4176-be07-ac10553312bb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm300172z;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors" /></meta><meta name="dc.Creator" content="Young Taek  Han" /></meta><meta name="dc.Creator" content="Gyeong-In  Choi" /></meta><meta name="dc.Creator" content="Dohyun  Son" /></meta><meta name="dc.Creator" content="Nam-Jung  Kim" /></meta><meta name="dc.Creator" content="Hwayoung  Yun" /></meta><meta name="dc.Creator" content="Sujin  Lee" /></meta><meta name="dc.Creator" content="Dong Jo  Chang" /></meta><meta name="dc.Creator" content="Hyun-Seok  Hong" /></meta><meta name="dc.Creator" content="Hee  Kim" /></meta><meta name="dc.Creator" content="Hee-Jin  Ha" /></meta><meta name="dc.Creator" content="Young-Ho  Kim" /></meta><meta name="dc.Creator" content="Hyun-Ju  Park" /></meta><meta name="dc.Creator" content="Jeewoo  Lee" /></meta><meta name="dc.Creator" content="Young-Ger  Suh" /></meta><meta name="dc.Description" content="Using the approach of ligand-based drug design, we discovered a novel series of 4,6-disubstituted 2-aminopyrimidines as RAGE inhibitors. In transgenic mouse models of AD, one of the 4,6-bis(4-chlor..." /></meta><meta name="Description" content="Using the approach of ligand-based drug design, we discovered a novel series of 4,6-disubstituted 2-aminopyrimidines as RAGE inhibitors. In transgenic mouse models of AD, one of the 4,6-bis(4-chlor..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 13, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300172z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300172z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300172z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300172z" /></link>
        
    
    

<title>Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300172z" /></meta><meta property="og:title" content="Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0011.jpeg" /></meta><meta property="og:description" content="Using the approach of ligand-based drug design, we discovered a novel series of 4,6-disubstituted 2-aminopyrimidines as RAGE inhibitors. In transgenic mouse models of AD, one of the 4,6-bis(4-chlorophenyl)pyrimidine analogs, 59, significantly lowered the concentration of toxic soluble Aβ in the brain and improved cognitive function. SPR analysis confirmed the direct binding of 59 with RAGE, which should contribute to its biological activities via inhibition of the RAGE–Aβ interaction. We also predicted the binding mode of the 4,6-bis(4-chlorophenyl)pyrimidine analogs to the RAGE V-domain through flexible docking study." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300172z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300172z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300172z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300172z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300172z&amp;href=/doi/10.1021/jm300172z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9120-9135</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201724m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300251n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young+Taek++Han">Young Taek Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gyeong-In++Choi">Gyeong-In Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dohyun++Son">Dohyun Son</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nam-Jung++Kim">Nam-Jung Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hwayoung++Yun">Hwayoung Yun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sujin++Lee">Sujin Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong+Jo++Chang">Dong Jo Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun-Seok++Hong">Hyun-Seok Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee++Kim">Hee Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee-Jin++Ha">Hee-Jin Ha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young-Ho++Kim">Young-Ho Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun-Ju++Park">Hyun-Ju Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeewoo++Lee">Jeewoo Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young-Ger++Suh">Young-Ger Suh</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">College of Pharmacy, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do, 425-839, Korea</span></div><div class="corresp-info"><strong>*</strong>Tel: 82-2-880-7875. Fax: 82-2-888-0649. E-mail: <a href="/cdn-cgi/l/email-protection#4d342a3e38250d3e2338632c2e63263f"><span class="__cf_email__" data-cfemail="95ecf2e6e0fdd5e6fbe0bbf4f6bbfee7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300172z&amp;href=/doi/10.1021%2Fjm300172z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9120–9135</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 28, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 February 2012</li><li><span class="item_label"><b>Published</b> online</span>13 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300172z" title="DOI URL">https://doi.org/10.1021/jm300172z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9120%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYoung%2BTaek%2BHan%252C%2BGyeong-In%2BChoi%252C%2BDohyun%2BSon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm300172z%26title%3DLigand-Based%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2B2-Aminopyrimidines%252C%2Ba%2BNovel%2BSeries%2Bof%2BReceptor%2Bfor%2BAdvanced%2BGlycation%2BEnd%2BProducts%2B%2528RAGE%2529%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9135%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300172z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3811</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300172z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Young&quot;,&quot;last_name&quot;:&quot;Taek Han&quot;},{&quot;first_name&quot;:&quot;Gyeong-In&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Dohyun&quot;,&quot;last_name&quot;:&quot;Son&quot;},{&quot;first_name&quot;:&quot;Nam-Jung&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hwayoung&quot;,&quot;last_name&quot;:&quot;Yun&quot;},{&quot;first_name&quot;:&quot;Sujin&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Jo Chang&quot;},{&quot;first_name&quot;:&quot;Hyun-Seok&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Hee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hee-Jin&quot;,&quot;last_name&quot;:&quot;Ha&quot;},{&quot;first_name&quot;:&quot;Young-Ho&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hyun-Ju&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Jeewoo&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Young-Ger&quot;,&quot;last_name&quot;:&quot;Suh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9120-9135&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300172z&quot;},&quot;abstract&quot;:&quot;Using the approach of ligand-based drug design, we discovered a novel series of 4,6-disubstituted 2-aminopyrimidines as RAGE inhibitors. In transgenic mouse models of AD, one of the 4,6-bis(4-chlorophenyl)pyrimidine analogs, 59, significantly lowered the concentration of toxic soluble Aβ in the brain and improved cognitive function. SPR analysis confirmed the direct binding of 59 with RAGE, which should contribute to its biological activities via inhibition of the RAGE–Aβ interaction. We also predicted the binding mode of the 4,6-bis(4-chlorophenyl)pyrimidine analogs to the RAGE V-domain through flexible docking study.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300172z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300172z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300172z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300172z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300172z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300172z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300172z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300172z&amp;href=/doi/10.1021/jm300172z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300172z" /></input><a href="/doi/pdf/10.1021/jm300172z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300172z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300172z%26sid%3Dliteratum%253Aachs%26pmid%3D22742537%26genre%3Darticle%26aulast%3DHan%26date%3D2012%26atitle%3DLigand-Based%2BDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2B2-Aminopyrimidines%252C%2Ba%2BNovel%2BSeries%2Bof%2BReceptor%2Bfor%2BAdvanced%2BGlycation%2BEnd%2BProducts%2B%2528RAGE%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9120%26epage%3D9135%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Using the approach of ligand-based drug design, we discovered a novel series of 4,6-disubstituted 2-aminopyrimidines as RAGE inhibitors. In transgenic mouse models of AD, one of the 4,6-bis(4-chlorophenyl)pyrimidine analogs, <b>59</b>, significantly lowered the concentration of toxic soluble Aβ in the brain and improved cognitive function. SPR analysis confirmed the direct binding of <b>59</b> with RAGE, which should contribute to its biological activities via inhibition of the RAGE–Aβ interaction. We also predicted the binding mode of the 4,6-bis(4-chlorophenyl)pyrimidine analogs to the RAGE V-domain through flexible docking study.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in elderly individuals. AD is characterized by progressive cognitive dysfunction and neuronal cell death, accompanied by an accumulation of extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles in the brain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Treatment with cholinesterase inhibitors, which results in the clinical improvement of memory and cognitive function, has been used as the first-line choice for AD to date. Recently a large number of preclinical and clinical studies focusing on various therapeutic targets involved in neuronal cell death, which is regarded as a fundamental cause of AD, have been performed. In particular, Aβ peptide is regarded as an important cytotoxic protein in the pathology of AD. Thus many current disease-modifying approaches for AD treatment focus on interrupting the pathological events related to the expression and accumulation of Aβ.<a onclick="showRef(event, 'cit1b cit1c cit1d cit1e'); return false;" href="javascript:void(0);" class="ref cit1b cit1c cit1d cit1e">(1b-1e)</a></div><div class="NLM_p">Aβ is produced primarily in somatic cells through the proteolysis of amyloid precursor protein (APP), and the entry of Aβ into the brain and its subsequent accumulation is essential for the pathogenesis of AD. Specific receptors and carrier-mediated transport systems at the BBB (blood–brain barrier) regulate the entry of the plasma-derived Aβ into the brain and the clearance of the brain-derived Aβ. Low-density lipoprotein receptor-related protein-1 (LRP-1) mediates the clearance of Aβ from the brain, and the receptor for advanced glycation end products (RAGE) is predominantly responsible for the plasma-derived Aβ influx into the brain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">RAGE is a multiligand receptor on the cell surface that belongs to the immunoglobulin (Ig) superfamily. RAGE consists of an extracellular region, which is composed of one ligand-binding V-type Ig domain and two Ig-like C-domains, a short hydrophobic transmembrane-spanning region, and a signal-transducing cytoplasmic domain.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> RAGE was originally identified as a receptor for the heterogeneous advanced glycation end products (AGE), which are generated under hyperglycemic conditions and lead to various diabetic complications. Along with the interactions of Aβ and AGE, the interactions of RAGE with the S100 protein family and the high-mobility group box-1 protein (HMGB1, also known as amphoterin) have been implicated in the pathogenesis of diverse chronic diseases such as rheumatoid arthritis, cardiovascular disease, and cancer. RAGE is expressed at low concentrations under normal physiological conditions except during embryonic development.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, RAGE overexpression in diseased tissues is observed in most RAGE-related pathogenic conditions, which supports the possibility that RAGE can serve as a therapeutic target.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">In Alzheimer’s disease, the RAGE–Aβ interaction not only promotes the transport of Aβ into the brain but also activates nuclear factor-κB (NF-κB), a transcription factor that plays a crucial role in various inflammatory responses. In addition, persistent RAGE hyperexpression arises from the positive feedback loop generated by the NF-κB-responsive element in the RAGE gene promoter.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The steady increase in Aβ accumulation and inflammation in the brain as the result of this vicious cycle aggravates AD. In this context, the inhibition of the RAGE–Aβ interaction, which decreases the rate of deposition of Aβ and inhibits the inflammatory response to Aβ in the brain, has been recognized as a more preclusive and curative AD treatment strategy than the use of the current symptom-relief medications such as cholinesterase inhibitors.<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> BBB permeability of a RAGE inhibitor might provide advantages such as an additional target inhibition,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> although it is not essential to reach and inhibit the RAGE. Therefore, efforts toward the delivery of the RAGE inhibitors into the brain could be avoided, in contrast to other brain-targeting “disease-modifying agents” such as the metal chelators.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Despite such advantages for the inhibitors of the RAGE–Aβ interaction in AD treatment, there are not many reports on RAGE inhibitors to date. To the best of our knowledge, most studies of RAGE inhibition have focused on protein inhibitors such as sRAGE and RAGE antibodies.<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a> In the case of small-molecule RAGE inhibitors, one of Pfizer’s compounds (PF-04494700) has reached a phase II clinical trial although the exact chemical structure has not yet been disclosed.<a onclick="showRef(event, 'cit1d ref9'); return false;" href="javascript:void(0);" class="ref cit1d ref9">(1d, 9)</a> Very recently, Zlokovic et al. reported a multimodal RAGE inhibitor during the preparation of our manuscript.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Considering suggestions that there exist common or overlapping ligand binding sites in RAGE,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> we assumed that all ligands for RAGE could serve as templates for the ligand-based design of RAGE inhibitors. However, most of the known ligands, except for monomeric AGE are macromolecules such as proteins and the secondary and tertiary structures of macromolecular ligands such as the β-sheet structure play a large role in the interaction with RAGE. It is also known that there is no essential difference in the binding with RAGE between the macromolecular and monomeric AGE.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, monomeric AGEs, which generally consist of an <i>N</i>-heterocyclic moiety and an amino acid moiety as a part of the AGE–protein linkage,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> were attractive as a template for the design of novel small-molecule RAGE inhibitors in terms of the structural simplicity and the chemical stability. In particular, argpyrimidine <b>1</b>, a monomeric AGE, was selected for design of the incipient RAGE inhibitors in the present study because the key structure of argpyrimidine seems to provide more synthetic accessibility and more drug-like features compared with that of other monomeric AGEs.<a onclick="showRef(event, 'cit12b'); return false;" href="javascript:void(0);" class="ref cit12b">(12b)</a> Therefore, our ligand-based design of RAGE inhibitors commenced with an investigation of the two essential moieties of the argpyrimidine. The modification of the pyrimidine moiety and the appropriate replacement of the amino acid moiety, which was divided into the linker part and the terminal polar part, were extensively investigated. In addition, the effects of the overall conformational changes of the argpyrimidine analogs on the RAGE-inhibitory activities were also examined by changing the substitution pattern of the identified equivalents of the amino acid moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Finally, mechanistic studies for the identified RAGE inhibitors were performed and the binding modes of the RAGE inhibitors were also predicted by flexible docking studies. Herein, we report the ligand-based development of a novel series of 2-aminopyrimidines that are RAGE inhibitors that may serve as potential AD therapeutics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of argpyrimidine <b>1</b> and overall strategy for the design of novel RAGE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis route for the <i>N</i>-acyl and <i>N</i>-alkyl pyrimidol analogs is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The ω-hydroxy-<i>N</i>-acyl analogs <b>7a</b>–<b>7d</b> were prepared from the known pyrimidol <b>4</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> by O-alkylation, followed by amidation via dimethylaluminum amide intermediates.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The treatment of alcohols <b>7a</b> and <b>7b</b> with carbon tetrabromide and amine substitution of the resulting bromides <b>8a</b> and <b>8b</b> furnished the <i>N</i>-acyl pyrimidol analogs <b>9a</b> and <b>9b</b>, respectively. Jones oxidation of alcohols <b>7c</b> and <b>7d</b> afforded the acids <b>8c</b> and <b>8d</b>, respectively. The <i>N</i>-acyl-5-hydroxy analog <b>9c</b> was produced by the debenzylation of <b>9a</b>. The reduction of amides <b>9a</b> and <b>9b</b> provided the <i>N</i>-alkyl pyrimidol analogs <b>10a</b> and <b>10b</b>, and the debenzylation of <b>10a</b> afforded the <i>N</i>-alkyl-5-hydroxy analog <b>10c</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Acyl and <i>N</i>-Alkyl Pyrimidol Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr or MeI, CsCO<sub>3</sub>, CH<sub>3</sub>CN, rt; (b) γ-butyrolactone or δ-valerolactone, Me<sub>3</sub>Al, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>CN, rt; (d) CrO<sub>3</sub>, aq. H<sub>2</sub>SO<sub>4</sub>/acetone, rt; (e) K<sub>2</sub>CO<sub>3</sub>, Et<sub>2</sub>NH, rt; (f) LAH, THF, rt; (g) Pd(OH)<sub>2</sub>, H<sub>2</sub>, MeOH, rt.</p></p></figure><div class="NLM_p">The <i>N</i>-aryl pyrimidol analogs <b>32</b> and <b>33</b> and the <i>N</i>-aryl pyrimidine analogs <b>34</b>–<b>60</b> were prepared via versatile coupling procedures from a variety of pyrimidine intermediates. The synthetic procedures for <b>32</b>–<b>60</b>, including the key aryl–aryl and aryl–amine couplings, are outlined in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. For the synthesis of the <i>N</i>-aryl pyrimidine analogs, the 2-chloropyrimidine intermediates <b>15</b>–<b>24</b> were initially prepared from the commercially available chloropyrimidines <b>11</b>–<b>13</b> or from pyrrolyl chloropyrimidine <b>14</b> by the appropriate combinations of the regioselective Suzuki reaction,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> alkylation, and amination, as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The chloropyrimidine intermediate <b>15</b> was prepared from 2,4,6-trichloropyrimidine (<b>11</b>) by the Suzuki reaction using 2.5 equiv of boronic acid, whereas the N-substituted 2-chloropyrimidines <b>16</b>–<b>18</b> were synthesized by the Suzuki reaction in the presence of 1.1 equiv of boronic acid followed by amination with the corresponding amines. The 2-chloro-6-methyl pyrimidine intermediates <b>20</b> and <b>22</b>–<b>24</b> were prepared from 2,4-dichloro-6-methyl pyrimidine (<b>12</b>) by Pd(0)-catalyzed cross-coupling reactions (<b>20a</b>–<b>20d</b> and <b>22</b>) or amination (<b>23</b> and <b>24</b>). The 2-chloro-6-methyl pyrimidine intermediates <b>21a</b>–<b>21f</b> were prepared using the Mitsunobu<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>21a</b>–<b>21e</b>) or Ullmann reaction<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<b>21f</b>) with <b>20d</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Chloropyrimidine Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-chlorophenylboronic acid (2.5 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (b) 4-chlorophenylboronic acid (1.1 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme/H<sub>2</sub>O, 70 °C; (c) cyclic amines or aniline, EtOH, rt; (d) cyclohexylzinc bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; (e) boronic acids, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (f) R<sub>4</sub>(CH<sub>2</sub>)<sub><i>n</i></sub>OH, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, rt; (g) 4-chlorophenylboronic acid, Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, 4 Ǻ MS, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, the naphthyloxy intermediate <b>28</b> was prepared from 4-fluoroacetophenone <b>25</b> because the corresponding boronic acid was not commercially available. The sequential aromatic substitution of <b>25</b> and the Claisen condensation of <b>26</b> gave diketone <b>27</b>, which was subjected to condensation with urea and then chlorination of the resulting pyrimidol to afford chloropyrimidine <b>28</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Naphthyloxyphenyl 2-Chloropyrimidine <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) naphthalen-2-ol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) EtOAc, EtOH, NaH, 18-crown-6, THF, reflux; (c) urea, <i>c</i>-HCl, EtOH, reflux; (d) POCl<sub>3</sub>, reflux.</p></p></figure><div class="NLM_p">For the synthesis of the <i>N</i>-aryl pyrimidol <b>33</b> and the <i>N</i>-aryl pyrimidine analogs <b>34</b>–<b>60</b>, the bromophenyl ether <b>30d</b> and the aminophenyl ethers <b>31a</b>–<b>31c</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The Mitsunobu reaction of the commercially available nitrophenols <b>29a</b>–<b>29c</b> with <i>N</i>,<i>N</i>-diethyl ethanolamine and then the reduction of the nitro group afforded anilines <b>31a</b>–<b>31c</b>. Bromophenol <b>30d</b> was also prepared by the Mitsunobu reaction of commercially available 4-bromophenol (<b>29d</b>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amino- and Bromophenyl Ethers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>N</i>-diethyl ethanolamine, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, rt; (b) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux.</p></p></figure><div class="NLM_p">Finally, the coupling reactions of the pyrimidine intermediates with the corresponding aryl counterparts readily furnished the various <i>N</i>-aryl pyrimidine analogs. The Buckwald–Hartwig reaction of aminopyrimidine <b>5a</b> with <b>30d</b> afforded the <i>N</i>-aryl benzyloxypyrimidine <b>32</b>, which was converted into the pyrimidol analog <b>33</b> by debenzylation, as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The <i>N</i>-aryl pyrimidine analogs <b>34</b>–<b>60</b> were prepared by the coupling reaction of the 2-chloropyrimidine intermediates with <b>31a</b>–<b>31c</b> under microwave irradiation conditions<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>N</i>-Aryl Pyrimidol Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, CsCO<sub>3</sub>, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, <b>30d</b>, toluene, reflux; (b) Pd(OH)<sub>2</sub>, H<sub>2</sub>, MeOH, rt.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>N</i>-Aryl Pyrimidine Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>31a</b>–<b>31c</b>, 4 N HCl in dioxane, <i>n</i>-BuOH, 160 °C (microwave irradiation).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Discovery of Novel Scaffolds for RAGE Inhibitors</h3><div class="NLM_p">Our initial strategy for the development of new RAGE inhibitors focused on the appropriate alteration of the 2-aminopentanoic acid moiety of argpyrimidine <b>1</b>. Thus, our modification of 2-aminopentanoic acid commenced with the identification of the appropriate equivalents of the propyl linker part and the terminal amino acid as the polar part. The synthesized analogs were evaluated for their RAGE–Aβ interaction inhibitory activity using an enzyme-linked immunosorbent assay (ELISA). In brief, Aβ was incubated with biotinylated RAGE on a streptavidin-coated plate in the presence of each analog. After the unbound Aβ was washed off the plate, to evaluate the RAGE inhibitory activity of the analog, the amount of remaining Aβ was measured using horseradish peroxidase-conjugated Aβ specific antibody (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1). Unfortunately, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the analogs of carboxylic acids, alcohols, and amines with alkyl and acyl linkers did not exhibit the desired activity for RAGE inhibition, even though we predicted that these compounds would form hydrogen bonds or electrostatic interactions with the basic residues of RAGE ligand binding site.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Only amine analogs <b>32</b>–<b>34</b>, which have an alkoxyaryl linker, exhibited weak inhibitory activities regardless of the phenol protection. Thus, we turned our attention to intensive optimization of the pyrimidine scaffold with the alkoxyarylamine side chain.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activities of the Initial 4,6-Dimethyl Pyrimidin-5-ol Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Percent inhibition values were determined by duplicate experiments using 20 μM of the synthesized analogs and are expressed as the means ± standard deviation.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">NA indicates not active.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Activity Relationship of the <i>N</i>-Aryl Pyrimidine Analogs</h3><div class="NLM_p">Because we observed no substituent effects of the hydroxyl group of the pyrimidol analogs <b>32</b>–<b>34</b>, we focused on the substituent effects at the 4- and 6-positions of the pyrimidine core on the RAGE inhibitory activities. In addition, we investigated the conformational effects on the inhibitory activities by changing the substitution positions of the side chain of the alkoxyaryl linker as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activities of the Synthesized Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0009.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0010.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Percent inhibition values were determined by duplicate experiments using 20 μM of the synthesized analogs and are expressed as the means ± standard deviations.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">NA indicates not active.</p></div></div><div></div></div><div class="NLM_p last">First, we investigated monosubstitution at the 4-position (<b>36</b>–<b>44</b>) of the pyrimidine core. Generally, the introduction of cyclic substituents at the 4-position increased the inhibitory activities regardless of the electronic character of the substituents. Interestingly, analog <b>43</b>, which possesses an aminoethoxy substituent at the <i>meta</i>-position of the aniline side chain, exhibited better inhibitory activity than the <i>para</i>-substituted analog <b>42</b>, whereas the <i>ortho</i>-substituted analog <b>44</b> exhibited a higher inhibitory activity than the <i>meta</i>- and <i>para</i>-substituted analogs. These results partly confirmed that there is a conformational effect of the side chain on the RAGE inhibitory activities. The conformational effects on the inhibition were also observed in the <i>para</i>-substituted analog <b>34</b> and the <i>meta</i>-substituted analog <b>35</b> in the 4,6-dimethylpyrimidine series. We extended our studies on the substituent effects to substituent elongation at the 4-position of the pyrimidine core (<b>45</b>–<b>53</b>). Elongation with an additional aryloxy (<b>45</b>) or arylalkoxy moiety (<b>46</b>–<b>49</b>) significantly decreased or eliminated the inhibitory activity, whereas elongation with an alicyclic chain (<b>50</b>–<b>52</b>) provided equipotent activities or slightly improved activities (<b>53</b>) for both the <i>meta</i>- and <i>para</i>-substituents. The inhibitory activities decreased as the length of the aliphatic linker between the two aromatic moieties increased (<b>45</b>–<b>47</b>). The disappearance of the inhibitory activities of the phenethyl ether analogs <b>47</b> and <b>48</b> is likely due to folding resulting from an intramolecular π–π interaction involving the biaryl ether moiety. We further investigated the disubstitution effect at the 4- and 6-positions based on the monosubstituted analogs <b>42</b>–<b>44</b>, which exhibited potent inhibitory activities. Disappointingly, all of the cyclic amine-substituted analogs (<b>54</b>–<b>57</b>) exhibited weak or poor inhibitory activities. However, the disubstituted analogs possessing the 4-chlorophenyl substituent (<b>58</b>–<b>60</b>) exhibited dramatically increased activities regardless of the substitution position of the aminoethoxy chain. In particular, the disubstituted analogs with aminoethoxy chains at the <i>meta-</i> and <i>ortho</i>-positions exhibited excellent inhibitory activities, with IC<sub>50</sub> values of 16.5 (<b>59</b>) and 4.6 μM (<b>60</b>), respectively. These results further supported the existence of conformational effects of the side chain on the RAGE inhibitory activities of the pyrimidine analogs.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Studies</h3><div class="NLM_p">We performed further in vivo studies on the pyrimidine analogs <b>53</b>, <b>59</b>, and <b>60</b>, which showed high in vitro RAGE inhibitory activities. In an NF-κB reporter assay using the C6 glioma cells, we observed that the Aβ-induced NF-κB signaling was down-regulated by all three analogs without cytotoxicity at the indicated concentrations (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S3). We also performed an acute model study on the three analogs to confirm the desired inhibition of Aβ brain entry. The acute model was designed based on a previous report that revealed a dominant role of RAGE in the transport of peripheral Aβ into brain.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In brief, each RAGE inhibitor was injected intraperitoneally prior to an injection of human Aβ into wild-type mice, and then the inhibitory activities were estimated by measuring the level of human Aβ in the brain extracts of the mice. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, all three analogs exhibited brain Aβ-lowering effects without significant changes of the amount of peripheral human Aβ. These observations obviously supported that the Aβ brain entry was inhibited by the pyrimidine analogs via their RAGE inhibition. Further long-term studies using the AD model and analog <b>59</b>, which exhibited the most potent Aβ brain-entry inhibition in acute model, were performed to validate the desired therapeutic effects of the pyrimidine analogs. The results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The efficacy of <b>59</b> in the AD model study was evaluated based on Aβ accumulation in the brain and the subsequent improvement in cognitive function. As expected, after oral administration of <b>59</b> for 3 months, we observed that analog <b>59</b> effectively lowered the Aβ brain accumulation, including the accumulation of insoluble Aβ (also see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S2) and soluble Aβ (particularly toxic soluble Aβ1–42),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and improved the cognitive function without significant side effects such as lethality.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Preliminary in Vivo Assay of the Inhibition of Aβ Brain Entry in an Acute Model<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>53</b><a class="ref internalNav" href="#t3fn3" aria-label="b">b</a>+Aβ, Aβ only</th><th class="colsep0 rowsep0" align="center"><b>59</b><a class="ref internalNav" href="#t3fn4" aria-label="c">c</a>+Aβ, Aβ only</th><th class="colsep0 rowsep0" align="center"><b>60</b><a class="ref internalNav" href="#t3fn3" aria-label="b">b</a>+Aβ, Aβ only</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human Aβ in brain<a class="ref internalNav" href="#t3fn5" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">126.78 ± 24.60, 144.27 ± 16.07</td><td class="colsep0 rowsep0" align="left">66.52 ± 8.74,<a class="ref internalNav" href="#t3fn7" aria-label="f">f</a>101.30 ± 11.15</td><td class="colsep0 rowsep0" align="left">74.03 ± 27.60, 90.62 ± 12.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% reduction</td><td class="colsep0 rowsep0" align="left">12.1</td><td class="colsep0 rowsep0" align="left">34.3</td><td class="colsep0 rowsep0" align="left">18.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human Aβ in plasma<a class="ref internalNav" href="#t3fn6" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1766.03 ± 239.07, 1861.19 ± 276.99</td><td class="colsep0 rowsep0" align="left">1027.00 ± 103.90, 1066.00 ± 57.35</td><td class="colsep0 rowsep0" align="left">1504.32 ± 463.39, 1547.63 ± 477.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% reduction</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">2.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The amount of human Aβ in the brain and the plasma of mice was measured following tail vein injection of vehicle or the analogs. The concentrations of human Aβ of mice are expressed as the means ± standard deviation.</p></div><div class="footnote" id="t3fn3"><sup>b</sup><p class="last">25 mg/kg, <i>n</i> = 4, male.</p></div><div class="footnote" id="t3fn4"><sup>c</sup><p class="last">25 mg/kg, <i>n</i> = 7, male.</p></div><div class="footnote" id="t3fn5"><sup>d</sup><p class="last">pg/mg protein of the brain extracts.</p></div><div class="footnote" id="t3fn6"><sup>e</sup><p class="last">ng/mL of plasma</p></div><div class="footnote" id="t3fn7"><sup>f</sup><p class="last"><i>P</i> < 0.05.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of Aβ Accumulation<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> in the Brain of Mice and the Improvement in Cognitive Function by Analog <b>59</b> in an AD Model</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">soluble Aβ<sub>1–40</sub></th><th class="colsep0 rowsep0" align="center" char=".">insoluble Aβ<sub>1–40</sub></th><th class="colsep0 rowsep0" align="center" char=".">soluble Aβ<sub>1–42</sub></th><th class="colsep0 rowsep0" align="center" char=".">insoluble Aβ<sub>1–42</sub></th><th class="colsep0 rowsep0" align="center" char=".">Y maze<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle (<i>n</i> = 5)</td><td class="colsep0 rowsep0" align="char" char=".">8.66 ± 1.81</td><td class="colsep0 rowsep0" align="char" char=".">137.38 ± 58.13</td><td class="colsep0 rowsep0" align="char" char=".">17.34 ± 5.17</td><td class="colsep0 rowsep0" align="char" char=".">513.73 ± 219.56</td><td class="colsep0 rowsep0" align="char" char=".">50.95 ± 10.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b>(<i>n</i> = 4)</td><td class="colsep0 rowsep0" align="char" char=".">6.25 ± 0.65<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">98.49 ± 11.68</td><td class="colsep0 rowsep0" align="char" char=".">12.04 ± 1.87<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">354.25 ± 65.18</td><td class="colsep0 rowsep0" align="char" char=".">63.60 ± 6.6<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The concentrations are expressed as the means ± standard deviation (ng/mg protein of brain extract).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Spontaneous alternation percentage.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last"><i>P</i> < 0.05.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Studies on the Binding of the RAGE-Inhibitory Analogs with RAGE</h3><div class="NLM_p">We investigated the mechanism of RAGE inhibition by analog <b>59</b> as a representative inhibitor. Using surface plasmon resonance (SPR),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> the binding of <b>59</b> with RAGE fixed on a sensor chip was observed in a dose-dependent manner with a <i>K</i><sub>D</sub> value of 1.02 × 10<sup>–4</sup> M, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. This observation supported the direct binding of <b>59</b> with RAGE, which would contribute to its RAGE inhibitory activity and the subsequent inhibition of Aβ accumulation in the brain.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR study on the binding of analog <b>59</b> with RAGE. The real-time interaction of <b>59</b> with biotinylated RAGE was assessed by measuring the surface plasmon resonance (SPR). RU, resonance units. Typical SPR response curves were measured using a series of concentrations of the tested compounds. The response values were normalized by subtracting the response value of the empty channel. The kinetic and equilibrium constants, shown in the text, were obtained by a global fit, using the Langmuir 1:1 bimolecular kinetic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Along with the SPR analysis, a docking study of the 4,6-diarylpyrimidine analogs <b>58</b>–<b>60</b> on RAGE was performed based on the results of the in vitro assays. The X-ray structure of RAGE was retrieved from the PDB (ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O3U">3O3U</a>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and the active site was defined within a 3.0 Å radius of the specific amino acid residues (Lys43, Lys44, Arg48, and Arg104), taking into account their important roles described in the literature.<a onclick="showRef(event, 'ref11 ref23'); return false;" href="javascript:void(0);" class="ref ref11 ref23">(11, 23)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the key residues showed important properties that allowed them to interact with <b>58</b>–<b>60</b>. Interestingly, the Surflex-Dock docking analysis revealed a good correlation with the in vitro data in terms of the binding energy scores as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The o<i>rtho</i>-isomer <b>60</b> (magenta), which exhibited the best in vitro activity, formed hydrogen bonds between the nitrogen of the pyrimidine core and Arg104 of the receptor (yellow dotted line). With respect to the binding energy scores, analog <b>60</b> also had the highest score (−log <i>K</i><sub>d</sub> = 7.73). The binding energy score of the <i>meta</i>-isomer <b>59</b> (orange) was ranked second (−log <i>K</i><sub>d</sub> = 6.23), although this compound formed various hydrogen bonds not only with Arg104 but also with Arg48 and Met102 (dotted red lines). These results are likely due to the orientation of the electronegative 4-chlorophenyl moiety of <b>60</b>, which was close to Lys43 and Lys44, which form a positively charged area in the ligand binding site. The p<i>ara</i>-isomer <b>58</b> (blue) was ranked third in terms of the in vitro activity and the binding energy score (−log <i>K</i><sub>d</sub> = 6.09). We assumed that the inappropriate orientation of the diethylaminoethyl ether moiety of <b>58</b>, in comparison with that of <i>ortho</i> and <i>meta</i> isomers, might induce weaker binding and thus lower activity.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding modes of the 4,6-diphenylpyrimidine analogs <b>58</b>–<b>60</b> on the RAGE V-domain. Superpositioning of the docking poses of <b>58</b>–<b>60</b> in the binding site of RAGE obtained by Surflex-Dock. (left) Ligand atoms are rendered in capped stick. The colors are as follows: <b>58</b> in blue, <b>59</b> in orange, and <b>60</b> in magenta. Yellow dotted lines indicate common hydrogen bonds between each compound and the receptor. Red dotted lines are additional hydrogen bonds of <b>59</b> with the receptor. Key residues of the receptor are shown in stick (gray carbon). Green cartoons represent the backbone of RAGE. (right) The surface of RAGE was rendered based on the electrostatic properties; a color gradient from red to violet is used to color the molecular surface, where red and violet are for positive and negative electrostatic surface potential, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Energy Scores of <b>58</b>–<b>60</b> and Comparisons with Their in Vitro Activities</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>58</b></th><th class="colsep0 rowsep0" align="center"><b>59</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">binding score<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">6.09</td><td class="colsep0 rowsep0" align="left">6.23</td><td class="colsep0 rowsep0" align="left">7.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro activity<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">33.6</td><td class="colsep0 rowsep0" align="left">54.0</td><td class="colsep0 rowsep0" align="left">70.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Binding scores are expressed in −log <i>K</i><sub>d</sub> values.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Percent inhibition by 20 μM analogs.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In connection with the development of novel RAGE inhibitors as potential AD therapeutics, we designed and synthesized a series of 2-aminopyrimidines on the structural basis of argpyrimidine, a monomeric AGE. Subsequently, we identified the 4,6-disubstituted 2-aminopyrimidine core as a novel scaffold for RAGE-inhibitory activity. We also established the structure–activity relationship of the inhibitors based on the in vitro RAGE inhibition. In particular, we identified the pyrimidine analogs <b>53</b>, <b>59</b>, and <b>60</b> as promising RAGE inhibitors. These compounds exhibited excellent in vitro activities and good in vivo activities in the acute model. Moreover, analog <b>59</b> resulted in significant inhibition of Aβ (especially toxic soluble Aβ) accumulation in the brain and in a noticeable improvement in cognitive function in a mouse AD model with oral administration. The mechanism of the RAGE inhibitory activities of the 2-aminopyrimidine analogs was partly elucidated by SPR analysis, the results of which support the hypothesis that the direct binding of the representative inhibitor <b>59</b> with RAGE contribute to its RAGE-inhibitory activities. In addition, the binding mode of the inhibitors with RAGE was predicted by a docking study of the 4,6-diarylpyrimidine analogs <b>58</b>–<b>60</b> on the RAGE V-domain.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div class="NLM_p">Unless noted otherwise, all starting materials and reagents were obtained commercially and were used without further purification. Tetrahydrofuran was distilled from sodium benzophenone ketyl. Dichloromethane and acetonitrile were freshly distilled from calcium hydride. All solvents used for routine product isolation and chromatography were of reagent grade and glass distilled. Reaction flasks were dried at 100 °C before use, and air- and moisture-sensitive reactions were performed under argon. Flash column chromatography was performed using silica gel 60 (230–400 mesh, Merck) with the indicated solvents. Thin<i>-</i>layer chromatography was performed using 0.25 mm silica gel plates (Merck). Mass spectra were obtained using a VG Trio-2 GC-MS instrument, and high resolution mass spectra were obtained using a JEOL JMS-AX 505WA unit. <sup>1</sup>H and <sup>13</sup>C spectra were recorded on a JEOL JNM-LA 300, Bruker Analytik ADVANCE digital 400, ADVANCE digital 500, or JEOL ECA-600 spectrometer in deuteriochloroform (CDCl<sub>3</sub>), deuteriomethanol (CD<sub>3</sub>OD), or deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>). Chemical shifts are expressed in parts per million (ppm, δ) downfield from tetramethylsilane and are referenced to the deuterated solvent (CHCl<sub>3</sub>). <sup>1</sup>H NMR data are reported in the order chemical shift, multiplicity (s, singlet; bs, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet or multiple resonance), numbers of protons, and coupling constants in hertz (Hz). All the final compounds were purified up to more than 95% purity. The purities were determined by a reverse-phase high-performance liquid chromatography using Eclipse Plus C18 (4.6 × 250 mm<sup>2</sup>) with an isocratic flow at 1 mL/min. The detail analytical conditions are available in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-(Benzyloxy)-4,6-dimethylpyrimidin-2-amine (<b>5a</b>)</h4><div class="NLM_p last">To a solution of <b>4</b> (100 mg, 0.72 mmol) and CsCO<sub>3</sub> (352 mg, 1.08 mmol) in acetonitrile (10 mL) was added benzyl bromide (0.12 mL, 0.94 mmol). The reaction mixture was stirred for 5 h at ambient temperature and filtered using a Celite pad. The mixture was concentrated <i>in vacuo</i> and then diluted with EtOAc. The organic layer was washed with water and brine, and the aqueous phase was extracted with EtOAc several times. The combined organic layer was dried over MgSO<sub>4</sub> and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 2:1) afforded 135 mg (82%) of <b>5a</b> as a white solid with a melting point of 134–136 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.38–7.36 (m, 5H), 4.74 (bs, 4H), 2.28 (s, 6H). LRMS (FAB) <i>m</i>/<i>z</i> 230 (M + H<sup>+</sup>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-Methoxy-4,6-dimethylpyrimidin-2-amine (<b>5b</b>)</h4><div class="NLM_p last">Amine <b>5b</b> was prepared from <b>4</b> (1.0 g, 7.19 mmol) by the procedure for <b>5a</b>, using iodomethane (0.58 mL, 9.34 mmol) instead of benzyl bromide. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 2:1) afforded 859 mg (78%) of <b>5b</b> as a yellow solid with a melting point of 94–98 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 4.72 (bs, 2H), 3.64 (s, 3H), 2.31 (s, 6H). LRMS (FAB) <i>m</i>/<i>z</i> 154 (M + H<sup>+</sup>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)-4-hydroxybutanamide (<b>7a</b>)</h4><div class="NLM_p last">To a solution of <b>5a</b> (20 mg, 0.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) at ambient temperature was added trimethylaluminum (0.05 mL of 2 M solution in toluene, 0.10 mmol) dropwise. The resulting yellowish mixture was stirred for 20 min, and then γ-butyrolactone (23 mg, 0.26 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added slowly. The reaction mixture was stirred overnight, diluted with EtOAc, and quenched with 10% aqueous citric acid and Rochelle’s solution. The aqueous phase was extracted with EtOAc several times. The combined organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 3:1) afforded 17 mg (62%) of <b>7a</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.06 (s, 1H), 7.39 (bs, 5H), 4.80 (s, 2H), 3.73 (t, 2H, <i>J</i> = 5.8 Hz), 2.87–2.85 (m, 2H), 2.38 (s, 6H), 2.03–1.97 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 176.4, 161.8, 161.8, 151.9, 146.4, 136.1, 128.8, 128.8, 128.7, 128.2, 128.2, 75.5, 62.1, 33.5, 27.8, 19.1, 19.1. LRMS (FAB) <i>m</i>/<i>z</i> 316 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>): 316.1656; found 316.1652.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-Hydroxy-<i>N</i>-(5-methoxy-4,6-dimethylpyrimidin-2-yl)butanamide (<b>7b</b>)</h4><div class="NLM_p last">Amide <b>7b</b> was prepared by the procedure for <b>7a</b>, using <b>5b</b> (1.0 g, 6.52 mmol) instead of <b>5a</b>. Purification of the residue via flash column chromatography on silica gel (EtOAc only) afforded 1.1 g (71%) of <b>7b</b> as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.23 (bs, 1H), 3.72–3.70 (m, 5H), 2.85 (bs, 2H), 2.78 (bs, 1H), 2.41 (s, 6H), 2.00–1.95 (m, 2H). LRMS (FAB) <i>m</i>/<i>z</i> 240 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 173.6, 161.4, 161.4, 151.7, 147.7, 62.0, 60.6, 33.5, 27.8, 18.7, 18.5. HRMS (FAB) calcd for C<sub>11</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>): 240.1343; found 240.1336.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)-5-hydroxypentanamide (<b>7c</b>)</h4><div class="NLM_p last">Amide <b>7c</b> was prepared from <b>5a</b> (1.0 g, 4.36 mmol) by the procedure for <b>7a</b>, using δ-valerolactone (0.6 mL, 6.54 mmol) instead of γ-butyrolactone. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 3:1) afforded 1.0 g (71%) of <b>7c</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 7.40–7.30 (m, 5H), 4.77 (s, 2H), 3.64–3.61 (m, 2H), 2.72–2.70 (m, 2H), 2.36 (s, 6H), 1.82–1.72 (m, 2H), 1.67–1.58 (m, 2H). LRMS (FAB) <i>m</i>/<i>z</i> 330 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>): 330.1812; found 330.1821.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Hydroxy-<i>N</i>-(5-methoxy-4,6-dimethylpyrimidin-2-yl)pentanamide (<b>7d</b>)</h4><div class="NLM_p last">Amide <b>7b</b> was prepared from <b>5b</b> (500 mg, 3.26 mmol) by the procedure for <b>7b</b>, using δ-valerolactone (0.45 mL, 4.89 mmol) instead of γ-butyrolactone. Purification of the residue via flash column chromatography on silica gel (EtOAc only) afforded 585 mg (71%) of <b>7d</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.24 (bs, 1H), 3.74–3.66 (m, 5H), 2.85–2.81 (m, 2H), 1.84–1.54 (m, 4H). LRMS (FAB) <i>m</i>/<i>z</i> 254 (M + H<sup>+</sup>).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)-4-bromobutanamide (<b>8a</b>)</h4><div class="NLM_p last">To a solution of <b>7a</b> (24 mg, 0.08 mmol) and triphenylphosphine (28 mg, 0.11 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/CN<sub>3</sub>CN (1:1, 2 mL) at ambient temperature was added carbon tetrabromide (38 mg, 0.12 mmol). The reaction mixture was stirred for 5 h and diluted with CH<sub>2</sub>Cl<sub>2</sub> (10 mL). The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:3) afforded 27 mg (96%) of <b>8a</b> as a white solid with a melting point of 149–152 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.60 (bs, 1H), 7.42–7.34 (m, 5H), 4.83 (s, 2H), 3.53 (t, 2H, <i>J</i> = 6.4 Hz), 2.92–2.90 (m, 2H), 2.41 (s, 6H), 2.31–2.22 (m, 2H). LRMS (FAB) <i>m</i>/<i>z</i> 378 (M + H<sup>+</sup>).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-Bromo-<i>N</i>-(5-methoxy-4,6-dimethylpyrimidin-2-yl)butanamide (<b>8b</b>)</h4><div class="NLM_p last">Amide <b>8b</b> was prepared by the procedure for <b>8a</b>, using <b>7b</b> (78 mg, 0.33 mmol) instead of <b>7a</b>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:1) afforded 97 mg (97%) of <b>8b</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.92 (bs, 1H), 3.71 (s, 3H), 3.53 (t, 2H, <i>J</i> = 6.2 Hz), 2.98–2.90 (m, 2H), 2.42 (s, 6H), 2.30–2.21 (m, 2H). LRMS (FAB) <i>m</i>/<i>z</i> 302 (M + H<sup>+</sup>).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-((5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)amino)-5-oxopentanoic acid (<b>8c</b>)</h4><div class="NLM_p last">Initially, <i>c</i>-H<sub>2</sub>SO<sub>4</sub> (20 mL) was slowly added to a solution of CrO<sub>3</sub> (3 g) in water (30 mL), and 0.4 M chromic acid was prepared by addition of water to the above mixture up to total volume of 75 mL. To a solution of <b>7c</b> (18 mg, 0.06 mmol) in acetone (5 mL) was added the 0.4 M chromic acid (0.1 mL) at ambient temperature. The reaction mixture was stirred for 30 min at ambient temperature, concentrated <i>in vacuo</i>, and then diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:9) afforded 7 mg (37%) of <b>8c</b> as a white solid with a melting point of 168–173 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.44–7.35 (m, 5H), 4.88 (s, 2H), 2.54 (t, 2H, <i>J</i> = 7.3 Hz), 2.42–2.36 (m, 8H), 1.97 (t, 2H, <i>J</i> = 7.3 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 344 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 180.1, 170.3, 161.9, 161.9, 152.1, 146.1, 136.2, 128.8, 128.8, 128.8, 128.2, 128.2, 64.0, 28.7, 27.4, 23.8, 18.6, 18.6. HRMS (FAB) calcd for C<sub>18</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>): 344.1605; found 344.1610.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-((5-Methoxy-4,6-dimethylpyrimidin-2-yl)amino)-5-oxopentanoic acid (<b>8d</b>)</h4><div class="NLM_p last">Acid <b>8d</b> was prepared by the procedure for <b>8c</b>, using <b>7d</b> (50 mg, 0.20 mmol) instead of <b>7c</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:6) afforded 23 mg (43%) of <b>8d</b> as a white solid with a melting point of 132–137 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.70 (s, 3H), 2.70 (t, 2H, <i>J</i> = 7.5 Hz), 2.53–2.43 (m, 8H), 2.06–1.98 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 178.1, 171.3, 161.6, 161.6, 152.0, 152.0, 60.7, 35.8, 32.3, 19.7, 18.2, 18.2. LRMS (FAB) <i>m</i>/<i>z</i> 268 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>12</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>): 268.1292; found 268.1312.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)-4-(diethylamino)butanamide (<b>9a</b>)</h4><div class="NLM_p last">A solution of <b>8a</b> (15 mg, 0.04 mmol) and K<sub>2</sub>CO<sub>3</sub> (28 mg, 0.2 mmol) in diethylamine (0.5 mL) was stirred for 12 h at ambient temperature and diluted with EtOAc (10 mL). The organic layer was washed with saturated NH<sub>4</sub>Cl solution and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:6) afforded 6 mg (40%) of <b>9a</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.40–7.33 (m, 5H), 4.78 (s, 2H), 2.65–2.54 (m, 8H), 1.91–1.81 (m, 2H), 1.05 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 172.4, 161.4, 161.4, 152.3, 146.2, 136.2, 128.7, 128.7, 128.6, 128.1, 128.1, 75.4, 52.2, 46.4, 46.4, 36.1, 21.9, 19.2, 19.2, 10.8, 10.8. LRMS (FAB) <i>m</i>/<i>z</i> 371 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>21</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 371.2442; found 371.2435.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(Diethylamino)-<i>N</i>-(5-methoxy-4,6-dimethylpyrimidin-2-yl)butanamide (<b>9b</b>)</h4><div class="NLM_p last">Amide <b>9b</b> was prepared by the procedure for <b>9a</b>, using <b>8b</b> (35 mg, 0.12 mmol) instead of <b>8a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:4) afforded 13 mg (39%) of <b>9b</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.69 (s, 3H), 2.61–2.50 (m, 8H), 2.41 (s, 6H), 1.85–1.81 (m, 2H), 1.03 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 172.6, 160.9, 160.9, 152.2, 147.4, 60.4, 52.2, 46.3, 46.3, 36.1, 22.1, 18.7, 18.7, 11.0, 11.0. LRMS (FAB) <i>m</i>/<i>z</i> 295 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>15</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 295.2129; found 295.2135.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(Diethylamino)-<i>N</i>-(5-hydroxy-4,6-dimethylpyrimidin-2-yl)butanamide (<b>9c</b>)</h4><div class="NLM_p last">A suspension of <b>9a</b> (12 mg, 0.03 mmol) and 20% Pd(OH)<sub>2</sub> (3 mg) in MeOH (5 mL) was stirred for 3 h under H<sub>2</sub> at ambient temperature. The reaction mixture was filtered through a Celite pad and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:1) afforded 7.1 mg (79%) of <b>9c</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 3.02–2.90 (m, 6H), 2.50–2.45 (m, 2H), 2.38 (s, 6H), 2.00–1.93 (m. 2H), 1.21 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 172.9, 155.4, 155.4, 148.6, 145.5, 52.6, 46.4, 46.4, 36.5, 22.3, 18.8, 18.8, 10.7, 10.7. LRMS (FAB) <i>m</i>/<i>z</i> 281 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>14</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 281.1972; found 281.1978.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i><sup>1</sup>-(5-(Benzyloxy)-4,6-dimethylpyrimidin-2-yl)-<i>N</i><sup>4</sup>,<i>N</i><sup>4</sup>-diethylbutane-1,4-diamine (<b>10a</b>)</h4><div class="NLM_p last">To a solution of <b>9a</b> (13 mg, 0.04 mmol) in dry THF (2 mL) at 0 °C was added LiAlH<sub>4</sub> (13.3 mg, 0.35 mmol) portionwise. The mixture was stirred for 8 h at ambient temperature, cooled to 0 °C, and quenched by slow addition of Rochelle’s solution followed by EtOAc. The organic phase was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:1) afforded 5 mg (40%) of <b>10a</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42–7.31 (m, 5H), 4.89 (bs, 1H), 4.71 (s, 2H), 3.37–3.36 (m, 2H), 2.55–2.45 (m, 6H), 2.28 (s, 6H), 1.56–1.51 (m, 4H), 1.01 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 357 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 160.7, 160.7, 158.3, 142.4, 136.9, 128.6, 128.6, 128.3, 128.1, 128.1, 75.4, 52.7, 46.8, 46.8, 41.8, 28.0, 24.5, 19.1, 19.1, 11.7, 11.7. HRMS (FAB) calcd for C<sub>21</sub>H<sub>33</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 357.2649; found 357.2654.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-Diethyl-<i>N</i><sup>4</sup>-(5-methoxy-4,6-dimethylpyrimidin-2-yl)butane-1,4-diamine (<b>10b</b>)</h4><div class="NLM_p last">Diamine <b>10b</b> was prepared by the procedure for <b>10a</b>, using <b>9b</b> (17 mg, 0.06 mmol) instead of <b>9a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 2:1) afforded 7.2 mg (44%) of <b>10b</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 3.67 (s, 3H), 3.38–3.34 (m, 2H), 2.65–2.52 (m, 6H), 2.28 (s, 6H), 1.58–1.55 (m, 4H), 1.05 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 160.3, 160.3, 158.3, 143.7, 60.7, 52.7, 46.8, 46.8, 41.7, 28.0, 24.4, 18.7, 18.7, 11.6, 11.6. LRMS (FAB) <i>m</i>/<i>z</i> 281 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>15</sub>H<sub>29</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 281.2336; found 281.2341.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-((4-(Diethylamino)butyl)amino)-4,6-dimethylpyrimidin-5-ol (<b>10c</b>)</h4><div class="NLM_p last">Pyrimidol <b>10c</b> was prepared using the procedure for <b>9c</b>, using <b>10a</b> (7 mg, 0.02 mmol) instead of <b>9a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 3:1) afforded 4 mg (73%) of <b>10c</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.92–2.80 (m, 6H), 2.58–2.47 (m, 2H), 2.37 (s, 6H), 2.00–1.91 (m, 2H), 1.18 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 267 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 157.1, 155.2, 155.2, 139.1, 52.6, 46.7, 46.7, 41.8, 28.0, 24.2, 18.7, 18.7, 11.4, 11.4. HRMS (FAB) calcd for C<sub>14</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 267.2179; found 281.2185.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2,4-Dichloro-6-(1<i>H</i>-pyrrol-1-yl)pyrimidine (<b>14</b>)</h4><div class="NLM_p last">To a solution of 4-amino-2,6-dichoropyrimidine (500 mg, 3.05 mmol) in acetic acid (5 mL) was added 2,5-dimethoxy-tetrahydrofuran (0.47 mL, 3.66 mmol). The reaction mixture was refluxed for 3 h and then diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:40:5) afforded 540 mg (83%) of <b>14</b> as a white solid with a melting point of 78–80 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.73–7.71 (m, 1H), 7.62 (s, 2H), 6.39 (s, 2H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Chloro-4,6-bis(4-chlorophenyl)pyrimidine (<b>15</b>)</h4><div class="NLM_p last">To a solution of <b>11</b> (300 mg, 1.64 mmol) and 4-chlorophenylboronic acid (642 mg, 4.10 mmol) in THF (10 mL) was added Na<sub>2</sub>CO<sub>3</sub> (867 mg, 8.18 mmol) in H<sub>2</sub>O (10 mL) and Pd(PPh<sub>3</sub>)<sub>4</sub> (95 mg, 0.08 mmol). The reaction mixture was refluxed for 4 h and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:40:5) afforded 305 mg (55%) of <b>15</b> as a white solid with a melting point of 163–165 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (s, 1H), 8.38 (d, 4H, <i>J</i> = 8.6 Hz), 7.67 (d, 4H, <i>J</i> = 8.6 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 335 (M + H<sup>+</sup>).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Chloro-4-(4-chlorophenyl)-6-(piperidin-1-yl)pyrimidine (<b>16</b>)</h4><div class="NLM_p last">To a solution of <b>11</b> (250 mg, 1.36 mmol) and 4-chlorophenylboronic acid (220 mg, 1.47 mmol) in glyme (10 mL) was added Na<sub>2</sub>CO<sub>3</sub> (447 mg, 4.22 mmol) in H<sub>2</sub>O (10 mL) and Pd(PPh<sub>3</sub>)<sub>4</sub> (78 mg, 0.07 mmol). The reaction mixture was stirred at 70 °C for 24 h. The glyme was removed under reduced pressure, and the residue was diluted with EtOAc. The organic phase was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. To a solution of the resulting white solid in EtOH (20 mL) was added piperidine (0.15 mL, 1.47 mmol). The reaction mixture was stirred for 5 h at ambient temperature and concentrated under reduced pressure. The residue was diluted with EtOAc. The EtOAc solution was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:1) afforded 138 mg (33%) of <b>16</b> as a white solid with a melting point of 147–150 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.87 (d, 2H, <i>J</i> = 8.6 Hz), 7.40 (d, 2H, <i>J</i> = 8.6 Hz), 6.69 (s, 1H), 3.67 (bs, 4H), 1.75–1.60 (m, 6H). LRMS (FAB) <i>m</i>/<i>z</i> 308 (M + H<sup>+</sup>).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-(2-Chloro-6-(4-chlorophenyl)pyrimidin-4-yl)morpholine (<b>17</b>)</h4><div class="NLM_p last">Morpholine <b>17</b> was prepared from <b>11</b> (250 mg, 1.36 mmol) by the procedure for <b>16</b>, using morpholine instead of piperidine. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:6) afforded 165 mg (39%) of <b>17</b> as a white solid with a melting point of 197–200 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, 2H, <i>J</i> = 8.6 Hz), 7.41 (d, 2H, <i>J</i> = 8.4 Hz), 6.70 (s, 1H), 3.80–3.77 (m, 4H), 3.71–3.69 (m, 4H). LRMS (ESI) <i>m</i>/<i>z</i> 310 (M + H<sup>+</sup>).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Chloro-4-(4-chlorophenyl)-6-(4-methylpiperazin-1-yl)pyrimidine (<b>18</b>)</h4><div class="NLM_p last">Pyrimidine <b>18</b> was prepared from <b>11</b> (250 mg, 1.36 mmol) by the procedure for <b>16</b>, using 1-methyl piperazine instead of piperidine. Purification of the residue via flash column chromatography on silica gel (EtOAc/MeOH = 100:1) afforded 140 mg (32%) of <b>18</b> as yellow solid with a melting point of 120–122 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, 2H, <i>J</i> = 8.6 Hz), 7.41 (d, 2H, <i>J</i> = 8.6 Hz), 6.72 (s, 1H), 3.82 (bs, 4H), 2.61 (bs, 4H), 2.42 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 323 (M + H<sup>+</sup>).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Chloro-4-(4-chlorophenyl)-6-(1<i>H</i>-pyrrol-1-yl)pyrimidine (<b>19</b>)</h4><div class="NLM_p last">To a solution of <b>14</b> (50 mg, 0.23 mmol) and 4-chlorophenylboronic acid (43 mg, 0.28 mmol) in THF (5 mL) was added Na<sub>2</sub>CO<sub>3</sub> (86 mg, 0.55 mmol) in H<sub>2</sub>O (5 mL) and Pd(PPh<sub>3</sub>)<sub>4</sub> (13 mg, 0.011 mmol). The reaction mixture was refluxed for 10 h and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:40:1) afforded 38 mg (57%) of <b>19</b> as a white solid with a melting point of 136–142 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.01 (d, 2H, <i>J</i> = 8.6 Hz), 7.57 (t, 2H, <i>J</i> = 2.3 Hz), 7.48 (d, 2H, <i>J</i> = 8.4 Hz), 7.42 (s, 1H), 6.41 (t, 2H, <i>J</i> = 2.3 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 290 (M + H<sup>+</sup>).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Chloro-4-methyl-6-phenylpyrimidine (<b>20a</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (100 mg, 0.61 mmol) and phenylboronic acid (89 mg, 0.73 mmol) in THF (5 mL) was added Na<sub>2</sub>CO<sub>3</sub> (155 mg, 1.46 mmol) in H<sub>2</sub>O (5 mL) and Pd(PPh<sub>3</sub>)<sub>4</sub> (35 mg, 0.031 mmol). The reaction mixture was stirred refluxed for 4 h and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:1) afforded 126 mg (62%) of <b>20a</b> as a white solid with a melting point of 45–49 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.16–8.13 (m, 2H), 7.84 (s, 1H), 7.55–7.49 (m, 3H), 2.56 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 205 (M + H<sup>+</sup>).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Chloro-4-(4-chlorophenyl)-6-methylpyrimidine (<b>20b</b>)</h4><div class="NLM_p last">Pyrimidine <b>20b</b> was prepared from <b>12</b> (200 mg, 1.23 mmol) by the procedure for <b>20a</b>, using 4-chlorophenylboronic acid (211 mg, 1.35 mmol) instead of phenylboronic acid. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:1) afforded 210 mg (71%) of <b>20b</b> as a white solid with a melting point of 118–121 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.00 (d, 2H, <i>J</i> = 8.4 Hz), 7.47–7.44 (m, 3H), 2.58 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 239 (M + H<sup>+</sup>).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Chloro-4-(4-methoxyphenyl)-6-methylpyrimidine (<b>20c</b>)</h4><div class="NLM_p last">Pyrimidine <b>20c</b> was prepared from <b>12</b> (100 mg, 0.61 mmol) by the procedure for <b>20a</b>, using 4-methoxyphenylboronic acid (102 mg, 0.67 mmol) instead of phenylboronic acid. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:5:0.1) afforded 106 mg (73%) of <b>20c</b> as a white solid with a melting point of 66–68 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (d, 2H, <i>J</i> = 8.8 Hz), 7.41 (s, 1H), 6.98 (d, 2H, <i>J</i> = 8.8 Hz), 3.86 (s, 3H), 2.54 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 235 (M + H<sup>+</sup>).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(2-Chloro-6-methylpyrimidin-4-yl)phenol (<b>20d</b>)</h4><div class="NLM_p last">Phenol <b>20d</b> was prepared from <b>12</b> (1.0 g, 6.13 mmol) by the procedure for <b>20a</b>, using 4-hydroxyphenylboronic acid (930 mg, 6.75 mmol) instead of phenylboronic acid. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:3:0.1) afforded 825 mg (61%) of <b>20c</b> as a white solid with a melting point of 208–210 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.98 (d, 2H, <i>J</i> = 8.6 Hz) 7.40 (s, 1H), 6.91 (d, 2H, <i>J</i> = 8.6 Hz), 2.54 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 221 (M + H<sup>+</sup>).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Chloro-4-(4-(cyclohexyloxy)phenyl)-6-methylpyrimidine (<b>21a</b>)</h4><div class="NLM_p last">To a solution of <b>20d</b> (20 mg, 0.091 mmol) and triphenylphosphine (31 mg, 0.12 mmol) in THF (2 mL) was added cyclohexanol (12 mg, 0.12 mmol) and diisopropyl azodicarboxylate (24 μL, 0.12 mmol). The reaction mixture was stirred for 3 h at ambient temperature and quenched with H<sub>2</sub>O. The reaction mixture was diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:5) afforded 18 mg (60%) of <b>21a</b> as a white solid with a melting point of 94–99 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.99 (d, 2H, <i>J</i> = 8.3 Hz), 7.39 (s, 1H), 6.95 (d, 2H, <i>J</i> = 8.4 Hz), 4.36–4.30 (m, 1H), 2.53 (s, 3H), 2.10–1.89 (m, 2H), 1.80–1.75 (m, 2H), 1.58–1.28 (m, 6H). LRMS (FAB) <i>m</i>/<i>z</i> 303 (M + H<sup>+</sup>).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Chloro-4-(4-(2-cyclohexylethoxy)phenyl)-6-methylpyrimidine (<b>21b</b>)</h4><div class="NLM_p last">Pyrimidine <b>21b</b> was prepared from <b>20d</b> (45 mg, 0.20 mmol) by the procedure for <b>21a</b>, using 2-cyclohexylethanol (34 mg, 0.27 mmol) instead of cyclohexanol. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:5) afforded 52 mg (78%) of <b>21b</b> as a white solid with a melting point of 79–83 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.01 (d, 2H, <i>J</i> = 8.6 Hz), 7.39 (s, 1H), 6.95 (d, 2H, <i>J</i> = 8.6 Hz), 4.03 (t, 2H, <i>J</i> = 6.9 Hz), 2.52 (s, 3H), 1.74–1.65 (m, 6H), 1.51–1.40 (m, 1H), 1.26–1.19 (m, 4H), 1.01–0.93 (m, 2H). LRMS (FAB) <i>m</i>/<i>z</i> 331 (M + H<sup>+</sup>).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-Chloro-4-methyl-6-(4-phenethoxyphenyl)pyrimidine (<b>21c</b>)</h4><div class="NLM_p last">Pyrimidine <b>21c</b> was prepared from <b>20d</b> (30 mg, 0.14 mmol) by the procedure for <b>21a</b>, using phenethyl alcohol (20 mg, 0.16 mmol) instead of cyclohexanol. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:5) afforded 29 mg (64%) of <b>21c</b> as a white solid with a melting point of 96–99 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, 2H, <i>J</i> = 8.9 Hz), 7.94 (s, 1H), 7.35–7.30 (m, 4H), 7.24–7.23 (m, 1H), 7.10 (d, 2H, <i>J</i> = 8.9 Hz), 4.29 (t, 2H, <i>J</i> = 6.9 Hz), 3.01 (t, 2H, <i>J</i> = 6.9 Hz), 2.49 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 345 (M + H<sup>+</sup>).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-Chloro-4-(4-((4-chlorobenzyl)oxy)phenyl)-6-methylpyrimidine (<b>21d</b>)</h4><div class="NLM_p last">Pyrimidine <b>21d</b> was prepared from <b>20d</b> (30 mg, 0.14 mmol) by the procedure for <b>21a</b>, using 4-chlorobenzyl alcohol (23 mg, 0.16 mmol) instead of cyclohexanol. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:6:0.5) afforded 32 mg (66%) of <b>21d</b> as yellow solid with a melting point of 166–168 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.03 (d, 2H, <i>J</i> = 9.0 Hz), 7.41 (s, 1H), 7.46 (bs, 4H), 7.03 (d, 2H, <i>J</i> = 9.0 Hz), 5.09 (s, 2H), 2.54 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 345 (M + H<sup>+</sup>).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-Chloro-4-(4-(4-chlorophenethoxy)phenyl)-6-methylpyrimidine (<b>21e</b>)</h4><div class="NLM_p last">Pyrimidine <b>21e</b> was prepared from <b>20d</b> (30 mg, 0.14 mmol) by the procedure for <b>21a</b>, using 4-chlorophenylethanol (26 mg, 0.16 mmol) instead of cyclohexanol. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:6) afforded 32 mg (66%) of <b>21e</b> as a white solid with a melting point of 112–115 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.08 (d, 2H, <i>J</i> = 9.0 Hz), 7.72 (s, 1H), 7.29 (bs, 4H), 7.02 (d, 2H, <i>J</i> = 9.0 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 359 (M + H<sup>+</sup>).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-Chloro-4-(4-(4-chlorophenoxy)phenyl)-6-methylpyrimidine (<b>21f</b>)</h4><div class="NLM_p last">To a solution of <b>20d</b> (85 mg, 0.39 mmol), 4-chlorophenylboronic acid (180 mg, 1.15 mmol), and copper acetate (69 mg, 0.39 mmol) in the presence of 4 Ǻ molecular sieves in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added triethylamine (0.25 mL, 1.79 mmol). The reaction mixture was vigorously stirred at ambient temperature for 24 h and filtered through a Celite pad. The filtrate was concentrated <i>in vacuo</i> and diluted with EtOAc. The organic layer was washed with saturated NH<sub>4</sub>Cl solution and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:6:0.5) affording 32 mg (38%) of <b>20d</b> and 17 mg (13%) of <b>21f</b> as a white solid with a melting point of 129–132 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (d, 2H, <i>J</i> = 8.8 Hz), 7.43 (s, 1H), 7.34–7.31 (m, 2H), 7.04 (d, 2H, <i>J</i> = 8.8 Hz), 7.00–6.97 (m, 2H), 2.56 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 331 (M + H<sup>+</sup>).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-Chloro-4-cyclohexyl-6-methylpyrimidine (<b>22</b>)</h4><div class="NLM_p last">To a 0.5 M solution of cyclohexylzinc bromide in THF (3.0 mL, 1.50 mmol) was added 2,4-dichloro-6-methylpyrimidine <b>12</b> (245 mg, 1.50 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (87 mg, 0.075 mmol) at ambient temperature. The reaction mixture was stirred, refluxed for 3 h, and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:0.5) afforded 270 mg (85%) of <b>22</b> as a white solid with a melting point of 77–81 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 6.92 (s, 1H), 2.68–2.52 (m, 1H), 2.47 (s, 3H), 1.93–1.81 (m, 4H), 1.74–1.71 (m, 1H), 1.52–1.21 (m, 5H). LRMS (FAB) <i>m</i>/<i>z</i> 211 (M + H<sup>+</sup>).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Chloro-4-methyl-6-(piperidin-1-yl)pyrimidine (<b>23</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (100 mg, 0.74 mmol) in EtOH (7 mL) was added piperidine (0.11 mL, 1.10 mmol). The reaction mixture was stirred for 1 h at ambient temperature and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:7) afforded 93 mg (60%) of <b>23</b> as a white solid with a melting point of 67–72 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 6.20 (s, 1H), 3.58 (bs, 4H), 2.29 (s, 3H), 1.69–1.55 (m, 6H). LRMS (FAB) <i>m</i>/<i>z</i> 212 (M + H<sup>+</sup>).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Chloro-6-methyl-<i>N</i>-phenylpyrimidin-4-amine (<b>24</b>)</h4><div class="NLM_p last">Amine <b>24</b> was prepared from <b>12</b> (100 mg, 0.74 mmol) by the procedure for <b>23</b>, using aniline (0.1 mL, 1.10 mmol) instead of piperidine. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane = 1:4) afforded 50 mg (31%) of <b>24</b> as a white solid with a melting point of 117–120 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.54 (d, 2H, <i>J</i> = 8.3 Hz), 7.37–7.31 (m, 2H), 7.13–7.08 (m, 1H), 2.30 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 220 (M + H<sup>+</sup>).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(4-(Naphthalen-2-yloxy)phenyl)ethanone (<b>26</b>)</h4><div class="NLM_p last">To a solution of <b>25</b> (1.0 g, 7.24 mmol) and K<sub>2</sub>CO<sub>3</sub> (3.0 g, 21.72 mmol) in dry DMF (20 mL) at ambient temperature was added 2-naphthol (1.5 g, 10.86 mmol). The reaction mixture was stirred for 24 h at 120 °C and diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:0.5) afforded 1.7 g (91%) of <b>26</b> as a white solid with a melting point of 68–72 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.02–8.00 (m, 2H), 7.94–7.85 (m, 2H), 7.79–7.76 (m, 1H), 7.51–7.41 (m, 3H), 7.24 (dd, 1H, <i>J</i> = 8.8, 2.4 Hz), 2.56 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 263 (M + H<sup>+</sup>).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(4-(Naphthalen-2-yloxy)phenyl)butane-1,3-dione (<b>27</b>)</h4><div class="NLM_p last">To a solution of <b>26</b> (580 mg, 2.21 mmol), ethyl acetate (0.44 mL, 4.42 mmol), 18-crown-6 (6 mg, 0.023 mmol), and EtOH (1 drop) in THF (50 mL) was added 60% NaH in mineral oil (177 mg, 4.42 mmol) portionwise. The reaction mixture was refluxed for 4 h and concentrated under reduced pressure. The residue was diluted with EtOAc. The EtOAc solution was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:30:0.5) afforded 525 mg (78%) of <b>27</b> as yellow solid with a melting point of 102–105 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.00–7.86 (m, 4H), 7.78 (d, 1H, <i>J</i> = 7.3 Hz), 7.51–7.44 (m, 3H), 7.26 (dd, 1H <i>J</i> = 8.8, 2.4 Hz), 7.10–7.05 (m, 2H), 6.33 (s, 1H), 2.16 (s, 3H).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-Chloro-4-methyl-6-(4-(naphthalen-2-yloxy)phenyl)pyrimidine (<b>28</b>)</h4><div class="NLM_p last">To a solution of <b>27</b> (420 mg, 1.38 mmol) in EtOH (7 mL) was added urea (133 mg, 2.21 mmol) and <i>c</i>-HCl (0.14 mL, 1.66 mmol). The reaction mixture was stirred, refluxed for 40 h, and cooled to ambient temperature. Et<sub>2</sub>O (50 mL) was slowly added to reaction mixture. After filtration of the reaction mixture, the resulting white solid was used for next reaction without further purification. A suspension of the white solid in POCl<sub>3</sub> (5 mL) was stirred at reflux condition for 5 h and concentrated <i>in vacuo</i>. The residue was diluted with CH<sub>2</sub>Cl<sub>2</sub>, and saturated NaHCO<sub>3</sub> solution was added dropwise at 0 °C. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (EtOAc/<i>n</i>-hexane/CH<sub>2</sub>Cl<sub>2</sub> = 1:20:0.5) afforded 153 mg (32%) of <b>28</b> as a white solid with a melting point of 142–144 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.09–8.03 (m, 2H), 7.88–7.83 (m, 2H), 7.74–7.72 (m, 1H), 7.51–7.42 (m, 4H), 7.28–7.25 (m, 1H), 7.15–7.10 (m, 2H), 2.57 (s, 3H). LRMS (FAB) <i>m</i>/<i>z</i> 347 (M + H<sup>+</sup>).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>,<i>N</i>-Diethyl-2-(4-nitrophenoxy)ethanamine (<b>30a</b>)</h4><div class="NLM_p last">To a solution of 4-nitrophenol <b>29a</b> (200 mg, 1.44 mmol) and triphenylphosphine (490 mg, 1.87 mmol) in THF (10 mL) was added <i>N</i>,<i>N</i>-diethyl ethanolamine (0.25 mL, 1.87 mmol) and diisopropyl azodicarboxylate (0.37 mL, 1.87 mmol). The reaction mixture was stirred for 3 h at ambient temperature and quenched with H<sub>2</sub>O. The reaction mixture was diluted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:20) afforded 278 mg (81%) of <b>30a</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.16 (d, 2H, <i>J</i> = 9.3 Hz), 6.93 (d, 2H, <i>J</i> = 9.3 Hz), 4.11 (t, 2H, <i>J</i> = 6.0 Hz), 2.88 (t, 2H, <i>J</i> = 6.0 Hz), 2.63 (q, 4H, <i>J</i> = 7.1 Hz), 1.05 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 239 (M + H<sup>+</sup>).</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>,<i>N</i>-Diethyl-2-(3-nitrophenoxy)ethanamine (<b>30b</b>)</h4><div class="NLM_p last">Amine <b>30b</b> was prepared by the procedure for <b>30a</b> using <b>29b</b> (200 mg, 1.44 mmol) instead of <b>29a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:20) afforded 285 mg (83%) of <b>30b</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.81–7.78 (m, 1H), 7.72 (t, 1H, <i>J</i> = 2.3 Hz), 7.40 (t, 1H, <i>J</i> = 11.2 Hz), 7.23–7.20 (m, 1H), 4.12 (t, 2H, <i>J</i> = 5.9 Hz), 2.91 (t, 2H, <i>J</i> = 6.0 Hz), 2.65 (q, 4H, <i>J</i> = 7.1 Hz), 1.08 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 239 (M + H<sup>+</sup>).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>,<i>N</i>-Diethyl-2-(2-nitrophenoxy)ethanamine (<b>30c</b>)</h4><div class="NLM_p last">Amine <b>30c</b> was prepared by the procedure for <b>30a</b>, using <b>29c</b> (300 mg, 2.16 mmol) instead of <b>29a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:20) afforded 420 mg (82%) of <b>30c</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.80 (dd, 1H, <i>J</i> = 1.7, 8.0 Hz), 7.52–7.46 (m, 1H), 7.08–6.97 (m, 2H), 4.16 (t, 2H, <i>J</i> = 6.1 Hz), 2.92 (t, 2H, <i>J</i> = 6.1 Hz), 2.63 (t, 4H, <i>J</i> = 7.1 Hz), 1.05 (t, 6H, J = 7.1 Hz). LRMS (ESI) <i>m</i>/<i>z</i> 239 (M + H<sup>+</sup>).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(4-Bromophenoxy)-<i>N</i>,<i>N</i>-diethylethanamine (<b>30d</b>)</h4><div class="NLM_p last">Amine <b>30d</b> was prepared by the procedure for <b>30a</b>, using 4-bromophenol <b>30d</b> (890 mg, 5.14 mmol) instead of <b>30a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:20) afforded 1.22 g (87%) of <b>30d</b> as yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.36–7.32 (m, 2H), 6.78–6.73 (m, 2H), 3.98 (t, 2H, <i>J</i> = 6.3 Hz), 2.83 (t, 2H, <i>J</i> = 6.2 Hz), 2.60 (q, 4H, <i>J</i> = 7.1 Hz), 1.04 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 272 (M + H<sup>+</sup>).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(2-(Diethylamino)ethoxy)aniline (<b>31a</b>)</h4><div class="NLM_p last">To a solution of <b>30a</b> (100 mg, 0.42 mmol) in EtOH (5 mL) was added SnCl<sub>2</sub>·2H<sub>2</sub>O (473 mg, 2.10 mmol). The reaction mixture was stirred, refluxed for 3 h, and concentrated <i>in vacuo</i>. The residue was diluted with EtOAc and saturated NaHCO<sub>3</sub> solution was added. The mixture was filtered using a Celite pad. The organic phase was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:10) afforded 77 mg (88%) of <b>31a</b> as a brown oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 6.75–6.67 (m, 4H), 3.99 (t, 2H, <i>J</i> = 5.9 Hz), 2.84 (t, 2H, <i>J</i> = 5.8 Hz), 2.65 (q, 4H, <i>J</i> = 7.2 Hz), 1.07 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 209 (M + H<sup>+</sup>).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-(2-(Diethylamino)ethoxy)aniline (<b>31b</b>)</h4><div class="NLM_p last">Aniline <b>31b</b> was prepared by the procedure for <b>31a</b>, using <b>30b</b> (1.9 g, 7.70 mmol) instead of <b>30a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:10) afforded 1.3 g (81%) of <b>31b</b> as a brown oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.02 (t, 1H, <i>J</i> = 8.0 Hz), 6.31–6.22 (m, 3H), 4.02 (t, 2H, <i>J</i> = 6.2 Hz), 3.62 (bs, 2H), 2.89 (t, 2H, <i>J</i> = 6.2 Hz), 2.65 (q, 4H, <i>J</i> = 7.1 Hz), 1.07 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 209 (M + H<sup>+</sup>).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-(2-(Diethylamino)ethoxy)aniline (<b>31c</b>)</h4><div class="NLM_p last">Aniline <b>31c</b> was prepared by the procedure for <b>31a</b>, using <b>30c</b> (320 mg, 1.34 mmol) instead of <b>30a</b>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:10) afforded 244 mg (87%) of <b>31c</b> as a brown oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 6.80–6.75 (m, 2H), 6.71–6.67 (m, 2H), 4.06 (t, 2H, <i>J</i> = 6.0 Hz), 3.65 (bs, 2H), 2.89 (t, 2H, <i>J</i> = 6.1 Hz), 2.64 (q, 4H, <i>J</i> = 7.1 Hz), 1.06 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 209 (M + H<sup>+</sup>).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 5-(Benzyloxy)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-4,6-dimethylpyrimidin-2-amine (<b>32</b>)</h4><div class="NLM_p last">To a solution of <b>5a</b> (100 mg, 0.44 mmol), <b>30d</b> (119 mg, 0.44 mmol), and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (xantphos) (26 mg, 0.04 mmol) in toluene (10 mL) was added CsCO<sub>3</sub> (215 mg, 0.66 mmol) and Pd(OAc)<sub>2</sub> (5 mg, 0.02 mmol). The reaction mixture was stirred refluxed for 24 h and quenched with H<sub>2</sub>O. The reaction mixture was diluted with EtOAc. The mixture was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:15) afforded 40 mg (22%) of <b>32</b> as colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.56–7.51 (m, 2H), 7.45–7.36 (m, 5H), 6.90–6.85 (m, 2H), 4.82 (s, 2H), 4.11 (t, 2H, <i>J</i> = 5.5 Hz), 3.00 (t, 2H, <i>J</i> = 5.5 Hz), 2.78 (q, 4H, <i>J</i> = 7.1 Hz), 2.29 (s, 6H), 1.14 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 160.9, 160.9, 155.6, 146.7, 144.6, 143.5, 136.7, 128.7, 128.7, 128.4, 128.2, 128.2, 120.3, 120.3, 114.9, 114.9, 75.5, 66.9, 51.8, 47.8, 47.8, 19.1, 19.1, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 421 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 421.2598; found 421.2604.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-((4-(2-(Diethylamino)ethoxy)phenyl)amino)-4,6-dimethylpyrimidin-5-ol (<b>33</b>)</h4><div class="NLM_p last">A suspension of <b>32</b> (20 mg, 0.05 mmol) and 20% Pd(OH)<sub>2</sub> (2 mg) in MeOH (5 mL) was stirred under H<sub>2</sub> for 10 h at ambient temperature. The reaction mixture was filtered through a Celite pad and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 7:1) afforded 13 mg (83%) of <b>33</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.53–7.48 (m, 2H), 6.89–6.85 (m, 2H), 4.12 (t, 2H, <i>J</i> = 5.5 Hz), 3.07 (t, 2H, <i>J</i> = 5.5 Hz), 2.84 (q, 4H, <i>J</i> = 7.3 Hz), 2.32 (s, 6H), 1.16 (t, 6H, <i>J</i> = 7.2 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 331 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 170.9, 154.7, 154.7, 153.9, 140.4, 134.2, 119.8, 119.8, 114.8, 114.8, 65.9, 51.5, 47.4, 47.4, 18.8, 18.8, 10.8, 10.8. HRMS (FAB) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 331.2129; found 331.2134.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> General Synthetic Procedure for the <i>N</i>-Aryl Pyrimidine Analogs</h4><div class="NLM_p">To a solution of 2-chloropyrimidine intermediates (1 equiv) and aniline (1 equiv) in <i>n</i>-BuOH (1 mL) was added catalytic amount of 4 N hydrogen chloride in dioxane. The reaction mixture was stirred for 1 h at 160 °C under microwave irradiation and concentrated <i>in vacuo</i>. The residue was diluted with EtOAc and saturated NaHCO<sub>3</sub> solution. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. Purification of the residue via flash column chromatography on silica gel (MeOH/CH<sub>2</sub>Cl<sub>2</sub> = 1:10–1:20) afforded the corresponding <i>N</i>-aryl pyrimidine analog.</div><div id="sec5_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4,6-dimethylpyrimidin-2-amine (<b>34</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>13</b> (20 mg, 0.14 mmol) afforded 18 mg of amine <b>34</b> (41%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.55–7.52 (m, 2H), 6.89–6.86 (m, 2H), 6.52 (s, 1H), 4.07 (t, 2H, <i>J</i> = 5.8 Hz), 2.92 (t, 2H, <i>J</i> = 5.7 Hz), 2.70 (q, 4H, <i>J</i> = 7.3 Hz), 2.30 (s, 6H), 1.10 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 315 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 167.5, 167.5, 160.0, 154.2, 133.2, 120.7, 220.6, 114.9, 114.9, 111.2, 66.7, 51.8, 47.8, 47.8, 23.9, 23.9, 11.7, 11.7. HRMS (FAB) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 315.2179; found 315.2184.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>N</i>-(3-(2-(Diethylamino)ethoxy)phenyl)-4,6-dimethylpyrimidin-2-amine (<b>35</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>13</b> (20 mg, 0.14 mmol) afforded 18 mg of amine <b>35</b> (41%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.56–7.55 (m, 1H), 7.18–7.14 (m, 2H), 6.57–6.53 (m, 2H), 4.11 (t, 2H, <i>J</i> = 5.7 Hz), 2.98 (t, 2H, <i>J</i> = 5.7 Hz), 2.74 (q, 4H, <i>J</i> = 7.1 Hz), 2.33 (s, 6H), 1.11 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 167.5, 167.5, 159.7, 159.3, 141.2, 129.5, 111.7, 111.3, 108.0, 105.3, 65.9, 51.6, 47.7, 47.7, 23.9, 23.9, 11.5, 11.5. LRMS (FAB) <i>m</i>/<i>z</i> 315 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 315.2179; found 315.2184.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 4-Cyclohexyl-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>36</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>22</b> (30 mg, 0.14 mmol) afforded 27 mg of amine <b>36</b> (51%) as a brown oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.54 (d, 2H, <i>J</i> = 8.9 Hz), 6.89 (s, 1H), 6.85 (d, 2H, <i>J</i> = 8.9 Hz), 6.41 (s, 1H), 4.05 (t, 2H, <i>J</i> = 6.2 Hz), 2.89 (t, 2H, <i>J</i> = 6.2 Hz), 2.66 (q, 4H, <i>J</i> = 7.0 Hz), 2.46 (td, 1H, <i>J</i> = 11.6, 3.3 Hz), 2.33 (s, 3H), 1.90 (d, 2H, <i>J</i> = 11.7 Hz), 1.84–1.81 (m, 2H), 1.72 (d, 1H, <i>J</i> = 12.7 Hz), 1.51–1.20 (m, 5H), 1.08 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 175.4, 167.5, 159.8, 153.9, 133.6, 120.3, 120.3, 114.8, 114.8, 108.9, 66.4, 51.6, 47.7, 47.7, 45.9, 32.0, 32.0, 26.3, 26.3, 26.0, 24.1, 11.5, 11.5. LRMS (FAB) <i>m</i>/<i>z</i> 383 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>35</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 383.2805; found 383.2811.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4-methyl-6-(piperidin-1-yl)pyrimidin-2-amine (<b>37</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>23</b> (25 mg, 0.12 mmol) afforded 14 mg of amine <b>37</b> (30%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.43 (m, 2H), 6.85–6.80 (m, 2H), 5.84 (s, 1H), 4.03 (t, 2H, <i>J</i> = 6.4 Hz), 3.58–3.54 (m, 4H), 2.86 (t, 2H, <i>J</i> = 6.2 Hz), 2.64 (q, 4H, <i>J</i> = 7.1 Hz), 2.23 (s, 3H), 1.66–1.58 (m, 6H), 1.06 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 187.3, 181.8, 180.1, 162.6, 137.4, 121.1, 121.1, 114.6, 114.6, 93.0, 66.5, 51.7, 47.7, 47.7, 45.5, 45.5, 29.7, 25.6, 25.6, 24.7, 11.6, 11.6. LRMS (FAB) <i>m</i>/<i>z</i> 384 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>22</sub>H<sub>34</sub>N<sub>5</sub>O (M + H<sup>+</sup>): 384.2758; found 384.2763.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> <i>N</i><sup>2</sup>-(4-(2-(Diethylamino)ethoxy)phenyl)-6-methyl-<i>N</i><sup>4</sup>-phenylpyrimidine-2,4-diamine (<b>38</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>24</b> (20 mg, 0.091 mmol) afforded 14 mg (39%) of diamine <b>38</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.57–7.48 (m, 4H), 7.27–7.22 (m, 2H), 7.01–6.97 (m, 1H), 6.91–6.87 (m, 2H), 6.03 (s, 1H), 4.15 (t, 2H, <i>J</i> = 5.5 Hz), 3.11 (t, 2H, <i>J</i> = 5.4 Hz), 2.87 (q, 4H, <i>J</i> = 7.3 Hz), 2.21 (s, 3H), 1.18 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 166.9, 161.6, 160.1, 154.4, 138.7, 133.0, 129.1, 129.1, 124.0, 122.1, 122.1, 121.6, 121.6, 114.6, 114.6, 94.7, 66.7, 51.7, 47.7, 47.7, 24.0, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 392 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O (M + H<sup>+</sup>): 392.2445; found 392.2456.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4-methyl-6-phenylpyrimidin-2-amine (<b>39</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>20a</b> (25 mg, 0.12 mmol) afforded 13 mg (29%) of amine <b>39</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.11–8.08 (m, 2H), 7.67–7.63 (m, 2H), 7.48–7.46 (m, 3H), 7.14 (s, 1H), 6.93–6.90 (m, 2H), 4.11 (t, 2H, <i>J</i> = 5.6 Hz), 2.98 (t, 2H, <i>J</i> = 5.6 Hz), 2.76 (q, 4H, <i>J</i> = 7.1 Hz), 2.42 (s, 3H), 1.13 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 186.5, 164.6, 160.3, 154.3, 137.4, 133.1, 130.4, 128.7, 128.7, 127.0, 127.0, 120.9, 120.9, 114.8, 114.8, 107.5, 66.8, 51.7, 47.7, 47.7, 24.3, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 377 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 377.2336; found 377.2338.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4-(4-methoxyphenyl)-6-methylpyrimidin-2-amine (<b>40</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>20c</b> (20 mg, 0.09 mmol) afforded 12 mg (35%) of amine <b>40</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.08–8.03 (m, 2H), 7.66–7.60 (m, 2H), 7.07 (s, 1H), 7.03–6.98 (m, 2H), 6.94–6.88 (m, 2H), 4.09 (t, 2H, <i>J</i> = 5.7 Hz), 3.84 (s, 3H), 2.95 (t, 2H, <i>J</i> = 5.7 Hz), 2.73 (q, 4H, <i>J</i> = 7.2 Hz), 2.39 (s, 3H), 1.12 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) δ 170.1, 166.3, 163.9, 162.4, 156.0, 135.9, 131.5, 130.2, 130.2, 122.9, 122.9, 116.2, 116.2, 115.6, 115.6, 107.7, 67.4, 56.4, 53.2, 49.1, 49.1, 24.6, 11.7, 11.7. LRMS (FAB) <i>m</i>/<i>z</i> 407 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 407.2442; found 407.2459.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> <i>N</i>-(3-(2-(Diethylamino)ethoxy)phenyl)-4-(4-methoxyphenyl)-6-methylpyrimidin-2-amine (<b>41</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>20c</b> (20 mg, 0.09 mmol) afforded 12 mg (35%) of amine <b>41</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.11–8.06 (m, 2H), 7.71–7.70 (m, 1H), 7.21–7.18 (m, 2H), 7.12 (s, 1H), 7.03–6.98 (m, 2H), 6.58–6.54 (m, 1H), 4.14 (t, 2H, <i>J</i> = 5.6 Hz), 3.85 (s, 3H), 3.00 (t, 2H, <i>J</i> = 5.6 Hz), 2.75 (q, 4H, <i>J</i> = 7.1 Hz), 2.42 (s, 3H), 1.12 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) 168.1, 164.1, 161.7, 159.9, 159.4, 141.3, 129.7, 129.4, 128.6, 128.6, 114.1, 114.1, 111.2, 108.2, 107.2, 105.1, 66.4, 55.3, 51.6, 47.8, 47.8, 24.3, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 407 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 407.2442; found 407.2447.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 4-(4-Chlorophenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>42</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>20b</b> (15 mg, 0.06 mmol) afforded 8 mg (31%) of amine <b>42</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.10–8.07 (m, 2H), 7.64–7.61 (m, 2H), 7.49–7.46 (m, 2H), 7.13 (s, 1H), 6.93–6.90 (m, 2H), 4.11 (t, 2H, <i>J</i> = 5.7 Hz), 2.97 (t, 2H, <i>J</i> = 5.7 Hz), 2.74 (q, 4H, <i>J</i> = 7.1 Hz), 2.42 (s, 3H), 1.13 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.8, 163.4, 160.4, 154.6, 136.6, 135.9, 133.0, 129.0, 129.0, 128.4, 128.4, 121.0, 121.0, 114.9, 114.9, 107.3, 66.9, 51.9, 47.8, 47.8, 24.3, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 411 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>): 411.1946; found 411.1952.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 4-(4-Chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>43</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>20b</b> (15 mg, 0.06 mmol) afforded 9 mg (35%) of amine <b>43</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.13–8.10 (m, 2H), 7.68 (m, 1H), 7.50–7.47 (m, 2H), 7.19–7.18 (m, 3H), 6.56–6.55 (m, 1H), 4.12 (t, 2H, <i>J</i> = 5.7 Hz), 2.96 (t, 2H, <i>J</i> = 5.7 Hz), 2.71 (q, 4H, <i>J</i> = 7.2 Hz), 2.45 (s, 3H), 1.11 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.8, 163.4, 160.0, 151.9, 141.0, 141.0, 135.8, 129.5, 129.0, 129.0, 128.4, 128.4, 111.2, 108.5, 107.8, 105.3, 66.5, 51.7, 47.8, 47.8, 24.4, 11.9, 11.9. LRMS (FAB) <i>m</i>/<i>z</i> 411 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>): 411.1946; found 411.1953.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 4-(4-Chlorophenyl)-<i>N</i>-(2-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>44</b>)</h5><div class="NLM_p last"><b>20b</b> (15 mg, 0.06 mmol) afforded 9 mg (35%) of amine <b>44</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.50–8.47 (m, 1H), 8.10 (d, 2H, <i>J</i> = 8.6 Hz), 7.49 (d, 2H, <i>J</i> = 8.8 Hz), 7.21 (s, 1H), 7.05–6.95 (m, 3H), 4.22 (t, 2H, <i>J</i> = 5.6 Hz), 3.06 (t, 2H, <i>J</i> = 5.6 Hz), 2.78 (q, 4H, <i>J</i> = 7.2 Hz), 2.45 (s, 3H), 1.15 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) 168.7, 163.4, 163.3, 154.6, 140.1, 136.5, 139.5, 128.9, 128.9, 128.4, 128.4, 121.4, 121.3, 118.7, 112.2, 107.5, 67.9, 51.7, 47.8, 47.8, 24.4, 11.7, 11.7. LRMS (FAB) <i>m</i>/<i>z</i> 411 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>): 411.1946; found 411.1957.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 4-(4-(4-Chlorophenoxy)phenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>45</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21f</b> (10 mg, 0.03 mmol) afforded 6 mg (41%) of amine <b>45</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.12–8.09 (m, 2H), 7.64–7.59 (m, 2H), 7.39–7.34 (m, 2H), 7.09 (s, 1H), 7.06–7.00 (m, 4H), 6.91–6.88 (m, 2H), 4.07 (t, 2H, <i>J</i> = 5.7 Hz), 2.93 (t, 2H, <i>J</i> = 5.7 Hz), 2.70 (q, 4H, <i>J</i> = 7.2 Hz), 2.40 (s, 3H), 1.10 (t, 6H, <i>J</i> = 7.2 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 503 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) δ 170.7, 166.0, 162.7, 161.6, 157.5, 156.3, 136.0, 133.7, 131.8, 131.8, 130.9, 130.9, 130.9, 123.2, 123.2, 122.7, 122.7, 120.2, 120.2, 116.5, 116.5, 108.3, 67.8, 53.5, 49.4, 49.4, 24.9, 12.1, 12.1. HRMS (FAB) calcd for C<sub>29</sub>H<sub>32</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 503.2208; found 503.2214.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 4-(4-((4-Chlorobenzyl)oxy)phenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>46</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21d</b> (10 mg, 0.03 mmol) afforded 6 mg (40%) of amine <b>46</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.05 (d, 2H, <i>J</i> = 9.0 Hz), 7.62 (d, 2H, <i>J</i> = 9.2 Hz), 7.44–7.35 (m, 4H), 7.07–7.04 (m, 3H), 6.90 (d, 2H, <i>J</i> = 9.2 Hz), 5.10 (s, 2H), 4.08 (t, 2H, <i>J</i> = 5.7 Hz), 2.93 (t, 2H, <i>J</i> = 5.7 Hz), 2.71 (q, 4H, <i>J</i> = 7.1 Hz), 2.39 (s, 3H), 1.11 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 125 MHz) δ 170.5, 166.5, 163.0, 162.7, 156.3, 138.1, 136.3, 135.6, 132.2, 131.0, 131.0, 130.6, 130.6, 130.5, 130.5, 123.2, 123.2, 116.8, 116.8, 116.5, 116.5, 108.1, 71.1, 67.1, 53.5, 49.5, 49.5, 24.9, 12.0, 12.0. LRMS (FAB) <i>m</i>/<i>z</i> 517 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>30</sub>H<sub>34</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 517.2365; found 517.2370.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 4-(4-(4-Chlorophenethoxy)phenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>47</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21e</b> (20 mg, 0.06 mmol) afforded 16 mg (54%) of amine <b>47</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.02 (d, 2H, <i>J</i> = 9.0 Hz), 7.63 (d, 2H, <i>J</i> = 9.2 Hz), 7.28 (bs, 4H), 7.04 (s, 1H), 6.96 (d, 2H, <i>J</i> = 9.0 Hz), 6.90 (d, 2H, <i>J</i> = 9.0 Hz), 4.21 (t, 2H, <i>J</i> = 6.7 Hz), 4.08 (t, 2H, <i>J</i> = 5.7 Hz), 4.05 (t, 2H, <i>J</i> = 6.6 Hz), 2.95 (t, 2H, <i>J</i> = 5.7 Hz), 2.73 (q, 4H, <i>J</i> = 7.2 Hz), 2.38 (s, 3H), 1.11 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) δ 170.4, 166.5, 163.2, 162.6, 156.2, 139.5, 136.2, 134.1, 132.5, 132.5, 131.9, 130.6, 130.6, 130.3, 130.3, 123.2, 123.2, 116.5, 116.5, 116.5, 116.5, 108.0, 70.4, 67.6, 53.5, 49.4, 49.4, 36.7, 24.9, 12.0, 12.0. LRMS (FAB) <i>m</i>/<i>z</i> 531 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>31</sub>H<sub>36</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 531.2521; found 531.2527.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4-methyl-6-(4-phenethoxyphenyl)pyrimidin-2-amine (<b>48</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21c</b> (27 mg, 0.08 mmol) afforded 15 mg (36%) of amine <b>48</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.95–7.92 (m, 2H), 7.56–7.53 (m, 2H), 7.21–7.16 (m, 4H), 7.15–7.07 (m, 1H), 6.96 (s, 1H), 6.89–6.85 (m, 2H), 6.83–6.80 (m, 2H), 4.13 (t, 2H, <i>J</i> = 6.9 Hz), 4.00 (t, 2H, <i>J</i> = 5.6 Hz), 2.98 (t, 2H, <i>J</i> = 6.8 Hz), 2.87 (t, 2H, <i>J</i> = 5.6 Hz), 2.65 (q, 4H, <i>J</i> = 7.1 Hz), 1.03 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 125 MHz) δ 170.3, 166.5, 163.3, 162.6, 156.2, 140.5, 136.2, 131.8, 130.9, 130.9, 130.5, 130.5, 130.3, 130.3, 128.3, 123.2, 123.2, 116.5, 116.5, 116.5, 116.5, 108.0, 70.8, 67.6, 53.5, 49.5, 49.5, 37.5, 24.9, 12.0, 12.0. LRMS (FAB) <i>m</i>/<i>z</i> 497 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>31</sub>H<sub>37</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 497.2911; found 497.2906.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> <i>N</i>-(4-(2-(Diethylamino)ethoxy)phenyl)-4-methyl-6-(4-(naphthalen-2-yloxy)phenyl)pyrimidin-2-amine (<b>49</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>28</b> (20 mg, 0.06 mmol) afforded 16 mg (53%) of amine <b>53</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.11 (d, 2H, <i>J</i> = 8.8 Hz), 7.91–7.84 (m, 2H), 7.75–7.72 (m, 1H), 7.64 (d, 2H, <i>J</i> = 9.0 Hz), 7.46–7.40 (m, 3H), 7.25 (dd, 1H, <i>J</i> = 2.5, 8.9 Hz), 7.10–7.08 (m, 3H), 6.92 (d, 2H, <i>J</i> = 9.2 Hz), 4.12 (t, 2H, <i>J</i> = 5.5 Hz), 3.07 (t, 2H, <i>J</i> = 5.4 Hz), 2.84 (q, 4H, <i>J</i> = 7.2 Hz), 1.15 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.3, 168.3, 164.0, 160.2, 159.6, 154.2, 134.3, 133.2, 132.3, 130.5, 130.0, 128.8, 128.8, 127.8, 127.2, 126.7, 125.0, 120.9, 120.9, 120.2, 118.6, 118.6, 115.1, 114.8, 114.8, 107.0, 66.3, 51.4, 47.5, 47.5, 24.1, 11.4, 11.4. LRMS (FAB) <i>m</i>/<i>z</i> 519 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>33</sub>H<sub>35</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 519.2755; found 519.2776.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 4-(4-(Cyclohexyloxy)phenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>50</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21a (</b>20 mg, 0.07 mmol) afforded 11 mg (33%) of amine <b>50</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.03 (d, 2H, <i>J</i> = 9.0 Hz), 7.64 (d, 2H, <i>J</i> = 9.2 Hz), 7.07 (s, 1H), 6.97 (d, 2H, <i>J</i> = 8.8 Hz), 6.92 (d, 2H, <i>J</i> = 9.2 Hz), 4.41–4.36 (m, 1H), 4.11 (t, 2H, <i>J</i> = 5.6 Hz), 3.01 (t, 2H, <i>J</i> = 5.6 Hz), 2.79 (q, 4H, <i>J</i> = 7.2 Hz), 2.39 (s, 3H), 2.05–1.95 (m, 2H), 1.85–1.75 (m, 2H), 1.61–1.27 (m, 6H), 1.14 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.0, 164.3, 160.2, 160.0, 159.5, 133.4, 129.4, 128.5, 128.5, 120.8, 120.8, 115.8, 115.8, 114.8, 114.8, 106.7, 75.4, 64.0, 51.7, 47.7, 47.7, 31.7, 31.7, 25.6, 23.7, 22.7, 22.7, 11.7, 11.7. LRMS (FAB) <i>m</i>/<i>z</i> 475 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>29</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 475.3068; found 475.3066.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 4-(4-(Cyclohexyloxy)phenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>51</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21a (</b>20 mg, 0.07 mmol) afforded 14 mg (45%) of amine <b>51</b> as a colorless oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.07–8.02 (m, 2H), 7.73–7.72 (m, 1H), 7.19–7.17 (m, 2H), 7.09 (s, 1H), 6.08–6.94 (m, 2H), 6.58–6.52 (m, 1H), 4.39–4.33 (m, 1H), 4.12 (t, 2H, <i>J</i> = 5.6 Hz), 2.97 (t, 2H, <i>J</i> = 5.5 Hz), 2.73 (q, 4H, <i>J</i> = 7.2 Hz), 2.34 (s, 3H), 2.00–1.95 (m, 2H), 1.80–1.77 (m, 2H), 1.60–1.31 (m, 6H), 1.10 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.1, 164.3, 160.1, 160.0, 159.5, 141.4, 129.5, 128.6, 128.6, 128.6, 115.9, 115.9, 111.3, 108,3, 107.2, 105.2, 75.4, 66.4, 51.7, 47.8, 47.8, 31.7, 31.7, 25.6, 24.3, 23.7, 23.7, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 475 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>29</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 475.3068; found 475.3073.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 4-(4-(2-Cyclohexylethoxy)phenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>52</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21b</b> (20 mg, 0.06 mmol) afforded 17 mg (55%) of amine <b>52</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.05 (d, 2H, <i>J</i> = 8.8 Hz), 7.62 (d, 2H, <i>J</i> = 9.2 Hz), 7.08 (s, 1H), 6.99 (d, 2H, <i>J</i> = 9.0 Hz), 6.91 (d, 2H, <i>J</i> = 9.2 Hz), 4.13–4.04 (m, 4H), 2.91 (t, 2H, <i>J</i> = 5.7 Hz), 2.69 (q, 4H, <i>J</i> = 7.1 Hz), 2.40 (s, 3H), 1.76–1.65 (m, 7H), 1.28–1.21 (m, 4H), 1.10 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 168.0, 164.2, 161.3, 160.2, 154.2, 133.3, 129.6, 128.5, 128.5, 120.8, 120.8, 114.8, 114.8, 114.6, 114.6, 106.7, 66.6, 66.1, 51.7, 47.7, 47.7, 36.5, 34.5, 33.3, 33.3, 26.5, 26.2, 26.2, 24.3, 11.7, 11.7. LRMS (FAB) <i>m</i>/<i>z</i> 503 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>31</sub>H<sub>43</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 503.3381; found 503.3371.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 4-(4-(2-Cyclohexylethoxy)phenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-methylpyrimidin-2-amine (<b>53</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>21b</b> (10 mg, 0.03 mmol) afforded 9 mg (58%) of amine <b>53</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.07 (d, 2H, <i>J</i> = 8.8 Hz), 7.74 (s, 1H), 7.20–7.17 (m, 2H), 7.11 (s, 1H), 6.98 (d, 2H, <i>J</i> = 8.8 Hz), 6.57–6.55 (m, 1H), 4.14 (t, 2H, <i>J</i> = 5.6 Hz), 4.05 (t, 2H, <i>J</i> = 6.5 Hz), 2.99 (t, 2H, <i>J</i> = 5.6 Hz), 2.74 (q, 4H, <i>J</i> = 7.2 Hz), 2.41 (s, 3H), 1.80–1.48 (m, 7H), 1.34–1.21 (m, 4H), 1.11 (t, 6H, <i>J</i> = 7.2 Hz), 1.05–0.93 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 168.1, 164.4, 161.4, 159.8, 159.8, 141.5, 129.7, 129.4, 128.6, 128.6, 114.7, 114.7, 107.7, 107.4, 105.2, 105.2, 66.2, 66.2, 50.6, 47.4, 47.4, 36.6, 34.6, 33.3, 33.3, 26.5, 26.2, 26.2, 24.3, 14.1, 14.1. LRMS (FAB) <i>m</i>/<i>z</i> 503 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>31</sub>H<sub>43</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>): 503.3381; found 503.3392.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 4-(4-Chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-(piperidin-1-yl)pyrimidin-2-amine (<b>54</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>16</b> (20 mg, 0.07 mmol) afforded 18 mg (58%) of amine <b>54</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.84 (d, 2H, <i>J</i> = 8.4 Hz), 7.49 (s, 1H), 7.34 (d, 2H, <i>J</i> = 8.4 Hz), 7.11 (t, 1H, <i>J</i> = 8.0 Hz), 6.98–6.92 (m, 2H), 6.47 (dd, 1H, <i>J</i> = 2.2, 8.1 Hz), 6.35 (s, 1H), 4.05 (t, 2H, <i>J</i> = 6.0 Hz), 3.64–3.61 (m, 4H), 2.89 (t, 2H, <i>J</i> = 6.0 Hz), 2.64 (q, 4H, <i>J</i> = 7.1 Hz), 1.62–1.58 (m, 6H), 1.04 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 163.2, 162.9, 159.8, 159.3, 141.7, 137.3, 135.6, 129.3, 128.7, 128.7, 128.2, 128.2, 111.2, 107.9, 105.0, 91.1, 66.1, 51.6, 47.7, 47.7, 45.5, 45.5, 25.6, 25.6, 24.7, 11.7, 11.7. LRMS (FAB) <i>m</i>/<i>z</i> 480 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>27</sub>H<sub>35</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>): 480.2525; found 480.2530.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 4-(4-Chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-morpholinopyrimidin-2-amine (<b>55</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>17</b> (20 mg, 0.07 mmol) afforded 11 mg (34%) of amine <b>55</b> as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.90 (d, 2H, <i>J</i> = 8.6 Hz), 7.48 (s, 1H), 7.41 (d, 2H, <i>J</i> = 8.4 Hz), 7.17 (t, 1H, <i>J</i> = 8.1 Hz), 7.05–6.99 (m, 2H), 6.55 (d, 1H, <i>J</i> = 8.1 Hz), 6.38 (s, 1H), 4.06 (t, 2H, <i>J</i> = 6.1 Hz), 3.81–3.78 (m, 4H), 3.69–3.67 (m, 4H), 2.89 (t, 2H, <i>J</i> = 6.0 Hz), 2.65 (q, 4H, <i>J</i> = 7.1 Hz), 1.07 (t, 6H, <i>J</i> = 7.1 Hz). LRMS (FAB) <i>m</i>/<i>z</i> 482 (M + H<sup>+</sup>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 163.9, 163.5, 159.1, 159.4, 141.4, 137.0, 135.9, 129.4, 128.8, 128.8, 128.2, 128.2, 111.3, 108.1, 105.3, 90.9, 66.6, 66.6, 66.5, 51.7, 47.8, 47.8, 44.6, 44.6, 11.9. HRMS (FAB) calcd for C<sub>26</sub>H<sub>33</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H<sup>+</sup>): 482.2317; found 482.2323.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> 4-(4-Chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine (<b>56</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>18</b> (21 mg, 0.07 mmol) afforded 12 mg (37%) of amine <b>56</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.01 (d, 2H, <i>J</i> = 8.6 Hz), 7.61 (s, 1H), 7.42 (d, 2H, <i>J</i> = 8.6 Hz). 7.17–7.09 (m, 2H), 6.61 (s, 1H), 6.53–6.50 (m, 1H), 4.08 (t, 2H, <i>J</i> = 5.6 Hz), 3.75–3.74 (m, 4H), 2.93 (t, 2H, <i>J</i> = 5.5 Hz). 2.69 (q, 4H, <i>J</i> = 7.2 Hz), 2.53–2.50 (m, 4H), 2.32 (s, 3H), 1.10 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 163.5, 163.3, 159.7, 159.4, 141.5, 137.1, 135.8, 129.4, 128.7, 128.7, 128.2, 128.2, 111.2, 108.0, 105.1, 91.0, 66.4, 54.7, 54.7, 51.6, 47.8, 47.8, 46.2, 44.1, 29.7, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 495 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>27</sub>H<sub>36</sub>ClN<sub>6</sub>O (M + H<sup>+</sup>): 495.2634; found 495.2639.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> 4-(4-Chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)-6-(1H-pyrrol-1-yl)pyrimidin-2-amine (<b>57</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>19</b> (25 mg, 0.09 mmol) afforded 14 mg (35%) of amine <b>57</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.14 (d, 2H, <i>J</i> = 8.6 Hz), 7.71–7.70 (m, 2H), 7.66 (s, 1H), 7.46 (d, 2H, <i>J</i> = 8.6 Hz), 7.32 (s, 1H), 7.19–7.17 (m, 2H), 6.58–6.55 (m, 1H), 6.33–6.32 (m, 2H), 4.11 (t, 2H, <i>J</i> = 5.6 Hz), 2.96 (t, 2H, <i>J</i> = 5.6 Hz), 2.72 (q, 4H, <i>J</i> = 7.1 Hz), 1.11 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz) δ 165.7, 159.9, 159.5, 158.4, 140.6, 137.0, 135.7, 129.6, 129.1, 129.1, 128.4, 128.4, 118.2, 118.2, 112.5, 112.5, 111.6, 108.9, 105.7, 94.7, 66.5, 51.6, 47.8, 47.8, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 462 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>26</sub>H<sub>29</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>): 462.2055; found 462.2061.</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 4,6-Bis(4-chlorophenyl)-<i>N</i>-(4-(2-(diethylamino)ethoxy)phenyl)pyrimidin-2-amine (<b>58</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>15</b> (20 mg, 0.06 mmol) afforded 9 mg (30%) of amine <b>58</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.23 (d, 4H, <i>J</i> = 8.8 Hz), 7.74 (s, 1H), 7.71 (d, 2H, <i>J</i> = 9.2 Hz), 7.53 (d, 4H, <i>J</i> = 8.8 Hz), 6.97 (d, 2H, <i>J</i> = 9.0 Hz), 4.15 (t, 2H, <i>J</i> = 5.5 Hz), 3.07–3.05 (m, 2H), 2.82–2.79 (m, 4H), 1.16 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 125 MHz) δ 164.7, 164.7, 169.7, 154.7, 136.8, 136.8, 136.0, 136.0, 132.8, 129.1, 129.1, 129.1, 129.1, 128.4, 128.4, 128.4, 128.4, 121.3, 121.3, 114.9, 114.9, 103.6, 66.8, 51.8, 47.8, 47.8, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 507 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>28</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 507.1713; found 507.1725.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> 4,6-Bis(4-chlorophenyl)-<i>N</i>-(3-(2-(diethylamino)ethoxy)phenyl)pyrimidin-2-amine (<b>59</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>15</b> (20 mg, 0.06 mmol) afforded 9 mg (30%) of amine <b>59</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.21 (d, 4H, <i>J</i> = 8.8 Hz), 7.78–7.76 (m, 1H), 7.74 (s, 1H), 7.51 (d, 4H, <i>J</i> = 8.8 Hz), 7.22–7.20 (m, 2H), 6.60–6.56 (m, 1H), 4.13 (t, 2H, <i>J</i> = 5.7 Hz), 2.96 (t, 2H, <i>J</i> = 5.7 Hz), 2.70 (q, 4H, <i>J</i> = 7.1 Hz), 1.11 (t, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ 164.6, 164.6, 160.2, 159.5, 140.9, 136.9, 136.9, 135.7, 135.7, 129.5, 129.0, 129.0, 129.0, 129.0, 128.4, 128.4, 128.4, 128.4, 111.2, 108.7, 105.2, 103.9, 66.5, 51.7, 47.8, 47.8, 11.8, 11.8. LRMS (FAB) <i>m</i>/<i>z</i> 507 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>28</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 507.1713; found 507.1718.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> 4,6-Bis(4-chlorophenyl)-<i>N</i>-(2-(2-(diethylamino)ethoxy)phenyl)pyrimidin-2-amine (<b>60</b>)</h5><div class="NLM_p last">Chloropyrimidine <b>15</b> (15 mg, 0.05 mmol) afforded 9 mg (39%) of amine <b>60</b> as a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.52–8.49 (m, 1H), 8.17 (d, 4H, <i>J</i> = 8.8 Hz), 7.74 (s, 1H), 7.50 (d, 4H, <i>J</i> = 8.8 Hz), 7.04–7.01 (m, 3H), 4.21 (t, 2H, <i>J</i> = 5.4 Hz), 3.03 (t, 2H, <i>J</i> = 5.4 Hz), 2.77 (q, 4H, <i>J</i> = 7.1 Hz), 1.16 (t, 6H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 164.6, 164.6, 160.6, 146.5, 136.8, 136.8, 136.1, 136.1, 130.4, 129.0, 129.0, 129.0, 129.0, 128.5, 128.5, 128.5, 128.5, 121.7, 121.4, 119.0, 112.7, 103.7, 64.3, 51.8, 47.8, 47.8, 11.9, 11.9. LRMS (FAB) <i>m</i>/<i>z</i> 507 (M + H<sup>+</sup>). HRMS (FAB) calcd for C<sub>28</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>): 507.1713; found 507.1718.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Molecular Modeling</h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Preparation of Molecular Structures</h4><div class="NLM_p last">All computational simulations were performed with the Sybyl-X 1.2 software package (Tripos, Inc., St. Louis, MO)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> based on CentOS Linux 5.5. The structures of the compounds were prepared in the MOL2 format using the sketcher module. Gasteiger–Hückel charges were assigned to the ligand atoms. The structure of each molecule was energy optimized using the conjugate gradient method, and the optimization was terminated when the energy gradient convergence criterion reached 0.001 kcal mol<sup>–1</sup> Å<sup>–1</sup>. The conformer library for all compounds was stored in a database.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Preparation of the Target Protein Structure and Flexible Docking</h4><div class="NLM_p last">The X-ray structure of RAGE (PDB id <a href="https://" class="ext-link">3O3U</a>) was retrieved from the PDB (Protein Data Bank). All crystallographic water molecules were removed, and the amide side chains were fixed. The active site was defined within a 3.0 Å radius of the specific amino acid residues (Lys43, Lys44, Arg48, and Arg104). The docking and subsequent scoring were performed using the default parameters of the Surflex-Dock program in Sybyl-X 1.2. The final scores for all Surflex-Dock solutions were calculated using a consensus scoring function (CScore) and then used for database ranking. After visual inspection of the docked poses, one of the conformers with a high consensus score (CScore= 5 or 4) was selected as the best docking pose that is described in the text.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Biological Study</h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Preparation of Biotinylated Human RAGE and Human Aβ1–42</h4><div class="NLM_p last">Biotinylated human RAGE proteins were expressed from the pETavi plasmid in Origami2(DE3) bacteria harboring the pBirA plasmid. The recombinant RAGE proteins were extracted and purified by immobilized metal affinity chromatography, as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Aβ was prepared according to established protocols.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The Aβ stock in DMSO was diluted directly into phosphate-buffered saline (PBS) before use, and 10 μM Aβ solution in PBS was incubated for 24 h at 4 °C to generate oligomeric aggregates.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> ELISA Test</h4><div class="NLM_p last">One microgram of purified biotinylated human RAGE, 1 μL of 10 μM Aβ solution, and 20 μM of the compound in 100 μL of TBS-T with 2.5% BSA were incubated on a streptavidin-coated plate for 60 min at ambient temperature. After the plate was washed with TBS-T, the horseradish peroxidase conjugated 4G8 antibody (4G8-HRP, 1:1000 dilution) in 100 μL of TBS-T with 2.5% BSA was added into each well to detect the bound Aβ. The plate was incubated for 60 min at ambient temperature. After washing with TBS-T, the plate was developed with TMB substrate; the reaction was stopped with sulfuric acid. The absorbance was read on a Sunrise plate reader (TECHAN) at 450 nm.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Acute Model Study in Wild-Type Mice</h4><div class="NLM_p last">ICR mice were obtained from SAMTACO (Korea). A single dose of the test compound (25 mg/kg) or vehicle was given by intraperitoneal (ip) injection to 3 month old ICR mice (25 g, <i>n</i> = 4, male). After 20 min, 200 μL of 25 μM human Aβ1–42 in PBS was injected into the tail vein and allowed to circulate for 30 min. Prior to sacrifice of the mice used for the determination of the amount of human Aβ in the brain, blood samples were taken from the retro-orbital plexus using EDTA-coated capillary tubes to determine the amount of circulating human Aβ.</div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Disease Model Study in Transgenic Mice</h4><div class="NLM_p last">APPsw/PS1 mice were obtained from the Jackson Laboratory (Bar Harbor, ME). All mice were maintained on a 12-h dark and 12-h light cycle with free access to rodent chow and water. All procedures for animal tests were approved by the Medifron Animal Care and Use Committee. All surgical procedures were performed with care to minimize pain and discomfort. To evaluate the inhibitory effect of the test compounds on Aβ deposition in this AD model, the test compounds were administrated by gavage of 50 mg/(kg·day) to 6 month old male APPsw/PS1 mice (<i>n</i> = 4–5) until these mice reached 9 months of age. The cognitive function of each mouse was measured after 2 months of administration.</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Y Maze Test</h4><div class="NLM_p last">The spontaneous alternation rate was assessed using a Y-shaped plastic maze<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (40 cm × 10 cm × 5 cm arm sizes). During 8 min sessions, the sequences of arm entries were recorded. Alternation was defined as successive entries into three arms, in overlapping triplet sets. The percent alternation was calculated as the ratio of actual alternations to possible alternations (defined as the total number of arm entries – 2) × 100%. The behavioral testing was performed in the dark phase.</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> ELISA of Brain Aβ</h4><div class="NLM_p last">Post-mortem brains of the mice were immediately removed. The brain samples were homogenized in 3 mL of RIPA buffer (100 mM Tris, pH 8.0, 150 mM NaCl, 0.5% DOC, 1% NP-40, 0.2% SDS, and proteinase inhibitor cocktail) and sonicated for 20 s on ice. For the analyses of the soluble and insoluble Aβ1–40 and Aβ1–42 by ELISA, the brain homogenates were centrifuged for 30 min at 100 000 × <i>g</i> at 4 °C, after which the supernatants (RIPA-soluble fraction) were transferred into new tubes. The pellets were dissolved in 70% formic acid (FA) for 30 min and then centrifuged for 30 min at 100 000 × <i>g</i> at 4 °C. The supernatants (FA-soluble fraction) were transferred into new tubes. The fractions obtained by this protocol were then stored at −80 °C for determination of the Aβ levels using ELISA kits (cat. no. 27713 for 40, cat. no. 27711 for 42, IBL).</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> SPR Study</h3><div class="NLM_p last">The experimental procedure for the SPR study followed the previously described protocol.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A ProteOn XPR36 system (BIO-RAD, Hercules, CA) equipped with a sensor chip was used for the real-time binding studies. TBS (25 mM Tris, 150 mM NaCl, 2 mM KCl, pH 7.4) with 0.05% Tween 20 was used as the assay running buffer and for sample preparation. Bacterially expressed biotinylated RAGE was individually immobilized onto five Neutravidin-coated channels of an NLC chip (BIO-RAD), leaving one channel blank as a reference. A 300 μL sample of biotinylated RAGE (1 μg/μL) was injected into the flow cells (30 μL/min) to allow saturation of the NLC chip by RAGE. The retention of RAGE on the sensor chip was confirmed using an anti-RAGE antibody. To perform binding kinetics analysis, 200 μL aliquots of serially diluted compounds ranging from 50 to 3.1 μM with 2% DMSO in TBS-T buffer were injected and flowed through the channels of the NLC chip for 1 min at 100 μL/min. The relationships between the response units (RU) obtained and the concentrations of the test compounds were plotted. To obtain the dissociation curves, after the analyte injection was stopped, TBS-T buffer (100 μL/min) was flowed over the chip for 400 s to dissociate the bound analytes. The ProteOn XPR36 control software ProteOn Manager v.2, provided by BIO-RAD, was used to record the changes in the RUs, to plot the binding curves, and to analyze the curves obtained from the SPR experiments.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108"><a href="/doi/suppl/10.1021/jm300172z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Validation data for ELISA assay, FSB staining of coronal section of AD model, NF-κB reporter assay on the C6 glioma cell, and purity data of the tested compounds. This material is available free charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300172z/suppl_file/jm300172z_si_001.pdf">jm300172z_si_001.pdf (392.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300172z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young-Ger Suh</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f48d9387819cb4879a81da9597da9f86"><span class="__cf_email__" data-cfemail="ceb7a9bdbba68ebda0bbe0afade0a5bc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young Taek Han</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gyeong-In Choi</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dohyun Son</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nam-Jung Kim</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwayoung Yun</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sujin Lee</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Jo Chang</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun-Seok Hong</span> - <span class="hlFld-Affiliation affiliation">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City,
Gyeonggi-Do, 425-839, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City,
Gyeonggi-Do, 425-839, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee-Jin Ha</span> - <span class="hlFld-Affiliation affiliation">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City,
Gyeonggi-Do, 425-839, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young-Ho Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City,
Gyeonggi-Do, 425-839, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun-Ju Park</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeewoo Lee</span> - <span class="hlFld-Affiliation affiliation">College of
Pharmacy, Seoul National University, 599
Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d306e6664-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Research Foundation grant funded by the Korea government (MEST) as a part of Global Drug Candidate Development Program for Neurodegenerative Diseases (2011-0018334).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i110" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i110"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i111" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i111"> Abbreviations Used</h2><tr><td class="NLM_term">RAGE</td><td class="NLM_def"><p class="first last">receptor for advanced glycation end products</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">LRP-1</td><td class="NLM_def"><p class="first last">low-density lipoprotein receptor-related protein-1</p></td></tr><tr><td class="NLM_term">Ig</td><td class="NLM_def"><p class="first last">immunoglobulin</p></td></tr><tr><td class="NLM_term">AGE</td><td class="NLM_def"><p class="first last">advanced glycation end products</p></td></tr><tr><td class="NLM_term">HMGB1</td><td class="NLM_def"><p class="first last">high-mobility group box-1 protein</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor-κB</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Sciences</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lij--XvzL3Obw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DSciences%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aderinwale, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousa, S. A.</span><span> </span><span class="NLM_article-title">Current therapies and new strategies for the management of Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Alzheimers Dis. Other Dementias</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1177%2F1533317510372372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20601643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BC3cjgtFKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=414-424&author=O.+G.+Aderinwaleauthor=H.+W.+Ernstauthor=S.+A.+Mousa&title=Current+therapies+and+new+strategies+for+the+management+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Current therapies and new strategies for the management of Alzheimer's disease</span></div><div class="casAuthors">Aderinwale Olapeju G; Ernst Hans W; Mousa Shaker A</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disorder that currently affects millions of Americans.  There is no cure at present and no real long-term hope for patients with AD.  While partially effective in improving symptoms, currently available treatments approved by the US Food and Drug Administration (FDA) do not halt progression of AD, or address the underlying mechanism of the disease, in part because the etiology of AD is still an active area of investigation.  Identification of risk factors and the pathogenic mechanism of AD hold the promise of bringing forth novel treatments and perhaps even a cure.  In this review, we will summarize some of the risk factors for AD, AD diagnosis, and current treatments.  Novel therapeutic strategies such as inhibition of beta-amyloid peptide (Abeta), tau-mediated pathogenesis, and receptors for advanced glycation end products (RAGE), as well as neuroprotective and anti-inflammatory approaches and the impact of cholesterol-lowering, botanical, and nutritional agents are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwGANhZhSBGuvW160gIxP_fW6udTcc2eZwU1A7dJNgJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjgtFKnuw%253D%253D&md5=e08d239fb72f64fbaf020458c7928b1f</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1177%2F1533317510372372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317510372372%26sid%3Dliteratum%253Aachs%26aulast%3DAderinwale%26aufirst%3DO.%2BG.%26aulast%3DErnst%26aufirst%3DH.%2BW.%26aulast%3DMousa%26aufirst%3DS.%2BA.%26atitle%3DCurrent%2520therapies%2520and%2520new%2520strategies%2520for%2520the%2520management%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis.%2520Other%2520Dementias%26date%3D2010%26volume%3D25%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Klafki, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2840</span><span class="NLM_x">–</span> <span class="NLM_lpage">2855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=2840-2855&author=H.-W.+Klafkiauthor=M.+Stafenbielauthor=J.+Kornhuberauthor=J.+Wiltfang&title=Therapeutic+approaches+to+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlafki%26aufirst%3DH.-W.%26aulast%3DStafenbiel%26aufirst%3DM.%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DWiltfang%26aufirst%3DJ.%26atitle%3DTherapeutic%2520approaches%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D2840%26epage%3D2855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rafii, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Recent development in Alzheimer’s disease</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1186%2F1741-7015-7-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19228370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&author=M.+S.+Rafiiauthor=P.+S.+Aisen&title=Recent+development+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in Alzheimer's disease therapeutics</span></div><div class="casAuthors">Rafii Michael S; Aisen Paul S</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a devastating neurological disorder that affects more than 37 million people worldwide.  The economic burden of Alzheimer's disease is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least $100 billion.  Current FDA-approved drugs for Alzheimer's disease do not prevent or reverse the disease, and provide only modest symptomatic benefits.  Driven by the clear unmet medical need and a growing understanding of the molecular pathophysiology of Alzheimer's disease, the number of agents in development has increased dramatically in recent years.  Truly *'disease-modifying' therapies that target the underlying mechanisms of Alzheimer's disease have now reached late stages of human clinical trials.  Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimer's disease, and tau protein which, when hyperphosphorylated, results in the self-assembly of tangles of paired helical filaments also believed to be involved in the pathogenesis of Alzheimer's disease.  In this review, we briefly discuss the current status of Alzheimer's disease therapies under study, as well the scientific context in which they have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQBqsOYVNCvy6Ufuk_1xoTfW6udTcc2eZwU1A7dJNgJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D&md5=fddd28d862a1be10ae4a10cc2769c3a4</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-7-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-7-7%26sid%3Dliteratum%253Aachs%26aulast%3DRafii%26aufirst%3DM.%2BS.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DRecent%2520development%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBMC%2520Med.%26date%3D2009%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease; current status and new perspectives</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2FS1474-4422%2803%2900502-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12941576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=539-547&author=E.+Scarpiniauthor=P.+Scheltensauthor=H.+Feldman&title=Treatment+of+Alzheimer%E2%80%99s+disease%3B+current+status+and+new+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current status and new perspectives</span></div><div class="casAuthors">Scarpini, Elio; Scheltens, Philip; Feldman, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">539-547</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  Pharmacol. treatment of AD is based on the use of acetylcholinesterase inhibitors, which have beneficial effects on cognitive, functional, and behavioral symptoms of the disease, but their role in AD pathogenesis is unknown.  Other pharmacol. therapies are becoming available-including the recently approved drug memantine, an NMDA channel blocker indicated for advanced AD.  Here, we review clin. features of the available cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) including their pharmacol. properties, the evidence for switching from one agent to another, "head to head" studies, and the emerging evidence for the use of memantine in AD.  New therapeutic approaches-including those more closely targeted to the pathogenesis of the disease-will also be reviewed.  These potentially disease modifying treatments include amyloid-β-peptide vaccination, secretase inhibitors, cholesterol-lowering drugs, metal chelators, and anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcyZp4rgEiurVg90H21EOLACvtfcHk0lhUm0DIBKkyUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D&md5=f7d73fefb0cfce13bf8c93eebf60a4dd</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2803%2900502-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252803%252900502-7%26sid%3Dliteratum%253Aachs%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520current%2520status%2520and%2520new%2520perspectives%26jtitle%3DLancet%2520Neurol.%26date%3D2003%26volume%3D2%26spage%3D539%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Clearance of Alzheimer’s Aβ peptide: The many roads to perdition</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=605-608&author=R.+E.+Tanziauthor=R.+D.+Moirauthor=S.+L.+Wagner&title=Clearance+of+Alzheimer%E2%80%99s+A%CE%B2+peptide%3A+The+many+roads+to+perdition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DClearance%2520of%2520Alzheimer%25E2%2580%2599s%2520A%25CE%25B2%2520peptide%253A%2520The%2520many%2520roads%2520to%2520perdition%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D605%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-F.</span><span> </span><span class="NLM_article-title">Clearance of amyloid-beta in Azheimer’s disease: Progress, problems and perspectives</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=931-938&author=Y.-J.+Wangauthor=H.-D.+Zhouauthor=X.-F.+Zhou&title=Clearance+of+amyloid-beta+in+Azheimer%E2%80%99s+disease%3A+Progress%2C+problems+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-J.%26aulast%3DZhou%26aufirst%3DH.-D.%26aulast%3DZhou%26aufirst%3DX.-F.%26atitle%3DClearance%2520of%2520amyloid-beta%2520in%2520Azheimer%25E2%2580%2599s%2520disease%253A%2520Progress%252C%2520problems%2520and%2520perspectives%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D931%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Neeper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliston, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span> </span><span class="NLM_article-title">Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">14998</span><span class="NLM_x">–</span> <span class="NLM_lpage">15004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14998-15004&author=M.+Neeperauthor=A.+M.+Schmidtauthor=J.+Brettauthor=S.+D.+Yanauthor=F.+Wangauthor=Y.-C.+Panauthor=K.+Ellistonauthor=D.+Sternauthor=A.+Shaw&title=Cloning+and+expression+of+a+cell+surface+receptor+for+advanced+glycosylation+end+products+of+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeeper%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DBrett%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DY.-C.%26aulast%3DElliston%26aufirst%3DK.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DShaw%26aufirst%3DA.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520cell%2520surface%2520receptor%2520for%2520advanced%2520glycosylation%2520end%2520products%2520of%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D14998%26epage%3D15004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Huttunen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fages, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauvala, H.</span><span> </span><span class="NLM_article-title">Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">19919</span><span class="NLM_x">–</span> <span class="NLM_lpage">19924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=19919-19924&author=H.+Huttunenauthor=C.+Fagesauthor=H.+Rauvala&title=Receptor+for+advanced+glycation+end+products+%28RAGE%29-mediated+neurite+outgrowth+and+activation+of+NF-%CE%BAB+require+the+cytoplasmic+domain+of+the+receptor+but+different+downstream+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuttunen%26aufirst%3DH.%26aulast%3DFages%26aufirst%3DC.%26aulast%3DRauvala%26aufirst%3DH.%26atitle%3DReceptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528RAGE%2529-mediated%2520neurite%2520outgrowth%2520and%2520activation%2520of%2520NF-%25CE%25BAB%2520require%2520the%2520cytoplasmic%2520domain%2520of%2520the%2520receptor%2520but%2520different%2520downstream%2520signaling%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D19919%26epage%3D19924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">Recent reviews about ligands of RAGE and related diseases, see:</p></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">RAGE: A multi-ligand receptor unveiling novel insights in health and disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2232</span><span class="NLM_x">–</span> <span class="NLM_lpage">2252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.2174%2F092986710791331086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20459381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2232-2252&author=P.+Alexiouauthor=K.+Chatzopoulouauthor=K.+Pegklidouauthor=V.+J.+Demopoulos&title=RAGE%3A+A+multi-ligand+receptor+unveiling+novel+insights+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE: a multi-ligand receptor unveiling novel insights in health and disease</span></div><div class="casAuthors">Alexiou, P.; Chatzopoulou, M.; Pegklidou, K.; Demopoulos, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2232-2252</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor for advanced glycation end products (RAGE) is expressed in a range of cell types such as endothelial cells, smooth muscle cells, mesangial cells, mononuclear phagocytes and certain neurons.  It is a multi-ligand receptor and a member of the Ig superfamily of cell surface mols.  Its repertoire of ligands includes advanced glycation end products (AGEs), amyloid fibrils, amphoterin and S100/calgranulins.  This variety of ligands allows RAGE to be implicated in a wide spectrum of pathol. conditions such as diabetes and its complications, Alzheimer's disease, cancer and inflammation.  Addnl., genetic polymorphisms in the RAGE gene may have impact on the functional activity of the receptor.  It becomes obvious that RAGE pathway is a complicated one and the question of whether blockade of RAGE is a feasible and safe strategy for the prevention/treatment of chronic diseases is gradually gaining the attention of the pharmaceutical community.  In this review the biol. of RAGE and the triggered signaling cascades involved in health and disease will be presented.  Addnl., its potential as an attractive pharmacotherapeutic target will be explored by pointing out the pharmacotherapeutic agents that have been developed for RAGE blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Kmu1QNiF3LVg90H21EOLACvtfcHk0lhUm0DIBKkyUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFeitb4%253D&md5=c8d2d2f33d37feb179f88f2abf09afcd</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F092986710791331086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791331086%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DChatzopoulou%26aufirst%3DK.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DRAGE%253A%2520A%2520multi-ligand%2520receptor%2520unveiling%2520novel%2520insights%2520in%2520health%2520and%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2232%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barlovic, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soro-Paavonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandeleit-Dahm, K. A.</span><span> </span><span class="NLM_article-title">RAGE biology, atherosclerosis and diabetes</span> <span class="citation_source-journal">Clin. Sci. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1042%2FCS20100501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=21457145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BC3MvgsVyruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=43-55&author=D.+P.+Barlovicauthor=A.+Soro-Paavonenauthor=K.+A.+Jandeleit-Dahm&title=RAGE+biology%2C+atherosclerosis+and+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE biology, atherosclerosis and diabetes</span></div><div class="casAuthors">Barlovic Drazenka Pongrac; Soro-Paavonen Aino; Jandeleit-Dahm Karin A M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">43-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes is characterized by accelerated atherosclerosis with widely distributed vascular lesions.  An important mechanism by which hyperglycaemia contributes to vascular injury is through the extensive intracellular and extracellular formation of AGEs (advanced glycation end products).  AGEs represent a heterogeneous group of proteins, lipids and nucleic acids, irreversibly cross-linked with reducing sugars.  AGEs are implicated in the atherosclerotic process, either directly or via receptor-mediated mechanisms, the most extensively studied receptor being RAGE (receptor for AGEs).  The AGE-RAGE interaction alters cellular signalling, promotes gene expression and enhances the release of pro-inflammatory molecules.  It elicits the generation of oxidative stress in numerous cell types.  The importance of the AGE-RAGE interaction and downstream pathways leading to injurious effects as a result of chronic hyperglycaemia in the development, progression and instability of diabetic atherosclerotic lesions has been amply demonstrated in animal studies.  Moreover, the deleterious link of AGEs with diabetic vascular complications has been suggested in many human studies.  In the present review, our current understanding of their role as an important mediator of vascular injury through the various stages of atherosclerosis in diabetes will be reviewed and critically assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTm5pkAG-JAWiSm0e6ZOaemfW6udTcc2eaIWTPwLMVijrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvgsVyruw%253D%253D&md5=9b477c777dbdd9739d6f47d1f3a9c752</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1042%2FCS20100501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20100501%26sid%3Dliteratum%253Aachs%26aulast%3DBarlovic%26aufirst%3DD.%2BP.%26aulast%3DSoro-Paavonen%26aufirst%3DA.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%2BA.%26atitle%3DRAGE%2520biology%252C%2520atherosclerosis%2520and%2520diabetes%26jtitle%3DClin.%2520Sci.%2520%2528London%2529%26date%3D2011%26volume%3D121%26spage%3D43%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sims, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietdijk, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, A. J.</span><span> </span><span class="NLM_article-title">HMGB1 and RAGE in inflammation and cancer</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1146%2Fannurev.immunol.021908.132603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20192808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=367-388&author=G.+P.+Simsauthor=D.+C.+Roweauthor=S.+T.+Rietdijkauthor=R.+Herbstauthor=A.+J.+Coyle&title=HMGB1+and+RAGE+in+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 and RAGE in inflammation and cancer</span></div><div class="casAuthors">Sims, Gary P.; Rowe, Daniel C.; Rietdijk, Svend T.; Herbst, Ronald; Coyle, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">367-388</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The immune system has evolved to respond not only to pathogens, but also to signals released from dying cells.  Cell death through necrosis induces inflammation, whereas apoptotic cell death provides an important signals for tolerance induction.  High mobility group box 1 (HMGB1) is a DNA-binding nuclear protein, released actively following cytokine stimulation as well as passively during cell death; it is the prototypic damage-assocd. mol. pattern (DAMP) mol. and has been implicated in several inflammatory disorders.  HMGB1 can assoc. with other mols., including TLR ligands and cytokines, and activates cells through the differential engagement of multiple surface receptors including TLR2, TLR4, and RAGE.  RAGE is a multiligand receptor that binds structurally diverse mols., including not only HMGB1, but also S100 family members and amyloid-β.  RAGE activation has been implicated in sterile inflammation as well as in cancer, diabetes, and Alzheimer's disease.  While HMGB1 through interactions with TLRs may also be important, this review focuses on the role of the HMGB1-RAGE axis in inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2HfiYhXSqSrVg90H21EOLACvtfcHk0ljQbauaenU_ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7k%253D&md5=eb505a55bf44e06fbff2026629248be1</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132603%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DG.%2BP.%26aulast%3DRowe%26aufirst%3DD.%2BC.%26aulast%3DRietdijk%26aufirst%3DS.%2BT.%26aulast%3DHerbst%26aufirst%3DR.%26aulast%3DCoyle%26aufirst%3DA.%2BJ.%26atitle%3DHMGB1%2520and%2520RAGE%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D367%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">T, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, C. Y.</span><span> </span><span class="NLM_article-title">RAGE and cardiovascular disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.2741%2F3700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=486-497&author=S.+Parkauthor=S.-J.+Yoonauthor=H.-J.+Tauthor=C.+Y.+Shim&title=RAGE+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and cardiovascular disease</span></div><div class="casAuthors">Park, Sungha; Yoon, Se-Jung; Tae, Hyun-Jin; Shim, Chi Young</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">486-497</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  RAGE is pattern recognizing receptors for diverse endogenous ligands.  RAGE activation by RAGE ligands is known to be assocd. with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells.  Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion mols.  Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis.  Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation.  RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathol. processes that result in various entities of cardiovascular disease.  Sol. RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo.  Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMHlUrKlArLVg90H21EOLACvtfcHk0ljQbauaenU_ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyltro%253D&md5=e3b9fdc26c996044b220313076546af2</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.2741%2F3700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3700%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DS.-J.%26aulast%3DT%26aufirst%3DH.-J.%26aulast%3DShim%26aufirst%3DC.%2BY.%26atitle%3DRAGE%2520and%2520cardiovascular%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2011%26volume%3D16%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bierhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiekofer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaninger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrassy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humpert, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloting, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritschler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haring, H.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleicher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span> </span><span class="NLM_article-title">Diabetes-associated sustained activation of the transcription factor nuclear factor-κB</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2792</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=2792-2808&author=A.+Bierhausauthor=S.+Schiekoferauthor=M.+Schwaningerauthor=M.+Andrassyauthor=P.+M.+Humpertauthor=J.+Chenauthor=M.+Hongauthor=T.+Lutherauthor=T.+Henleauthor=I.+Klotingauthor=M.+Morcosauthor=M.+Hofmannauthor=H.+Tritschlerauthor=B.+Weigleauthor=M.+Kasperauthor=M.+Smithauthor=G.+Perryauthor=A.-M.+Schmidtauthor=D.+M.+Sternauthor=H.-U.+Haringauthor=E.+Schleicherauthor=P.+P.+Nawroth&title=Diabetes-associated+sustained+activation+of+the+transcription+factor+nuclear+factor-%CE%BAB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DSchiekofer%26aufirst%3DS.%26aulast%3DSchwaninger%26aufirst%3DM.%26aulast%3DAndrassy%26aufirst%3DM.%26aulast%3DHumpert%26aufirst%3DP.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DM.%26aulast%3DLuther%26aufirst%3DT.%26aulast%3DHenle%26aufirst%3DT.%26aulast%3DKloting%26aufirst%3DI.%26aulast%3DMorcos%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DM.%26aulast%3DTritschler%26aufirst%3DH.%26aulast%3DWeigle%26aufirst%3DB.%26aulast%3DKasper%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.-M.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DHaring%26aufirst%3DH.-U.%26aulast%3DSchleicher%26aufirst%3DE.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26atitle%3DDiabetes-associated%2520sustained%2520activation%2520of%2520the%2520transcription%2520factor%2520nuclear%2520factor-%25CE%25BAB%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D2792%26epage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span> </span><span class="NLM_article-title">Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">16498</span><span class="NLM_x">–</span> <span class="NLM_lpage">16506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=16498-16506&author=J.+Liauthor=A.+M.+Schmidt&title=Characterization+and+functional+analysis+of+the+promoter+of+RAGE%2C+the+receptor+for+advanced+glycation+end+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26atitle%3DCharacterization%2520and%2520functional%2520analysis%2520of%2520the%2520promoter%2520of%2520RAGE%252C%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D16498%26epage%3D16506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Deane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagare, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deane, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meenakshisundaram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarcone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlokovic, B. V.</span><span> </span><span class="NLM_article-title">A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1377-1392&author=R.+Deaneauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+D.+Bellauthor=N.+T.+Rossauthor=B.+Larueauthor=R.+Loveauthor=S.+Perryauthor=N.+Paquetteauthor=R.+J.+Deaneauthor=T.+Meenakshisundaramauthor=T.+Zarconeauthor=G.+Fritzauthor=A.+E.+Friedmanauthor=B.+L.+Millerauthor=B.+V.+Zlokovic&title=A+multimodal+RAGE-specific+inhibitor+reduces+amyloid+%CE%B2-mediated+brain+disorder+in+a+mouse+model+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DLarue%26aufirst%3DB.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DPaquette%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DR.%2BJ.%26aulast%3DMeenakshisundaram%26aufirst%3DT.%26aulast%3DZarcone%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DA%2520multimodal%2520RAGE-specific%2520inhibitor%2520reduces%2520amyloid%2520%25CE%25B2-mediated%2520brain%2520disorder%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D1377%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Men, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. G.</span><span> </span><span class="NLM_article-title">Nanoparticle and other metal chelation thetapeutics in Alzheimer disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1741</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1741&publication_year=2005&pages=246-252&author=G.+Liuauthor=M.+R.+Garrettauthor=P.+Menauthor=X.+Zhuauthor=G.+Perryauthor=M.+G.+Smith&title=Nanoparticle+and+other+metal+chelation+thetapeutics+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGarrett%26aufirst%3DM.%2BR.%26aulast%3DMen%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BG.%26atitle%3DNanoparticle%2520and%2520other%2520metal%2520chelation%2520thetapeutics%2520in%2520Alzheimer%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1741%26spage%3D246%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span> </span><span class="NLM_article-title">PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1097%2FWAD.0b013e318204b550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=21192237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&author=M.+N.+Sabbaghauthor=A.+Agroauthor=J.+Bellauthor=P.+S.+Aisenauthor=E.+Schweizerauthor=D.+Galasko&title=PF-04494700%2C+an+oral+inhibitor+of+receptor+for+advanced+glycation+end+products+%28RAGE%29%2C+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Agro, Albert; Bell, Joanne; Aisen, Paul S.; Schweizer, Edward; Galasko, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the safety and tolerability of PF-04494700, an oral inhibitor of receptor for advanced glycation end products, in patients with mild-to-moderate dementia of the Alzheimer type.  Patients aged 50 years and older who met the National Institute of Neurol. and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Assocn. criteria for Alzheimer disease with an Mini-Mental State Examn. (MMSE) score between 12 and 26 (inclusive) were randomized to 10 wk of double-blind treatment with either a 10 mg "low dose" of PF-04494700 (after a 6-d loading dose of 30 mg/d), a 20 mg "high dose" of PF-04494700 (after a loading dose of 60 mg/d), or placebo.  Safety measures included adverse events, lab. tests, vital signs, and 12-lead ECG.  27 Patients received PF-04494700 30/co mg (female: 63%; mean age: 74.6 y; mean MMSE: 21.1), 28 patients received PF-04494700 60/20 mg (female: 57%; mean age: 76.6 y; mean MMSE: 21.6), and 12 patients received placebo (female: 67%; mean age: 74.1 y; mean MMSE: 19.2).  A higher proportion of patients completed 10 wk of double-blind treatment on both the "low-dose" regimen of PF-04494700 (88.9%) and the "high-dose" regimen (85.7%) than patients who were on placebo (66.7%).  Discontinuation owing to adverse events and incidence of severe adverse events, resp., were lower in the "low-dose" regimen (7.4%, 11.1%) and the "high-dose" regimen (3.6%, 10.7%) compared with placebo (25.0%, 16.7%).  There were no clin. meaningful differences in vital signs, lab. test results, or mean ECG parameters in patients treated with PF-04494700.  PF-04494700 had no consistent effect on plasma levels of β-amyloid, inflammatory biomarkers, or secondary cognitive outcomes.  Ten weeks of treatment with PF-04494700 was safe and well tolerated in patients with mild-to-moderate Alzheimer disease, indicating the feasibility of a larger long-term efficacy trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYOId4vbstBLVg90H21EOLACvtfcHk0ljrPqRvQb3yag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL&md5=99a792014511f247fe283378d8503ceb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e318204b550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e318204b550%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DAgro%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DGalasko%26aufirst%3DD.%26atitle%3DPF-04494700%252C%2520an%2520oral%2520inhibitor%2520of%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528RAGE%2529%252C%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2011%26volume%3D25%26spage%3D206%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Srikanth, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maczurek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westcott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juskiw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Münch, G.</span><span> </span><span class="NLM_article-title">Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2Fj.neurobiolaging.2009.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19464758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVWmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=763-777&author=V.+Srikanthauthor=A.+Maczurekauthor=T.+Phanauthor=M.+Steeleauthor=B.+Westcottauthor=D.+Juskiwauthor=G.+M%C3%BCnch&title=Advanced+glycation+endproducts+and+their+receptor+RAGE+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease</span></div><div class="casAuthors">Srikanth, Velandai; Maczurek, Annette; Phan, Thanh; Steele, Megan; Westcott, Bernadette; Juskiw, Damian; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">763-777</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common dementing disorder of late life.  Although there might be various different triggering events in the early stages of the disease, they seem to converge on a few characteristic final pathways in the late stages, characterized by inflammation and neurodegeneration.  In this review, we revisit the hypothesis that advanced glycation endproducts (AGEs) and their receptor RAGE may play an important role in disease pathogenesis.  Accumulation of AGEs in cells and tissues is a normal feature of aging, but is accelerated in AD.  In AD, AGEs can be detected in pathol. deposits such as amyloid plaques and neurofibrillary tangles.  AGEs explain many of the neuropathol. and biochem. features of AD such as extensive protein crosslinking, glial induction of oxidative stress and neuronal cell death.  Oxidative stress and AGEs initiate a pos. feedback loop, where normal age-related changes develop into a pathophysiol. cascade.  RAGE and its decoy receptor sol. RAGE, may contribute to or protect against AD pathogenesis by influencing transport of β-amyloid into the brain or by manipulating inflammatory mechanisms.  Targeted pharmacol. interventions using AGE-inhibitors, RAGE-antagonists, RAGE-antibodies, sol. RAGE or RAGE signalling inhibitors such as membrane-permeable antioxidants may be promising therapeutic strategies to slow down the progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWteNhizjZprVg90H21EOLACvtfcHk0ljrPqRvQb3yag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVWmsrw%253D&md5=19e434013c3b1bf46e0ef57790eba26b</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSrikanth%26aufirst%3DV.%26aulast%3DMaczurek%26aufirst%3DA.%26aulast%3DPhan%26aufirst%3DT.%26aulast%3DSteele%26aufirst%3DM.%26aulast%3DWestcott%26aufirst%3DB.%26aulast%3DJuskiw%26aufirst%3DD.%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26atitle%3DAdvanced%2520glycation%2520endproducts%2520and%2520their%2520receptor%2520RAGE%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D763%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yammani, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresnick, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, R. F.</span><span> </span><span class="NLM_article-title">Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1002%2Fart.22042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=16948116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=2901-2911&author=R.+R.+Yammaniauthor=C.+S.+Carlsonauthor=A.+R.+Bresnickauthor=R.+F.+Loeser&title=Increase+in+production+of+matrix+metalloproteinase+13+by+human+articular+chondrocytes+due+to+stimulation+with+S100A4%3A+Role+of+the+receptor+for+advanced+glycation+end+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products</span></div><div class="casAuthors">Yammani, Raghunatha R.; Carlson, Cathy S.; Bresnick, Anne R.; Loeser, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2901-2911</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. S100 proteins have been implicated in various inflammatory conditions, including arthritis.  The aims of this study were to det. whether chondrocytes produce S100A4 and whether S100A4 can stimulate the prodn. of matrix metalloproteinase 13 (MMP-13) by articular chondrocytes via receptor for advanced glycation end products (RAGE)-mediated signaling.  Methods. The expression of chondrocyte S100A4 was analyzed by immunohistochem. using normal and osteoarthritic (OA) cartilage and by immunoblotting of chondrocyte cell lysates.  RAGE signaling was examd. by stimulating chondrocytes with S100A4 and monitoring for the activation of MAP kinases and NF-κB.  Prodn. of MMP-13 was detd. in the conditioned medium.  A pulldown assay using biotin-labeled S100A4 was used to demonstrate binding to RAGE.  Results. S100A4 expression was detected in human articular chondrocytes by immunoblotting and appeared to increase in the cell lysates from OA tissue.  Marked pos. immunostaining for S100A4 was also noted in sections of human cartilage with changes due to OA.  Stimulation of chondrocytes with S100A4 increased the phosphorylation of Pyk-2, MAP kinases, and activated NF-κB, followed by increased prodn. of MMP-13 in the conditioned medium.  This signaling was inhibited in cells pretreated with sol. RAGE, advanced glycation end product-bovine serum albumin, or the antioxidant Mn(III)tetrakis (4-benzoic acid) porphyrin, or by overexpression of a dominant-neg. RAGE construct.  A pulldown assay showed that S100A4 binds to RAGE in chondrocytes.  Conclusion. This is the first study to demonstrate that S100A4 binds to RAGE and stimulates a RAGE-mediated signaling cascade, leading to increased prodn. of MMP-13.  Since both S100A4 and RAGE are up-regulated in OA cartilage, this signaling pathway could contribute to cartilage degrdn. in OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXQ_IBJsrMbVg90H21EOLACvtfcHk0lgfU_yc4sMUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksLnI&md5=5d3855a5814325255b26a41bd318c5f8</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1002%2Fart.22042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22042%26sid%3Dliteratum%253Aachs%26aulast%3DYammani%26aufirst%3DR.%2BR.%26aulast%3DCarlson%26aufirst%3DC.%2BS.%26aulast%3DBresnick%26aufirst%3DA.%2BR.%26aulast%3DLoeser%26aufirst%3DR.%2BF.%26atitle%3DIncrease%2520in%2520production%2520of%2520matrix%2520metalloproteinase%252013%2520by%2520human%2520articular%2520chondrocytes%2520due%2520to%2520stimulation%2520with%2520S100A4%253A%2520Role%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%26jtitle%3DArthritis%2520Rheum.%26date%3D2006%26volume%3D54%26spage%3D2901%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. M.</span><span> </span><span class="NLM_article-title">RAGE and Alzheimer’s disease: A progression factor for amyloid-β-induced cellular perturbation?</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19387116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BD1M3psFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=833-843&author=S.+D.+Yanauthor=A.+Bierhausauthor=P.+P.+Nawrothauthor=D.+M.+Stern&title=RAGE+and+Alzheimer%E2%80%99s+disease%3A+A+progression+factor+for+amyloid-%CE%B2-induced+cellular+perturbation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?</span></div><div class="casAuthors">Yan Shi Du; Bierhaus Angelika; Nawroth Peter P; Stern David M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">833-43</span>
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    </div><div class="casAbstract">Receptor for Advanced Glycation Endproducts (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface molecules which serves as a receptor for amyloid-beta peptide (Abeta) on neurons, microglia, astrocytes, and cells of vessel wall.  Increased expression of RAGE is observed in regions of the brain affected by Alzheimer's disease (AD), and Abeta-RAGE interaction in vitro leads to cell stress with the generation of reactive oxygen species and activation of downstream signaling mechanisms including the MAP kinase pathway.  RAGE-mediated activation of p38 MAP kinase in neurons causes Abeta-induced inhibition of long-term potentiation in slices of entorhinal cortex.  Increased expression of RAGE in an Abeta-rich environment, using transgenic mouse models, accelerates and accentuates pathologic, biochemical, and behavioral abnormalities compared with mice overexpressing only mutant amyloid-beta protein precursor.  Interception of Abeta interaction with RAGE, by infusion of soluble RAGE, decreases Abeta content and amyloid load, as well as improving learning/memory and synaptic function, in a murine transgenic model of Abeta accumulation.  These data suggest that RAGE may be a therapeutic target for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwn01bLaXJ0SjiVMCqkKxVfW6udTcc2eYLPukxQlf3e7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3psFGmug%253D%253D&md5=3d1c5b7bd492104e1915d264a7d0846e</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DStern%26aufirst%3DD.%2BM.%26atitle%3DRAGE%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520A%2520progression%2520factor%2520for%2520amyloid-%25CE%25B2-induced%2520cellular%2520perturbation%253F%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D833%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span> </span><span class="NLM_article-title">Solution structure of the variable-type domain of the receptor for advanced glycation end products: New insight into AGE-RAGE interaction</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">12299</span><span class="NLM_x">–</span> <span class="NLM_lpage">12311</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800910v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12299-12311&author=S.+Matsumotoauthor=T.+Yoshidaauthor=H.+Murataauthor=S.+Haradaauthor=N.+Fujitaauthor=S.+Nakamuraauthor=Y.+Yamamotoauthor=T.+Watanabeauthor=H.+Yonekuraauthor=H.+Yamamotoauthor=T.+Ohkuboauthor=Y.+Kobayashi&title=Solution+structure+of+the+variable-type+domain+of+the+receptor+for+advanced+glycation+end+products%3A+New+insight+into+AGE-RAGE+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi800910v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800910v%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DSolution%2520structure%2520of%2520the%2520variable-type%2520domain%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%253A%2520New%2520insight%2520into%2520AGE-RAGE%2520interaction%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12299%26epage%3D12311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Münch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thome, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Advanced glycation endproducts in ageing and Alzheimer’s disease</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2FS0165-0173%2896%2900016-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=9063589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADyaK2s3hslKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=134-143&author=G.+M%C3%BCnchauthor=J.+Thomeauthor=P.+Foleyauthor=R.+Schinzelauthor=P.+Riederer&title=Advanced+glycation+endproducts+in+ageing+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced glycation endproducts in ageing and Alzheimer's disease</span></div><div class="casAuthors">Munch G; Thome J; Foley P; Schinzel R; Riederer P</div><div class="citationInfo"><span class="NLM_cas:title">Brain research. Brain research reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">134-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Accumulation of advanced glycation endproducts (AGE) in the brain is a feature of ageing and degeneration, especially in Alzheimer's disease (AD).  Increased AGE levels explain many of the neuropathological and biochemical features of AD such as extensive protein crosslinking (beta-amyloid and MAP-tau), oxidative stress and neuronal cell death.  Oxidative stress and AGEs initiate a positive feedback loop, where normal age-related changes develop into a pathophysiological cascade.  Combined intervention using antioxidants, metal chelators, anti-inflammatory drugs and AGE-inhibitors may be a promising neuroprotective strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh5wFRQg1QoaqcneEtCi92fW6udTcc2eanM9xpHRn_2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3hslKhug%253D%253D&md5=82b683c67b8a6e3abe19bdb6029b8a97</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2896%2900016-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252896%252900016-1%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26aulast%3DThome%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DSchinzel%26aufirst%3DR.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAdvanced%2520glycation%2520endproducts%2520in%2520ageing%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D134%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reddy, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyaz, A.</span><span> </span><span class="NLM_article-title">Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2Fj.drudis.2006.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=16793534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=646-654&author=V.+P.+Reddyauthor=A.+Beyaz&title=Inhibitors+of+the+Maillard+reaction+and+AGE+breakers+as+therapeutics+for+multiple+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases</span></div><div class="casAuthors">Reddy, V. Prakash; Beyaz, Ayse</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13 & 14</span>),
    <span class="NLM_cas:pages">646-654</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Maillard reaction is a complex series of reactions that involve reducing-sugars and proteins, giving a multitude of end-products that are known as advanced glycation end-products (AGEs).  AGEs can contribute to the pathogenesis of diabetes and neurol. diseases such as Alzheimer's disease.  AGEs also play a major role in vascular stiffening, atherosclerosis, osteoarthritis, inflammatory arthritis and cataracts.  Thus, AGE inhibitors and AGE breakers offer a potential strategy as therapeutics for diverse diseases.  Various AGE inhibitors have been developed in recent years, and their underlying mechanism is based on the attenuation of glycoxidn. and/or oxidative stress by the sequestration of metal ions, reactive 1,2-dicarbonyl compds., and reactive oxygen and reactive nitrogen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0eytO4rBcObVg90H21EOLACvtfcHk0ljrpymqmoGPzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqtbw%253D&md5=6909c59fba12468b9663484a0a43907e</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DV.%2BP.%26aulast%3DBeyaz%26aufirst%3DA.%26atitle%3DInhibitors%2520of%2520the%2520Maillard%2520reaction%2520and%2520AGE%2520breakers%2520as%2520therapeutics%2520for%2520multiple%2520diseases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D646%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Roschek, B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rector, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillmore, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Punta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. A.</span><span> </span><span class="NLM_article-title">Peroxyl radical clocks</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">3527</span><span class="NLM_x">–</span> <span class="NLM_lpage">3532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0601462" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3527-3532&author=B.+Roschekauthor=K.+A.+Tallmanauthor=C.+L.+Rectorauthor=J.+G.+Gillmoreauthor=D.+A.+Prattauthor=C.+Puntaauthor=N.+A.+Porter&title=Peroxyl+radical+clocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo0601462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0601462%26sid%3Dliteratum%253Aachs%26aulast%3DRoschek%26aufirst%3DB.%26aulast%3DTallman%26aufirst%3DK.%2BA.%26aulast%3DRector%26aufirst%3DC.%2BL.%26aulast%3DGillmore%26aufirst%3DJ.%2BG.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DPunta%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26atitle%3DPeroxyl%2520radical%2520clocks%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3527%26epage%3D3532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliccho, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 1-heterocyclic-3-aminopyrrolidinones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1141-1145&author=I.+M.+Bellauthor=D.+C.+Beshoreauthor=S.+N.+Gallicchoauthor=T.+M.+Williams&title=Efficient+synthesis+of+1-heterocyclic-3-aminopyrrolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26aulast%3DGalliccho%26aufirst%3DS.%2BN.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DEfficient%2520synthesis%2520of%25201-heterocyclic-3-aminopyrrolidinones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1141%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Delia, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomaker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinda, A. S.</span><span> </span><span class="NLM_article-title">The synthesis of substituted phenylpyrimidines via Suzuki coupling reactions</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=127-131&author=T.+J.+Deliaauthor=J.+M.+Schomakerauthor=A.+S.+Kalinda&title=The+synthesis+of+substituted+phenylpyrimidines+via+Suzuki+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelia%26aufirst%3DT.%2BJ.%26aulast%3DSchomaker%26aufirst%3DJ.%2BM.%26aulast%3DKalinda%26aufirst%3DA.%2BS.%26atitle%3DThe%2520synthesis%2520of%2520substituted%2520phenylpyrimidines%2520via%2520Suzuki%2520coupling%2520reactions%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2006%26volume%3D43%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peng, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Journet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, G. A.</span><span> </span><span class="NLM_article-title">Highly regioselective amination of 6-aryl-2,4-dichloropyrimidine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/ol052578p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=395-398&author=Z.-H.+Pengauthor=M.+Journetauthor=G.+A.+Humphrey&title=Highly+regioselective+amination+of+6-aryl-2%2C4-dichloropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fol052578p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052578p%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.-H.%26aulast%3DJournet%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DG.%2BA.%26atitle%3DHighly%2520regioselective%2520amination%2520of%25206-aryl-2%252C4-dichloropyrimidine%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D395%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span> </span><span class="NLM_article-title">Preparation of esters of phosphoric acid by the reaction of trivalent phosphorus compounds with diethyl azodicarboxylate in the presence of alcohols</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1246%2Fbcsj.40.935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADyaF2sXksVegtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1967&pages=935-939&author=O.+Mitsunobuauthor=M.+Yamadaauthor=T.+Mukaiyama&title=Preparation+of+esters+of+phosphoric+acid+by+the+reaction+of+trivalent+phosphorus+compounds+with+diethyl+azodicarboxylate+in+the+presence+of+alcohols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of esters of phosphoric acid by the reaction of trivalent phosphorus compounds with diethyl azodicarboxylate in the presence of alcohols</span></div><div class="casAuthors">Mitsunobu, Oyo; Yamada, Masaaki; Mukaiyama, Teruaki</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">935-9</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">Diethyl azodicarboxylate (I) (5.2 g.) in 20 ml. Et2O was added dropwise to 7.86 g. PPh3 and 3.24 g. PhCH2OH in 30 ml. of Et2O at room temp. with vigorous stirring.  After 2 days, 74.3% triphenylphosphine oxide (II), m. 148-50°, and 69.6% diethyl N-benzylhydrazodicarboxylate, b. 125-7° n22D 1.5066, was obtained.  Similarly prepd. was 91.4% tributyl phosphate, b. 103-12°.  II was also prepd. by treating 5.22 g. I in 10 ml. Et2O with 7.86 g. PPh3 and 2 ml. allyl alc. in 20 ml. Et2O at room temp.  I (1.74 g.) in 5 ml. Et2O was added dropwise to 1.78 g. allyl diethyl phosphite and 1 ml. EtOH in 10 ml. Et2O at room temp. with vigorous stirring to give 78.0% Et3PO4, b3-4 62-8°.  Similarly, PrEt2PO4, iso-PrEt2PO4, and Et2PhPO4, b4 137-9°, were prepd. in 74.5, 61.7, and 87% yields, resp.  I (1.74 g.) in 5 ml. Et2O was added dropwise to 1.93 g. diethyl N,N-diethylphosphoroamidite and 1.5 ml. allyl alc. in 10 ml. Et2O with vigorous stirring at room temp.  After the reaction mixt. was kept overnight at room temp., 75% diethyl N-(N,N-diethylethylamino)phosphoryl-N'-diethylhydrazodicarboxylate, b0.06 139-43°, was obtained by fractionation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16zjZHqGTd7Vg90H21EOLACvtfcHk0ljNtitLwRM81w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXksVegtrc%253D&md5=83e58d59103e8cd0887c009903dc1d64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.40.935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.40.935%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMukaiyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520esters%2520of%2520phosphoric%2520acid%2520by%2520the%2520reaction%2520of%2520trivalent%2520phosphorus%2520compounds%2520with%2520diethyl%2520azodicarboxylate%2520in%2520the%2520presence%2520of%2520alcohols%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1967%26volume%3D40%26spage%3D935%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, T. R.</span><span> </span><span class="NLM_article-title">Synthesis of diary ethers through the copper-promoted arylation of phenols with aryboronic acids. An expedient synthesis of thyroxine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2937</span><span class="NLM_x">–</span> <span class="NLM_lpage">2940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2937-2940&author=D.+A.+Evansauthor=J.+L.+Katzauthor=T.+R.+West&title=Synthesis+of+diary+ethers+through+the+copper-promoted+arylation+of+phenols+with+aryboronic+acids.+An+expedient+synthesis+of+thyroxine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520diary%2520ethers%2520through%2520the%2520copper-promoted%2520arylation%2520of%2520phenols%2520with%2520aryboronic%2520acids.%2520An%2520expedient%2520synthesis%2520of%2520thyroxine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2937%26epage%3D2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulfield, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinghorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitdehaag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vanZeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saniere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deronzier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorleans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span> </span><span class="NLM_article-title">Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1524-1527&author=Z.+Rankovicauthor=J.+Caiauthor=J.+Kerrauthor=X.+Fraderaauthor=J.+Robinsonauthor=A.+Mistryauthor=E.+Hamiltonauthor=G.+McGarryauthor=F.+Andrewsauthor=W.+Caulfieldauthor=I.+Cummingauthor=M.+Dempsterauthor=J.+Wallerauthor=P.+Scullionauthor=I.+Martinauthor=A.+Mitchellauthor=C.+Longauthor=M.+Baughauthor=P.+Westwoodauthor=E.+Kinghornauthor=J.+Bruinauthor=W.+Hamiltonauthor=J.+Uitdehaagauthor=M.+vanZeelandauthor=D.+Potinauthor=L.+Saniereauthor=A.+Fouquetauthor=F.+Chevallierauthor=H.+Deronzierauthor=C.+Dorleansauthor=E.+Nicolai&title=Design+and+optimization+of+a+series+of+novel+2-cyano-pyrimidines+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DJ.%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DE.%26aulast%3DMcGarry%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DF.%26aulast%3DCaulfield%26aufirst%3DW.%26aulast%3DCumming%26aufirst%3DI.%26aulast%3DDempster%26aufirst%3DM.%26aulast%3DWaller%26aufirst%3DJ.%26aulast%3DScullion%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DMitchell%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DC.%26aulast%3DBaugh%26aufirst%3DM.%26aulast%3DWestwood%26aufirst%3DP.%26aulast%3DKinghorn%26aufirst%3DE.%26aulast%3DBruin%26aufirst%3DJ.%26aulast%3DHamilton%26aufirst%3DW.%26aulast%3DUitdehaag%26aufirst%3DJ.%26aulast%3DvanZeeland%26aufirst%3DM.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DFouquet%26aufirst%3DA.%26aulast%3DChevallier%26aufirst%3DF.%26aulast%3DDeronzier%26aufirst%3DH.%26aulast%3DDorleans%26aufirst%3DC.%26aulast%3DNicolai%26aufirst%3DE.%26atitle%3DDesign%2520and%2520optimization%2520of%2520a%2520series%2520of%2520novel%25202-cyano-pyrimidines%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1524%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazerio, C. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span> </span><span class="NLM_article-title">Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinational kinase-directed heterocycle library</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2182</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0567485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2182-2183&author=Q.+Zhangauthor=Y.+Liuauthor=F.+Gaoauthor=Q.+Dingauthor=C.+Choauthor=W.+Hurauthor=Y.+Jinauthor=T.+Unoauthor=C.+A.+P.+Joazerioauthor=N.+Gray&title=Discovery+of+EGFR+selective+4%2C6-disubstituted+pyrimidines+from+a+combinational+kinase-directed+heterocycle+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja0567485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0567485%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJoazerio%26aufirst%3DC.%2BA.%2BP.%26aulast%3DGray%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520EGFR%2520selective%25204%252C6-disubstituted%2520pyrimidines%2520from%2520a%2520combinational%2520kinase-directed%2520heterocycle%2520library%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2182%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Deane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Submamaryan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manness, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frangione, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liliensiek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlokovic, B.</span><span> </span><span class="NLM_article-title">RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1038%2Fnm890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12808450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFOjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=907-913&author=R.+Deaneauthor=D.+S.+Yanauthor=R.+K.+Submamaryanauthor=B.+LaRueauthor=S.+Jovanovicauthor=E.+Hoggauthor=D.+Welchauthor=L+Mannessauthor=C.+Linauthor=J.+Yuauthor=H.+Zhuauthor=J.+Ghisoauthor=B.+Frangioneauthor=A.+Sternauthor=A.+M.+Schmidtauthor=D.+L.+Armstrongauthor=B.+Arnoldauthor=B.+Liliensiekauthor=P.+Nawrothauthor=F.+Hofmanauthor=M.+Kindyauthor=D.+Sternauthor=B.+Zlokovic&title=RAGE+mediates+amyloid-beta+peptide+transport+across+the+blood-brain+barrier+and+accumulation+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain</span></div><div class="casAuthors">Deane, Rashid; Yan, Shi Du; Submamaryan, Ram Kumar; LaRue, Barbara; Jovanovic, Suzana; Hogg, Elizabeth; Welch, Deborah; Manness, Lawrence; Lin, Chang; Yu, Jin; Zhu, Hong; Ghiso, Jorge; Frangione, Blas; Stern, Alan; Schmidt, Ann Marie; Armstrong, Don L.; Arnold, Bernd; Liliensiek, Birgit; Nawroth, Peter; Hofman, Florence; Kindy, Mark; Stern, David; Zlokovic, Berislav</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">907-913</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress underlying neuronal dysfunction and dementia.  Systemic Aβ infusion and studies in genetically manipulated mice show that Aβ interaction with receptor for advanced glycation end products (RAGE)-bearing cells in the vessel wall results in transport of Aβ across the blood-brain barrier (BBB) and expression of proinflammatory cytokines and endothelin-1 (ET-1), the latter mediating Aβ-induced vasoconstriction.  Inhibition of RAGE-ligand interaction suppresses accumulation of Aβ in brain parenchyma in a mouse transgenic model.  These findings suggest that vascular RAGE is a target for inhibiting pathogenic consequences of Aβ-vascular interactions, including development of cerebral amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzPBfBH_bYLLVg90H21EOLACvtfcHk0ljlvpajDAR3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFOjsL0%253D&md5=b27866af499c76d56d2ea585783863f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm890%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DD.%2BS.%26aulast%3DSubmamaryan%26aufirst%3DR.%2BK.%26aulast%3DLaRue%26aufirst%3DB.%26aulast%3DJovanovic%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DD.%26aulast%3DManness%26aufirst%3DL%26aulast%3DLin%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DStern%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DArmstrong%26aufirst%3DD.%2BL.%26aulast%3DArnold%26aufirst%3DB.%26aulast%3DLiliensiek%26aufirst%3DB.%26aulast%3DNawroth%26aufirst%3DP.%26aulast%3DHofman%26aufirst%3DF.%26aulast%3DKindy%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DZlokovic%26aufirst%3DB.%26atitle%3DRAGE%2520mediates%2520amyloid-beta%2520peptide%2520transport%2520across%2520the%2520blood-brain%2520barrier%2520and%2520accumulation%2520in%2520brain%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D907%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Reviews about soluble Aβ toxicity, see:</p></div><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferreira, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Felice, F. G.</span><span> </span><span class="NLM_article-title">Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=332-345&author=S.+T.+Ferreiraauthor=M.+N.+Vieiraauthor=F.+G.+De+Felice&title=Soluble+protein+oligomers+as+emerging+toxins+in+Alzheimer%E2%80%99s+and+other+amyloid+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BT.%26aulast%3DVieira%26aufirst%3DM.%2BN.%26aulast%3DDe%2BFelice%26aufirst%3DF.%2BG.%26atitle%3DSoluble%2520protein%2520oligomers%2520as%2520emerging%2520toxins%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520amyloid%2520diseases%26jtitle%3DIUBMB%2520Life%26date%3D2007%26volume%3D59%26spage%3D332%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Akira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshi, K.</span><span> </span><span class="NLM_article-title">Amyloid oligomers: Dynamics and toxicity in the cytosol and nucleus</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2010&pages=1369-1379&author=K.+Akiraauthor=K.+Hiroshi&title=Amyloid+oligomers%3A+Dynamics+and+toxicity+in+the+cytosol+and+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DK.%26aulast%3DHiroshi%26aufirst%3DK.%26atitle%3DAmyloid%2520oligomers%253A%2520Dynamics%2520and%2520toxicity%2520in%2520the%2520cytosol%2520and%2520nucleus%26jtitle%3DFEBS%2520J.%26date%3D2010%26volume%3D277%26spage%3D1369%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyington, J. C.</span><span> </span><span class="NLM_article-title">The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">40762</span><span class="NLM_x">–</span> <span class="NLM_lpage">40770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=40762-40770&author=H.+Parkauthor=J.+C.+Boyington&title=The+1.5+%C3%85+crystal+structure+of+human+receptor+for+advanced+glycation+endproducts+%28RAGE%29+ectodomains+reveals+unique+features+determining+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DBoyington%26aufirst%3DJ.%2BC.%26atitle%3DThe%25201.5%2520%25C3%2585%2520crystal%2520structure%2520of%2520human%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520%2528RAGE%2529%2520ectodomains%2520reveals%2520unique%2520features%2520determining%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D40762%26epage%3D40770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Stern, D.; Yan, S. D.; Schmidt, A. M.; Lamster, I.</span><span> </span><span class="NLM_article-title">Ligand binding site of RAGE and uses thereof</span>. US 2001/0053357 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+Stern&author=S.+D.+Yan&author=A.+M.+Schmidt&author=I.+Lamster&title=Ligand+binding+site+of+RAGE+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DD.%26atitle%3DLigand%2520binding%2520site%2520of%2520RAGE%2520and%2520uses%2520thereof%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>Sybyl, 7.0 ed.; SYBYL molecular modeling software, <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sybyl%2C+7.0+ed.%3B+SYBYL+molecular+modeling+software%2C+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26pub%3DTripos%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kumano-Kuramochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakibara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekizawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, S.</span><span> </span><span class="NLM_article-title">Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1093%2Fjb%2Fmvm213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=18032414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2008&pages=229-236&author=M.+Kumano-Kuramochiauthor=Q.+Xieauthor=Y.+Sakakibaraauthor=S.+Niimiauthor=K.+Sekizawaauthor=S.+Kombaauthor=S.+Machida&title=Expression+and+characterization+of+recombinant+C-terminal+biotinylated+extracellular+domain+of+human+receptor+for+advanced+glycation+end+products+%28hsRAGE%29+in+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli</span></div><div class="casAuthors">Kumano-Kuramochi, Miyuki; Xie, Qiuhong; Sakakibara, Yoshikiyo; Niimi, Setsuko; Sekizawa, Kyoko; Komba, Shiro; Machida, Sachiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-236</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor involved in the development of diabetic complications.  Using an E. coli expression system, we have successfully expressed and purified the C-terminal biotinylated extracellular domain of human RAGE (hsRAGE), which consists of 3 Ig-like domains carrying 3 putative disulfide bonds.  Over 90% of hsRAGE was expressed in sol. form in trxB and gor mutant E. coli strain Origami (DE3).  Most hsRAGE was biotinylated with a C-terminal AviTag, and stably immobilized onto matrix via streptavidin without any treatment.  Immobilized hsRAGE without glycosylation recognized its ligands, such as AGEs.  Biotinylated hsRAGE was also able to apply in the detection of AGEs on microtiter wells like antibodies used in enzyme-linked immunoassay.  SPR anal. demonstrated that the dissocn. const. (Kd) of RAGE for AGE-BSA was 23.1 nM with the 2-state reaction model, and 13.5 nM with the 1:1 binding model, comparable to those of RAGEs on cell surface.  These results indicate that biotinylated hsRAGE must be useful not only in analyzing RAGE-ligand interactions but also detect AGEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotsFyd3rYTXrVg90H21EOLACvtfcHk0ljlvpajDAR3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1KisLg%253D&md5=99b8ad08bd6f0eec6f31a881598b66e7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvm213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvm213%26sid%3Dliteratum%253Aachs%26aulast%3DKumano-Kuramochi%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DSakakibara%26aufirst%3DY.%26aulast%3DNiimi%26aufirst%3DS.%26aulast%3DSekizawa%26aufirst%3DK.%26aulast%3DKomba%26aufirst%3DS.%26aulast%3DMachida%26aufirst%3DS.%26atitle%3DExpression%2520and%2520characterization%2520of%2520recombinant%2520C-terminal%2520biotinylated%2520extracellular%2520domain%2520of%2520human%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528hsRAGE%2529%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Biochem.%26date%3D2008%26volume%3D143%26spage%3D229%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chromy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacor, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span> </span><span class="NLM_article-title">Self-assembly of Abeta(1–42) into globular neurotoxins</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">12749</span><span class="NLM_x">–</span> <span class="NLM_lpage">12760</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi030029q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=12749-12760&author=B.+A.+Chromyauthor=R.+J.+Nowakauthor=M.+P.+Lambertauthor=K.+L.+Violaauthor=L.+Changauthor=P.+T.+Velascoauthor=B.+W.+Jonesauthor=S.+J.+Fernandezauthor=P.+N.+Lacorauthor=P.+Horowitzauthor=C.+E.+Finchauthor=G.+A.+Krafftauthor=W.+L.+Klein&title=Self-assembly+of+Abeta%281%E2%80%9342%29+into+globular+neurotoxins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fbi030029q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030029q%26sid%3Dliteratum%253Aachs%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DNowak%26aufirst%3DR.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BP.%26aulast%3DViola%26aufirst%3DK.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DVelasco%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DB.%2BW.%26aulast%3DFernandez%26aufirst%3DS.%2BJ.%26aulast%3DLacor%26aufirst%3DP.%2BN.%26aulast%3DHorowitz%26aufirst%3DP.%26aulast%3DFinch%26aufirst%3DC.%2BE.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26atitle%3DSelf-assembly%2520of%2520Abeta%25281%25E2%2580%259342%2529%2520into%2520globular%2520neurotoxins%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D12749%26epage%3D12760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dahlgren, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stine, W. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaDu, M. J.</span><span> </span><span class="NLM_article-title">In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">32046</span><span class="NLM_x">–</span> <span class="NLM_lpage">32053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=32046-32053&author=K.+N.+Dahlgrenauthor=A.+M.+Manelliauthor=W.+B.+Stineauthor=L.+K.+Bakerauthor=G.+A.+Krafftauthor=M.+J.+LaDu&title=In+vitro+characterization+of+conditions+for+amyloid-beta+peptide+oligomerization+and+fibrillogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DK.%2BN.%26aulast%3DManelli%26aufirst%3DA.%2BM.%26aulast%3DStine%26aufirst%3DW.%2BB.%26aulast%3DBaker%26aufirst%3DL.%2BK.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520conditions%2520for%2520amyloid-beta%2520peptide%2520oligomerization%2520and%2520fibrillogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D32046%26epage%3D32053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span> </span><span class="NLM_article-title">Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46363</span><span class="NLM_x">–</span> <span class="NLM_lpage">46366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1074%2Fjbc.C400260200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=15385542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46363-46366&author=R.+Kayedauthor=Y.+Sokolovauthor=B.+Edmondsauthor=T.+M.+McIntireauthor=S.+C.+Miltonauthor=J.+E.+Hallauthor=C.+G.+Glabe&title=Permeabilization+of+lipid+bilayers+is+a+common+conformation-dependent+activity+of+soluble+amyloid+oligomers+in+protein+misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</span></div><div class="casAuthors">Kayed, Rakez; Sokolov, Yuri; Edmonds, Brian; McIntire, Theresa M.; Milton, Saskia C.; Hall, James E.; Glabe, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">46363-46366</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid fibrillization is multistep process involving sol. oligomeric intermediates, including spherical oligomers and protofibrils.  Amyloid oligomers have a common, generic structure, and they are intrinsically toxic to cells, even when formed from non-disease related proteins, which implies they also share a common mechanism of pathogenesis and toxicity.  Here we report that sol. oligomers from several types of amyloids specifically increase lipid bilayer conductance regardless of the sequence, while fibrils and sol. low mol. wt. species have no effect.  The increase in membrane conductance occurs without any evidence of discrete channel or pore formation or ion selectivity.  The conductance is dependent on the concn. of oligomers and can be reversed by anti-oligomer antibody.  These results indicate that sol. oligomers from many types of amyloidogenic proteins and peptides increase membrane conductance in a conformation-specific fashion and suggest that this may represent the common primary mechanism of pathogenesis in amyloid-related degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZv4RcRRTY7Vg90H21EOLACvtfcHk0lj8_kltAdzmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaqtr8%253D&md5=ef1f794bf39581185bb3cbadb9091045</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400260200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400260200%26sid%3Dliteratum%253Aachs%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DSokolov%26aufirst%3DY.%26aulast%3DEdmonds%26aufirst%3DB.%26aulast%3DMcIntire%26aufirst%3DT.%2BM.%26aulast%3DMilton%26aufirst%3DS.%2BC.%26aulast%3DHall%26aufirst%3DJ.%2BE.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26atitle%3DPermeabilization%2520of%2520lipid%2520bilayers%2520is%2520a%2520common%2520conformation-dependent%2520activity%2520of%2520soluble%2520amyloid%2520oligomers%2520in%2520protein%2520misfolding%2520diseases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46363%26epage%3D46366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savonenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vehmas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K. I.</span><span> </span><span class="NLM_article-title">Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2006&pages=1149-1162&author=T.+Melnikovaauthor=A.+Savonenkoauthor=Q.+Wangauthor=X.+Liangauthor=T.+Handauthor=L.+Wuauthor=W.+E.+Kaufmannauthor=A.+Vehmasauthor=K.+I.+Andreasson&title=Cycloxygenase-2+activity+promotes+cognitive+deficits+but+not+increased+amyloid+burden+in+a+model+of+Alzheimer%E2%80%99s+disease+in+a+sex-dimorphic+pattern"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DSavonenko%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKaufmann%26aufirst%3DW.%2BE.%26aulast%3DVehmas%26aufirst%3DA.%26aulast%3DAndreasson%26aufirst%3DK.%2BI.%26atitle%3DCycloxygenase-2%2520activity%2520promotes%2520cognitive%2520deficits%2520but%2520not%2520increased%2520amyloid%2520burden%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520a%2520sex-dimorphic%2520pattern%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D141%26spage%3D1149%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Maezawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laferla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L. W.</span><span> </span><span class="NLM_article-title">Congo red and thioflavin-T analogs detect Abeta oligomers</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=17953662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=457-468&author=I.+Maezawaauthor=H.+S.+Hongauthor=R.+Liuauthor=C.+Y.+Wuauthor=R.+H.+Chengauthor=M.+P.+Kungauthor=H.+F.+Kungauthor=K.+S.+Lamauthor=S.+Oddoauthor=F.+M.+Laferlaauthor=L.+W.+Jin&title=Congo+red+and+thioflavin-T+analogs+detect+Abeta+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Congo red and thioflavin-T analogs detect Aβ oligomers</span></div><div class="casAuthors">Maezawa, Izumi; Hong, Hyun-Seok; Liu, Ruiwu; Wu, Chun-Yi; Cheng, R. Holland; Kung, Mei-Ping; Kung, Hank F.; Lam, Kit S.; Oddo, Salvatore; LaFerla, Frank M.; Jin, Lee-Way</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Several small mol. ligands for amyloid-β (Aβ) fibrils deposited in brain have been developed to facilitate radiol. diagnosis of Alzheimer's disease (AD).  Recently, the build-up of Aβ oligomers (AβO) in brain has been recognized as an addnl. hallmark of AD and may play a more significant role in early stages.  Evidence suggests that quant. assessment of AβO would provide a more accurate index of therapeutic effect of drug trials.  Therefore, there is an urgent need to develop methods for efficient identification as well as structural anal. of AβO.  We found that some well established amyloid ligands, analogs of Congo red and thioflavin-T (ThT), bind AβO with high affinity and detect AβO in vitro and in vivo.  Binding studies revealed the presence of binding sites for Congo red- and thioflavin-T-analogs on AβO.  Furthermore, these ligands can be used for imaging intracellular AβO in living cells and animals and as pos. contrast agent for ultrastructural imaging of AβO, two applications useful for structural anal. of AβO in cells.  We propose that by improving the binding affinity of current ligands, in vivo imaging of AβO is feasible by a 'signal subtraction' procedure.  This approach may facilitate the identification of individuals with early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLlAZIbpn1T7Vg90H21EOLACvtfcHk0lj8_kltAdzmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqs70%253D&md5=0bc56e05072d219bfbafee42e418982d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaezawa%26aufirst%3DI.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DR.%2BH.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DLaferla%26aufirst%3DF.%2BM.%26aulast%3DJin%26aufirst%3DL.%2BW.%26atitle%3DCongo%2520red%2520and%2520thioflavin-T%2520analogs%2520detect%2520Abeta%2520oligomers%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D457%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Seungbeom Lee, Dae Gyu Kim, Kyeojin Kim, Taewoo Kim, Semi Lim, Hyejin Kong, Sunghoon Kim, <span class="NLM_string-name hlFld-ContribAuthor">Young-Ger Suh</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminophenylpyrimidines as Novel Inhibitors of Aminoacyl-tRNA Synthetase Interacting Multifunctional Protein 2 (AIMP2)-DX2 for Lung Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 3908-3914. <a href="https://doi.org/10.1021/acs.jmedchem.9b01765" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01765%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminophenylpyrimidines%252Bas%252BNovel%252BInhibitors%252Bof%252BAminoacyl-tRNA%252BSynthetase%252BInteracting%252BMultifunctional%252BProtein%252B2%252B%252528AIMP2%252529-DX2%252Bfor%252BLung%252BCancer%252BTreatment%26aulast%3DLee%26aufirst%3DSeungbeom%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24102019%26date%3D01042020%26date%3D25032020%26volume%3D63%26issue%3D8%26spage%3D3908%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Bongarzone</span>, <span class="hlFld-ContribAuthor ">Vilius  Savickas</span>, <span class="hlFld-ContribAuthor ">Federico  Luzi</span>, and <span class="hlFld-ContribAuthor ">Antony D.  Gee</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7213-7232. <a href="https://doi.org/10.1021/acs.jmedchem.7b00058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BReceptor%252Bfor%252BAdvanced%252BGlycation%252BEndproducts%252B%252528RAGE%252529%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DBongarzone%26aufirst%3DSalvatore%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12012017%26date%3D19052017%26date%3D14092017%26date%3D08052017%26volume%3D60%26issue%3D17%26spage%3D7213%26epage%3D7232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nguyen Huu Trong  Phan</span>, <span class="hlFld-ContribAuthor ">Hyeji  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunik  Shin</span>, <span class="hlFld-ContribAuthor ">Hee-Seung  Lee</span>, and <span class="hlFld-ContribAuthor ">Jeong-Hun  Sohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Dehydrosulfurative C–N Cross-Coupling and Concomitant Oxidative Dehydrogenation for One-Step Synthesis of 2-Aryl(alkyl)aminopyrimidines from 3,4-Dihydropyrimidin-1H-2-thiones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (19)
                                     , 5154-5157. <a href="https://doi.org/10.1021/acs.orglett.6b02617" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02617%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDehydrosulfurative%252BC%2525E2%252580%252593N%252BCross-Coupling%252Band%252BConcomitant%252BOxidative%252BDehydrogenation%252Bfor%252BOne-Step%252BSynthesis%252Bof%252B2-Aryl%252528alkyl%252529aminopyrimidines%252Bfrom%252B3%25252C4-Dihydropyrimidin-1H-2-thiones%26aulast%3DPhan%26aufirst%3DNguyen%2BHuu%2BTrong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31082016%26date%3D28092016%26date%3D07102016%26volume%3D18%26issue%3D19%26spage%3D5154%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian P.  Cary</span>, <span class="hlFld-ContribAuthor ">Allen F.  Brooks</span>, <span class="hlFld-ContribAuthor ">Maria V.  Fawaz</span>, <span class="hlFld-ContribAuthor ">Lindsey R.  Drake</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Desmond</span>, <span class="hlFld-ContribAuthor ">Phillip  Sherman</span>, <span class="hlFld-ContribAuthor ">Carole A.  Quesada</span>, and <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 391-398. <a href="https://doi.org/10.1021/acschemneuro.5b00319" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252B%25255B18F%25255DRAGER%25253A%252BA%252BFirst%252BGeneration%252BSmall-Molecule%252BPET%252BRadioligand%252BTargeting%252Bthe%252BReceptor%252Bfor%252BAdvanced%252BGlycation%252BEndproducts%26aulast%3DCary%26aufirst%3DBrian%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04122015%26date%3D15012016%26date%3D01022016%26date%3D16032016%26date%3D15012016%26volume%3D7%26issue%3D3%26spage%3D391%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeon Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Mi Suk  Jeong</span>, <span class="hlFld-ContribAuthor ">Se Bok  Jang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (13)
                                     , 6904. <a href="https://doi.org/10.3390/ijms22136904" title="DOI URL">https://doi.org/10.3390/ijms22136904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22136904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22136904%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMolecular%252BCharacteristics%252Bof%252BRAGE%252Band%252BAdvances%252Bin%252BSmall-Molecule%252BInhibitors%26aulast%3DKim%26aufirst%3DHyeon%2BJin%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D13%26spage%3D6904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teruki  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Michiyo  Matsuno</span>, <span class="hlFld-ContribAuthor ">Norihito  Ikui</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Mizushina</span>, <span class="hlFld-ContribAuthor ">Yume  Omiya</span>, <span class="hlFld-ContribAuthor ">Rikako  Ishibashi</span>, <span class="hlFld-ContribAuthor ">Taro  Ueda</span>, <span class="hlFld-ContribAuthor ">Hajime  Mizukami</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Medicines</span><span> <strong>2021,</strong> <em>75 </em>
                                    (3)
                                     , 675-681. <a href="https://doi.org/10.1007/s11418-021-01495-0" title="DOI URL">https://doi.org/10.1007/s11418-021-01495-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11418-021-01495-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11418-021-01495-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Medicines%26atitle%3DIdentification%252Bof%252Bpheophorbide%252Ba%252Bas%252Ban%252Binhibitor%252Bof%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252Bin%252BMallotus%252Bjaponicus%26aulast%3DMatsumoto%26aufirst%3DTeruki%26date%3D2021%26date%3D2021%26volume%3D75%26issue%3D3%26spage%3D675%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexey Yu.  Dubovtsev</span>, <span class="hlFld-ContribAuthor ">Valeria V.  Zvereva</span>, <span class="hlFld-ContribAuthor ">Nikolay V.  Shcherbakov</span>, <span class="hlFld-ContribAuthor ">Dmitry V.  Dar'in</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Novikov</span>, <span class="hlFld-ContribAuthor ">Vadim Yu.  Kukushkin</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-catalyzed [2 + 2 + 2] cycloaddition of two cyanamides and one ynamide: highly regioselective synthesis of 2,4,6-triaminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (20)
                                     , 4577-4584. <a href="https://doi.org/10.1039/D1OB00513H" title="DOI URL">https://doi.org/10.1039/D1OB00513H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00513H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00513H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAcid-catalyzed%252B%25255B2%252B%25252B%252B2%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252Btwo%252Bcyanamides%252Band%252Bone%252Bynamide%25253A%252Bhighly%252Bregioselective%252Bsynthesis%252Bof%252B2%25252C4%25252C6-triaminopyrimidines%26aulast%3DDubovtsev%26aufirst%3DAlexey%2BYu.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D20%26spage%3D4577%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janki J.  Patel</span>, <span class="hlFld-ContribAuthor ">Mayur I.  Morja</span>, <span class="hlFld-ContribAuthor ">Kishor H.  Chikhalia</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of designed 4‐thiazolidinone fused pyrimidine derivatives as potent antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (10)
                                     , 3531-3543. <a href="https://doi.org/10.1002/jhet.4070" title="DOI URL">https://doi.org/10.1002/jhet.4070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252Bdesigned%252B4%2525E2%252580%252590thiazolidinone%252Bfused%252Bpyrimidine%252Bderivatives%252Bas%252Bpotent%252Bantimicrobial%252Bagents%26aulast%3DPatel%26aufirst%3DJanki%2BJ.%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D10%26spage%3D3531%26epage%3D3543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chhabi Lal  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Prakash  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Sadan  Dahal</span>, <span class="hlFld-ContribAuthor ">Dawon  Bae</span>, <span class="hlFld-ContribAuthor ">Tae-gyu  Nam</span>, <span class="hlFld-ContribAuthor ">Jung-Ae  Kim</span>, <span class="hlFld-ContribAuthor ">Byeong-Seon  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-ol. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104130. <a href="https://doi.org/10.1016/j.bioorg.2020.104130" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104130%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DInhibition%252Bof%252Bcolitis%252Bby%252Bring-modified%252Banalogues%252Bof%252B6-acetamido-2%25252C4%25252C5-trimethylpyridin-3-ol%26aulast%3DChaudhary%26aufirst%3DChhabi%2BLal%26date%3D2020%26volume%3D103%26spage%3D104130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrizia  Hrelia</span>, <span class="hlFld-ContribAuthor ">Giulia  Sita</span>, <span class="hlFld-ContribAuthor ">Marina  Ziche</span>, <span class="hlFld-ContribAuthor ">Emma  Ristori</span>, <span class="hlFld-ContribAuthor ">Angela  Marino</span>, <span class="hlFld-ContribAuthor ">Marika  Cordaro</span>, <span class="hlFld-ContribAuthor ">Raffaella  Molteni</span>, <span class="hlFld-ContribAuthor ">Vittoria  Spero</span>, <span class="hlFld-ContribAuthor ">Marco  Malaguti</span>, <span class="hlFld-ContribAuthor ">Fabiana  Morroni</span>, <span class="hlFld-ContribAuthor ">Silvana  Hrelia</span>. </span><span class="cited-content_cbyCitation_article-title">Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-18. <a href="https://doi.org/10.1155/2020/8363245" title="DOI URL">https://doi.org/10.1155/2020/8363245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/8363245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F8363245%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DCommon%252BProtective%252BStrategies%252Bin%252BNeurodegenerative%252BDisease%25253A%252BFocusing%252Bon%252BRisk%252BFactors%252Bto%252BTarget%252Bthe%252BCellular%252BRedox%252BSystem%26aulast%3DHrelia%26aufirst%3DPatrizia%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David Z  Huang</span>, <span class="hlFld-ContribAuthor ">Valentina L  Kouznetsova</span>, <span class="hlFld-ContribAuthor ">Igor F  Tsigelny</span>. </span><span class="cited-content_cbyCitation_article-title">Deep-learning- and pharmacophore-based prediction of RAGE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Physical Biology</span><span> <strong>2020,</strong> <em>17 </em>
                                    (3)
                                     , 036003. <a href="https://doi.org/10.1088/1478-3975/ab6819" title="DOI URL">https://doi.org/10.1088/1478-3975/ab6819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1478-3975/ab6819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1478-3975%2Fab6819%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Biology%26atitle%3DDeep-learning-%252Band%252Bpharmacophore-based%252Bprediction%252Bof%252BRAGE%252Binhibitors%26aulast%3DHuang%26aufirst%3DDavid%2BZ%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D3%26spage%3D036003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Daniele  Tedesco</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Lara  Davani</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced analytical methodologies in Alzheimer’s disease drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>178 </em>, 112899. <a href="https://doi.org/10.1016/j.jpba.2019.112899" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.112899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.112899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.112899%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DAdvanced%252Banalytical%252Bmethodologies%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bdrug%252Bdiscovery%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2020%26volume%3D178%26spage%3D112899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  An</span>, <span class="hlFld-ContribAuthor ">Jia-dong  Liu</span>, <span class="hlFld-ContribAuthor ">Xian-na  Peng</span>, <span class="hlFld-ContribAuthor ">You-guang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chan  Wang</span>, <span class="hlFld-ContribAuthor ">Tong-hui  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation and
              in vitro
              bioactivity evaluation of N-heterocyclic-linked dihomooxacalix[4]arene derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (70)
                                     , 41287-41297. <a href="https://doi.org/10.1039/C9RA06876G" title="DOI URL">https://doi.org/10.1039/C9RA06876G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA06876G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA06876G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPreparation%252Band%252Bin%252Bvitro%252Bbioactivity%252Bevaluation%252Bof%252BN-heterocyclic-linked%252Bdihomooxacalix%25255B4%25255Darene%252Bderivatives%26aulast%3DAn%26aufirst%3DLin%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D70%26spage%3D41287%26epage%3D41297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Shin  Ding</span>, <span class="hlFld-ContribAuthor ">Noeen  Malik</span>, <span class="hlFld-ContribAuthor ">Sebastian  Mendoza</span>, <span class="hlFld-ContribAuthor ">Daniel  Tuchman</span>, <span class="hlFld-ContribAuthor ">Carmen Hurtado  Del Pozo</span>, <span class="hlFld-ContribAuthor ">Raquel Lopez  Diez</span>, <span class="hlFld-ContribAuthor ">Ann-Marie  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">PET imaging study of brown adipose tissue (BAT) activity in mice devoid of receptor for advanced glycation end products (RAGE). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biosciences</span><span> <strong>2019,</strong> <em>44 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s12038-019-9900-8" title="DOI URL">https://doi.org/10.1007/s12038-019-9900-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12038-019-9900-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12038-019-9900-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biosciences%26atitle%3DPET%252Bimaging%252Bstudy%252Bof%252Bbrown%252Badipose%252Btissue%252B%252528BAT%252529%252Bactivity%252Bin%252Bmice%252Bdevoid%252Bof%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252B%252528RAGE%252529%26aulast%3DDing%26aufirst%3DYu-Shin%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azime Berna  Özçelik</span>, <span class="hlFld-ContribAuthor ">Mevlüt  Akdağ</span>, <span class="hlFld-ContribAuthor ">Muhammed  Ergün</span>, <span class="hlFld-ContribAuthor ">Mehtap  Uysal</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer Hastalığının Tedavisinde Kullanılan İlaçlar ve Yeni Yaklaşımlar. </span><span class="cited-content_cbyCitation_journal-name">Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.18185/erzifbed.591088" title="DOI URL">https://doi.org/10.18185/erzifbed.591088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18185/erzifbed.591088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18185%2Ferzifbed.591088%26sid%3Dliteratum%253Aachs%26jtitle%3DErzincan%2520%25C3%259Cniversitesi%2520Fen%2520Bilimleri%2520Enstit%25C3%25BCs%25C3%25BC%2520Dergisi%26atitle%3DAlzheimer%252BHastal%2525C4%2525B1%2525C4%25259F%2525C4%2525B1n%2525C4%2525B1n%252BTedavisinde%252BKullan%2525C4%2525B1lan%252B%2525C4%2525B0la%2525C3%2525A7lar%252Bve%252BYeni%252BYakla%2525C5%25259F%2525C4%2525B1mlar%26aulast%3D%25C3%2596z%25C3%25A7elik%26aufirst%3DAzime%2BBerna%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Armando  Rojas</span>, <span class="hlFld-ContribAuthor ">Miguel  Morales</span>, <span class="hlFld-ContribAuthor ">Ileana  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Paulina  Araya</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of RAGE Axis Signaling: A Pharmacological Challenge. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (3)
                                     , 340-346. <a href="https://doi.org/10.2174/1389450119666180820105956" title="DOI URL">https://doi.org/10.2174/1389450119666180820105956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450119666180820105956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450119666180820105956%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DInhibition%252Bof%252BRAGE%252BAxis%252BSignaling%25253A%252BA%252BPharmacological%252BChallenge%26aulast%3DRojas%26aufirst%3DArmando%26date%3D2019%26volume%3D20%26issue%3D3%26spage%3D340%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Sheng  Ma</span>, <span class="hlFld-ContribAuthor ">Yongfang  Yao</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">Siqi  Feng</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 555-567. <a href="https://doi.org/10.1016/j.ejmech.2018.11.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand-based%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bxanthine%252Bderivatives%252Bas%252BLSD1%25252FKDM1A%252Binhibitors%26aulast%3DMa%26aufirst%3DQi-Sheng%26date%3D2019%26volume%3D162%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Riuzzi</span>, <span class="hlFld-ContribAuthor ">Guglielmo  Sorci</span>, <span class="hlFld-ContribAuthor ">Roberta  Sagheddu</span>, <span class="hlFld-ContribAuthor ">Sara  Chiappalupi</span>, <span class="hlFld-ContribAuthor ">Laura  Salvadori</span>, <span class="hlFld-ContribAuthor ">Rosario  Donato</span>. </span><span class="cited-content_cbyCitation_article-title">RAGE in the pathophysiology of skeletal muscle. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cachexia, Sarcopenia and Muscle</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 1213-1234. <a href="https://doi.org/10.1002/jcsm.12350" title="DOI URL">https://doi.org/10.1002/jcsm.12350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcsm.12350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcsm.12350%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cachexia%252C%2520Sarcopenia%2520and%2520Muscle%26atitle%3DRAGE%252Bin%252Bthe%252Bpathophysiology%252Bof%252Bskeletal%252Bmuscle%26aulast%3DRiuzzi%26aufirst%3DFrancesca%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D7%26spage%3D1213%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ngoc Son  Le Pham</span>, <span class="hlFld-ContribAuthor ">Jihong  Lee</span>, <span class="hlFld-ContribAuthor ">Hyunik  Shin</span>, <span class="hlFld-ContribAuthor ">Jeong-Hun  Sohn</span>. </span><span class="cited-content_cbyCitation_article-title">Decarboxylative cross-couplings of 2-aminopyrimidine-5-carboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (28)
                                     , 3843-3851. <a href="https://doi.org/10.1016/j.tet.2018.05.018" title="DOI URL">https://doi.org/10.1016/j.tet.2018.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDecarboxylative%252Bcross-couplings%252Bof%252B2-aminopyrimidine-5-carboxylic%252Bacids%26aulast%3DLe%2BPham%26aufirst%3DNgoc%2BSon%26date%3D2018%26volume%3D74%26issue%3D28%26spage%3D3843%26epage%3D3851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barry I.  Hudson</span>, <span class="hlFld-ContribAuthor ">Marc E.  Lippman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting RAGE Signaling in Inflammatory Disease. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Medicine</span><span> <strong>2018,</strong> <em>69 </em>
                                    (1)
                                     , 349-364. <a href="https://doi.org/10.1146/annurev-med-041316-085215" title="DOI URL">https://doi.org/10.1146/annurev-med-041316-085215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-med-041316-085215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-med-041316-085215%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Medicine%26atitle%3DTargeting%252BRAGE%252BSignaling%252Bin%252BInflammatory%252BDisease%26aulast%3DHudson%26aufirst%3DBarry%2BI.%26date%3D2018%26volume%3D69%26issue%3D1%26spage%3D349%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karthik  Dhananjayan</span>, <span class="hlFld-ContribAuthor ">Josephine  Forbes</span>, <span class="hlFld-ContribAuthor ">Gerald  Münch</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced Glycation, Diabetes, and Dementia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 169-193. <a href="https://doi.org/10.1016/B978-0-12-809454-9.00009-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-809454-9.00009-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809454-9.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809454-9.00009-3%26sid%3Dliteratum%253Aachs%26atitle%3DAdvanced%252BGlycation%25252C%252BDiabetes%25252C%252Band%252BDementia%26aulast%3DDhananjayan%26aufirst%3DKarthik%26date%3D2018%26spage%3D169%26epage%3D193%26pub%3DElsevier%26atitle%3DType%252B2%252BDiabetes%252Band%252BDementia%26date%3D2018%26volume%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Shekhtman</span>, <span class="hlFld-ContribAuthor ">Ravichandran  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Ann Marie  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Glycation & the RAGE axis: targeting signal transduction through DIAPH1. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Proteomics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (2)
                                     , 147-156. <a href="https://doi.org/10.1080/14789450.2017.1271719" title="DOI URL">https://doi.org/10.1080/14789450.2017.1271719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14789450.2017.1271719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14789450.2017.1271719%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Proteomics%26atitle%3DGlycation%252B%252526%252Bthe%252BRAGE%252Baxis%25253A%252Btargeting%252Bsignal%252Btransduction%252Bthrough%252BDIAPH1%26aulast%3DShekhtman%26aufirst%3DAlexander%26date%3D2017%26date%3D2016%26volume%3D14%26issue%3D2%26spage%3D147%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Jie  Wei</span>, <span class="hlFld-ContribAuthor ">Zheng-jun  Quan</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-xia  Da</span>, <span class="hlFld-ContribAuthor ">Xi-cun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(
              i
              ) chloride promoted Csp
              2
              –N cross-coupling of 1,2-di(pyrimidin-2-yl) disulfides with amines: an efficient approach to obtain C2-amino functionalized pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (8)
                                     , 2395-2398. <a href="https://doi.org/10.1039/C5OB02535D" title="DOI URL">https://doi.org/10.1039/C5OB02535D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02535D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02535D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper%252528%252Bi%252B%252529%252Bchloride%252Bpromoted%252BCsp%252B2%252B%2525E2%252580%252593N%252Bcross-coupling%252Bof%252B1%25252C2-di%252528pyrimidin-2-yl%252529%252Bdisulfides%252Bwith%252Bamines%25253A%252Ban%252Befficient%252Bapproach%252Bto%252Bobtain%252BC2-amino%252Bfunctionalized%252Bpyrimidines%26aulast%3DWei%26aufirst%3DKai-Jie%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D8%26spage%3D2395%26epage%3D2398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seok-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Young Taek  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of pyrimidine-2-carboxamide analogs: investigation for novel RAGE inhibitors with reduced hydrophobicity and toxicity. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2015,</strong> <em>38 </em>
                                    (11)
                                     , 1952-1962. <a href="https://doi.org/10.1007/s12272-015-0596-5" title="DOI URL">https://doi.org/10.1007/s12272-015-0596-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-015-0596-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-015-0596-5%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine-2-carboxamide%252Banalogs%25253A%252Binvestigation%252Bfor%252Bnovel%252BRAGE%252Binhibitors%252Bwith%252Breduced%252Bhydrophobicity%252Band%252Btoxicity%26aulast%3DKim%26aufirst%3DSeok-Ho%26date%3D2015%26date%3D2015%26volume%3D38%26issue%3D11%26spage%3D1952%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyeojin  Kim</span>, <span class="hlFld-ContribAuthor ">Su-Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Young Taek  Han</span>, <span class="hlFld-ContribAuthor ">Sung-Jun  Hong</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Dong-Jo  Chang</span>, <span class="hlFld-ContribAuthor ">Taewoo  Kim</span>, <span class="hlFld-ContribAuthor ">Bumhee  Lim</span>, <span class="hlFld-ContribAuthor ">Jeeyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Young-Joon  Surh</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5444-5448. <a href="https://doi.org/10.1016/j.bmcl.2015.07.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bthe%252BSTAT3%252Bsignaling%252Bpathway%25253A%252BInsights%252Binto%252Btheir%252Bstructural%252Bfeatures%252Band%252Bmode%252Bof%252Baction%26aulast%3DKim%26aufirst%3DKyeojin%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5444%26epage%3D5448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Genny  Degani</span>, <span class="hlFld-ContribAuthor ">Mara  Colzani</span>, <span class="hlFld-ContribAuthor ">Alberto  Tettamanzi</span>, <span class="hlFld-ContribAuthor ">Luca  Sorrentino</span>, <span class="hlFld-ContribAuthor ">Alessandro  Aliverti</span>, <span class="hlFld-ContribAuthor ">Guenter  Fritz</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Aldini</span>, <span class="hlFld-ContribAuthor ">Laura  Popolo</span>. </span><span class="cited-content_cbyCitation_article-title">An improved expression system for the VC1 ligand binding domain of the receptor for advanced glycation end products in Pichia pastoris. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2015,</strong> <em>114 </em>, 48-57. <a href="https://doi.org/10.1016/j.pep.2015.06.012" title="DOI URL">https://doi.org/10.1016/j.pep.2015.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2015.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2015.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DAn%252Bimproved%252Bexpression%252Bsystem%252Bfor%252Bthe%252BVC1%252Bligand%252Bbinding%252Bdomain%252Bof%252Bthe%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252Bin%252BPichia%252Bpastoris%26aulast%3DDegani%26aufirst%3DGenny%26date%3D2015%26volume%3D114%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Goo  Kang</span>, <span class="hlFld-ContribAuthor ">Chan-Yong  Park</span>, <span class="hlFld-ContribAuthor ">Hongsuk  Shin</span>, <span class="hlFld-ContribAuthor ">Ramandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Garima  Arora</span>, <span class="hlFld-ContribAuthor ">Chan-mo  Yu</span>, <span class="hlFld-ContribAuthor ">Ill Young  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3650-3653. <a href="https://doi.org/10.1016/j.bmcl.2015.06.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Banti-tubercular%252Bactivity%252Bof%252B2-nitroimidazooxazines%252Bwith%252Bmodification%252Bat%252Bthe%252BC-7%252Bposition%252Bas%252BPA-824%252Banalogs%26aulast%3DKang%26aufirst%3DYoung-Goo%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3650%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kwanghyun  Choi</span>, <span class="hlFld-ContribAuthor ">Kwang Su  Lim</span>, <span class="hlFld-ContribAuthor ">Juhee  Shin</span>, <span class="hlFld-ContribAuthor ">Seo Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>, <span class="hlFld-ContribAuthor ">Hyun-Seok  Hong</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4919-4935. <a href="https://doi.org/10.1016/j.bmc.2015.05.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D6-Phenoxy-2-phenylbenzoxazoles%25252C%252Bnovel%252Binhibitors%252Bof%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252B%252528RAGE%252529%26aulast%3DChoi%26aufirst%3DKwanghyun%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4919%26epage%3D4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng-Jun  Quan</span>, <span class="hlFld-ContribAuthor ">Hai-Peng  Gong</span>, <span class="hlFld-ContribAuthor ">Yu-Xia  Da</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xi-Cun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(I) carboxylate catalyzed C–N coupling of 2-amino pyrimidines with aryl halides to selectively generate secondary and tertiary amines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (14)
                                     , 2113-2118. <a href="https://doi.org/10.1016/j.tet.2015.02.047" title="DOI URL">https://doi.org/10.1016/j.tet.2015.02.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.02.047%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper%252528I%252529%252Bcarboxylate%252Bcatalyzed%252BC%2525E2%252580%252593N%252Bcoupling%252Bof%252B2-amino%252Bpyrimidines%252Bwith%252Baryl%252Bhalides%252Bto%252Bselectively%252Bgenerate%252Bsecondary%252Band%252Btertiary%252Bamines%26aulast%3DZhang%26aufirst%3DYue%26date%3D2015%26volume%3D71%26issue%3D14%26spage%3D2113%26epage%3D2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Taek  Han</span>, <span class="hlFld-ContribAuthor ">Kyeojin  Kim</span>, <span class="hlFld-ContribAuthor ">Dohyun  Son</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Jeeyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Hyun-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>. </span><span class="cited-content_cbyCitation_article-title">Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (3)
                                     , 579-587. <a href="https://doi.org/10.1016/j.bmc.2014.12.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFine%252Btuning%252Bof%252B4%25252C6-bisphenyl-2-%2525283-alkoxyanilino%252529pyrimidine%252Bfocusing%252Bon%252Bthe%252Bactivity-sensitive%252Baminoalkoxy%252Bmoiety%252Bfor%252Ba%252Btherapeutically%252Buseful%252Binhibitor%252Bof%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252B%252528RAGE%252529%26aulast%3DHan%26aufirst%3DYoung%2BTaek%26date%3D2015%26volume%3D23%26issue%3D3%26spage%3D579%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Taek  Han</span>, <span class="hlFld-ContribAuthor ">Kyeojin  Kim</span>, <span class="hlFld-ContribAuthor ">Gyeong-In  Choi</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Dohyun  Son</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Jun-Hyeng  Son</span>, <span class="hlFld-ContribAuthor ">Suk-Jae  Chung</span>, <span class="hlFld-ContribAuthor ">Hyun-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>79 </em>, 128-142. <a href="https://doi.org/10.1016/j.ejmech.2014.03.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazole-5-carboxamides%25252C%252Bnovel%252Binhibitors%252Bof%252Breceptor%252Bfor%252Badvanced%252Bglycation%252Bend%252Bproducts%252B%252528RAGE%252529%26aulast%3DHan%26aufirst%3DYoung%2BTaek%26date%3D2014%26volume%3D79%26spage%3D128%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parveen  Salahuddin</span>, <span class="hlFld-ContribAuthor ">Gulam  Rabbani</span>, <span class="hlFld-ContribAuthor ">Rizwan  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Biology Letters</span><span> <strong>2014,</strong> <em>19 </em>
                                    (3)
                                     <a href="https://doi.org/10.2478/s11658-014-0205-5" title="DOI URL">https://doi.org/10.2478/s11658-014-0205-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2478/s11658-014-0205-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2478%2Fs11658-014-0205-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Biology%2520Letters%26atitle%3DThe%252Brole%252Bof%252Badvanced%252Bglycation%252Bend%252Bproducts%252Bin%252Bvarious%252Btypes%252Bof%252Bneurodegenerative%252Bdisease%25253A%252Ba%252Btherapeutic%252Bapproach%26aulast%3DSalahuddin%26aufirst%3DParveen%26date%3D2014%26volume%3D19%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan T.  Ross</span>, <span class="hlFld-ContribAuthor ">Rashid  Deane</span>, <span class="hlFld-ContribAuthor ">Sheldon  Perry</span>, <span class="hlFld-ContribAuthor ">Benjamin L.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of small molecule inhibitors of RAGE-Aβ binding. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (36)
                                     , 7653-7658. <a href="https://doi.org/10.1016/j.tet.2013.05.079" title="DOI URL">https://doi.org/10.1016/j.tet.2013.05.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.05.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.05.079%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bof%2525C2%2525A0RAGE-A%2525CE%2525B2%252Bbinding%26aulast%3DRoss%26aufirst%3DNathan%2BT.%26date%3D2013%26volume%3D69%26issue%3D36%26spage%3D7653%26epage%3D7658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenhui  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-neuroinflammatory agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (13)
                                     , 1559-1571. <a href="https://doi.org/10.4155/fmc.13.125" title="DOI URL">https://doi.org/10.4155/fmc.13.125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.125%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAnti-neuroinflammatory%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhou%26aufirst%3DWei%26date%3D2013%26volume%3D5%26issue%3D13%26spage%3D1559%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giancarlo  Aldini</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>, <span class="hlFld-ContribAuthor ">N.  Chondrogianni</span>, <span class="hlFld-ContribAuthor ">Tilman  Grune</span>, <span class="hlFld-ContribAuthor ">Jolanta  Sereikaite</span>, <span class="hlFld-ContribAuthor ">Izabela  Sadowska-Bartosz</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Bartosz</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Research</span><span> <strong>2013,</strong> <em>47 </em>
                                    (sup1)
                                     , 93-137. <a href="https://doi.org/10.3109/10715762.2013.792926" title="DOI URL">https://doi.org/10.3109/10715762.2013.792926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10715762.2013.792926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10715762.2013.792926%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Research%26atitle%3DMolecular%252Bstrategies%252Bto%252Bprevent%25252C%252Binhibit%25252C%252Band%252Bdegrade%252Badvanced%252Bglycoxidation%252Band%252Badvanced%252Blipoxidation%252Bend%252Bproducts%26aulast%3DAldini%26aufirst%3DGiancarlo%26date%3D2013%26date%3D2013%26volume%3D47%26issue%3Dsup1%26spage%3D93%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh J.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Arvind M.  Korwar</span>, <span class="hlFld-ContribAuthor ">Sheon  Mary</span>, <span class="hlFld-ContribAuthor ">Hemangi S.  Bhonsle</span>, <span class="hlFld-ContribAuthor ">Ashok P.  Giri</span>. </span><span class="cited-content_cbyCitation_article-title">Glycated proteome: From reaction to intervention. </span><span class="cited-content_cbyCitation_journal-name">PROTEOMICS - Clinical Applications</span><span> <strong>2013,</strong> <em>7 </em>
                                    (1-2)
                                     , 155-170. <a href="https://doi.org/10.1002/prca.201200101" title="DOI URL">https://doi.org/10.1002/prca.201200101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prca.201200101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprca.201200101%26sid%3Dliteratum%253Aachs%26jtitle%3DPROTEOMICS%2520-%2520Clinical%2520Applications%26atitle%3DGlycated%252Bproteome%25253A%252BFrom%252Breaction%252Bto%252Bintervention%26aulast%3DKulkarni%26aufirst%3DMahesh%2BJ.%26date%3D2013%26date%3D2013%26volume%3D7%26issue%3D1-2%26spage%3D155%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy K.  Lane</span>, <span class="hlFld-ContribAuthor ">Minh H.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Brendan R.  D'Souza</span>, <span class="hlFld-ContribAuthor ">Nathan A.  Spahn</span>, <span class="hlFld-ContribAuthor ">Janis  Louie</span>. </span><span class="cited-content_cbyCitation_article-title">The iron-catalyzed construction of 2-aminopyrimidines from alkynenitriles and cyanamides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2013,</strong> <em>49 </em>
                                    (70)
                                     , 7735. <a href="https://doi.org/10.1039/c3cc44422h" title="DOI URL">https://doi.org/10.1039/c3cc44422h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3cc44422h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3cc44422h%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DThe%252Biron-catalyzed%252Bconstruction%252Bof%252B2-aminopyrimidines%252Bfrom%252Balkynenitriles%252Band%252Bcyanamides%26aulast%3DLane%26aufirst%3DTimothy%2BK.%26date%3D2013%26volume%3D49%26issue%3D70%26spage%3D7735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of argpyrimidine <b>1</b> and overall strategy for the design of novel RAGE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-Acyl and <i>N</i>-Alkyl Pyrimidol Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr or MeI, CsCO<sub>3</sub>, CH<sub>3</sub>CN, rt; (b) γ-butyrolactone or δ-valerolactone, Me<sub>3</sub>Al, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>CN, rt; (d) CrO<sub>3</sub>, aq. H<sub>2</sub>SO<sub>4</sub>/acetone, rt; (e) K<sub>2</sub>CO<sub>3</sub>, Et<sub>2</sub>NH, rt; (f) LAH, THF, rt; (g) Pd(OH)<sub>2</sub>, H<sub>2</sub>, MeOH, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Chloropyrimidine Intermediates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-chlorophenylboronic acid (2.5 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (b) 4-chlorophenylboronic acid (1.1 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme/H<sub>2</sub>O, 70 °C; (c) cyclic amines or aniline, EtOH, rt; (d) cyclohexylzinc bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; (e) boronic acids, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (f) R<sub>4</sub>(CH<sub>2</sub>)<sub><i>n</i></sub>OH, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, rt; (g) 4-chlorophenylboronic acid, Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, 4 Ǻ MS, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Naphthyloxyphenyl 2-Chloropyrimidine <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) naphthalen-2-ol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) EtOAc, EtOH, NaH, 18-crown-6, THF, reflux; (c) urea, <i>c</i>-HCl, EtOH, reflux; (d) POCl<sub>3</sub>, reflux.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amino- and Bromophenyl Ethers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>N</i>-diethyl ethanolamine, diisopropyl azodicarboxylate, PPh<sub>3</sub>, THF, rt; (b) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>N</i>-Aryl Pyrimidol Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, CsCO<sub>3</sub>, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, <b>30d</b>, toluene, reflux; (b) Pd(OH)<sub>2</sub>, H<sub>2</sub>, MeOH, rt.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>N</i>-Aryl Pyrimidine Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>31a</b>–<b>31c</b>, 4 N HCl in dioxane, <i>n</i>-BuOH, 160 °C (microwave irradiation).</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR study on the binding of analog <b>59</b> with RAGE. The real-time interaction of <b>59</b> with biotinylated RAGE was assessed by measuring the surface plasmon resonance (SPR). RU, resonance units. Typical SPR response curves were measured using a series of concentrations of the tested compounds. The response values were normalized by subtracting the response value of the empty channel. The kinetic and equilibrium constants, shown in the text, were obtained by a global fit, using the Langmuir 1:1 bimolecular kinetic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/medium/jm-2012-00172z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding modes of the 4,6-diphenylpyrimidine analogs <b>58</b>–<b>60</b> on the RAGE V-domain. Superpositioning of the docking poses of <b>58</b>–<b>60</b> in the binding site of RAGE obtained by Surflex-Dock. (left) Ligand atoms are rendered in capped stick. The colors are as follows: <b>58</b> in blue, <b>59</b> in orange, and <b>60</b> in magenta. Yellow dotted lines indicate common hydrogen bonds between each compound and the receptor. Red dotted lines are additional hydrogen bonds of <b>59</b> with the receptor. Key residues of the receptor are shown in stick (gray carbon). Green cartoons represent the backbone of RAGE. (right) The surface of RAGE was rendered based on the electrostatic properties; a color gradient from red to violet is used to color the molecular surface, where red and violet are for positive and negative electrostatic surface potential, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300172z/production/images/large/jm-2012-00172z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300172z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i112">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Sciences</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lg5IvPG_QcLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DSciences%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Aderinwale, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mousa, S. A.</span><span> </span><span class="NLM_article-title">Current therapies and new strategies for the management of Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Alzheimers Dis. Other Dementias</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1177%2F1533317510372372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20601643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BC3cjgtFKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=414-424&author=O.+G.+Aderinwaleauthor=H.+W.+Ernstauthor=S.+A.+Mousa&title=Current+therapies+and+new+strategies+for+the+management+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Current therapies and new strategies for the management of Alzheimer's disease</span></div><div class="casAuthors">Aderinwale Olapeju G; Ernst Hans W; Mousa Shaker A</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disorder that currently affects millions of Americans.  There is no cure at present and no real long-term hope for patients with AD.  While partially effective in improving symptoms, currently available treatments approved by the US Food and Drug Administration (FDA) do not halt progression of AD, or address the underlying mechanism of the disease, in part because the etiology of AD is still an active area of investigation.  Identification of risk factors and the pathogenic mechanism of AD hold the promise of bringing forth novel treatments and perhaps even a cure.  In this review, we will summarize some of the risk factors for AD, AD diagnosis, and current treatments.  Novel therapeutic strategies such as inhibition of beta-amyloid peptide (Abeta), tau-mediated pathogenesis, and receptors for advanced glycation end products (RAGE), as well as neuroprotective and anti-inflammatory approaches and the impact of cholesterol-lowering, botanical, and nutritional agents are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwGANhZhSBGuvW160gIxP_fW6udTcc2eZdDNYUf04qXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjgtFKnuw%253D%253D&md5=e08d239fb72f64fbaf020458c7928b1f</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1177%2F1533317510372372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317510372372%26sid%3Dliteratum%253Aachs%26aulast%3DAderinwale%26aufirst%3DO.%2BG.%26aulast%3DErnst%26aufirst%3DH.%2BW.%26aulast%3DMousa%26aufirst%3DS.%2BA.%26atitle%3DCurrent%2520therapies%2520and%2520new%2520strategies%2520for%2520the%2520management%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis.%2520Other%2520Dementias%26date%3D2010%26volume%3D25%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Klafki, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhuber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2840</span><span class="NLM_x">–</span> <span class="NLM_lpage">2855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=2840-2855&author=H.-W.+Klafkiauthor=M.+Stafenbielauthor=J.+Kornhuberauthor=J.+Wiltfang&title=Therapeutic+approaches+to+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlafki%26aufirst%3DH.-W.%26aulast%3DStafenbiel%26aufirst%3DM.%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DWiltfang%26aufirst%3DJ.%26atitle%3DTherapeutic%2520approaches%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D2840%26epage%3D2855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rafii, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Recent development in Alzheimer’s disease</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1186%2F1741-7015-7-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19228370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&author=M.+S.+Rafiiauthor=P.+S.+Aisen&title=Recent+development+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in Alzheimer's disease therapeutics</span></div><div class="casAuthors">Rafii Michael S; Aisen Paul S</div><div class="citationInfo"><span class="NLM_cas:title">BMC medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a devastating neurological disorder that affects more than 37 million people worldwide.  The economic burden of Alzheimer's disease is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least $100 billion.  Current FDA-approved drugs for Alzheimer's disease do not prevent or reverse the disease, and provide only modest symptomatic benefits.  Driven by the clear unmet medical need and a growing understanding of the molecular pathophysiology of Alzheimer's disease, the number of agents in development has increased dramatically in recent years.  Truly *'disease-modifying' therapies that target the underlying mechanisms of Alzheimer's disease have now reached late stages of human clinical trials.  Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimer's disease, and tau protein which, when hyperphosphorylated, results in the self-assembly of tangles of paired helical filaments also believed to be involved in the pathogenesis of Alzheimer's disease.  In this review, we briefly discuss the current status of Alzheimer's disease therapies under study, as well the scientific context in which they have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQBqsOYVNCvy6Ufuk_1xoTfW6udTcc2eZdDNYUf04qXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7nsVKksA%253D%253D&md5=fddd28d862a1be10ae4a10cc2769c3a4</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-7-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-7-7%26sid%3Dliteratum%253Aachs%26aulast%3DRafii%26aufirst%3DM.%2BS.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DRecent%2520development%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBMC%2520Med.%26date%3D2009%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Scarpini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span> </span><span class="NLM_article-title">Treatment of Alzheimer’s disease; current status and new perspectives</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2FS1474-4422%2803%2900502-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12941576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=539-547&author=E.+Scarpiniauthor=P.+Scheltensauthor=H.+Feldman&title=Treatment+of+Alzheimer%E2%80%99s+disease%3B+current+status+and+new+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Alzheimer's disease: current status and new perspectives</span></div><div class="casAuthors">Scarpini, Elio; Scheltens, Philip; Feldman, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">539-547</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  Pharmacol. treatment of AD is based on the use of acetylcholinesterase inhibitors, which have beneficial effects on cognitive, functional, and behavioral symptoms of the disease, but their role in AD pathogenesis is unknown.  Other pharmacol. therapies are becoming available-including the recently approved drug memantine, an NMDA channel blocker indicated for advanced AD.  Here, we review clin. features of the available cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) including their pharmacol. properties, the evidence for switching from one agent to another, "head to head" studies, and the emerging evidence for the use of memantine in AD.  New therapeutic approaches-including those more closely targeted to the pathogenesis of the disease-will also be reviewed.  These potentially disease modifying treatments include amyloid-β-peptide vaccination, secretase inhibitors, cholesterol-lowering drugs, metal chelators, and anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcyZp4rgEiurVg90H21EOLACvtfcHk0lhlq9bDbS84jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSisr8%253D&md5=f7d73fefb0cfce13bf8c93eebf60a4dd</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2803%2900502-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252803%252900502-7%26sid%3Dliteratum%253Aachs%26aulast%3DScarpini%26aufirst%3DE.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253B%2520current%2520status%2520and%2520new%2520perspectives%26jtitle%3DLancet%2520Neurol.%26date%3D2003%26volume%3D2%26spage%3D539%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Clearance of Alzheimer’s Aβ peptide: The many roads to perdition</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=605-608&author=R.+E.+Tanziauthor=R.+D.+Moirauthor=S.+L.+Wagner&title=Clearance+of+Alzheimer%E2%80%99s+A%CE%B2+peptide%3A+The+many+roads+to+perdition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DClearance%2520of%2520Alzheimer%25E2%2580%2599s%2520A%25CE%25B2%2520peptide%253A%2520The%2520many%2520roads%2520to%2520perdition%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D605%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-F.</span><span> </span><span class="NLM_article-title">Clearance of amyloid-beta in Azheimer’s disease: Progress, problems and perspectives</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=931-938&author=Y.-J.+Wangauthor=H.-D.+Zhouauthor=X.-F.+Zhou&title=Clearance+of+amyloid-beta+in+Azheimer%E2%80%99s+disease%3A+Progress%2C+problems+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-J.%26aulast%3DZhou%26aufirst%3DH.-D.%26aulast%3DZhou%26aufirst%3DX.-F.%26atitle%3DClearance%2520of%2520amyloid-beta%2520in%2520Azheimer%25E2%2580%2599s%2520disease%253A%2520Progress%252C%2520problems%2520and%2520perspectives%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D931%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Neeper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliston, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A.</span><span> </span><span class="NLM_article-title">Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">14998</span><span class="NLM_x">–</span> <span class="NLM_lpage">15004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14998-15004&author=M.+Neeperauthor=A.+M.+Schmidtauthor=J.+Brettauthor=S.+D.+Yanauthor=F.+Wangauthor=Y.-C.+Panauthor=K.+Ellistonauthor=D.+Sternauthor=A.+Shaw&title=Cloning+and+expression+of+a+cell+surface+receptor+for+advanced+glycosylation+end+products+of+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeeper%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DBrett%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DY.-C.%26aulast%3DElliston%26aufirst%3DK.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DShaw%26aufirst%3DA.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520cell%2520surface%2520receptor%2520for%2520advanced%2520glycosylation%2520end%2520products%2520of%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D14998%26epage%3D15004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Huttunen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fages, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauvala, H.</span><span> </span><span class="NLM_article-title">Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">19919</span><span class="NLM_x">–</span> <span class="NLM_lpage">19924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=19919-19924&author=H.+Huttunenauthor=C.+Fagesauthor=H.+Rauvala&title=Receptor+for+advanced+glycation+end+products+%28RAGE%29-mediated+neurite+outgrowth+and+activation+of+NF-%CE%BAB+require+the+cytoplasmic+domain+of+the+receptor+but+different+downstream+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuttunen%26aufirst%3DH.%26aulast%3DFages%26aufirst%3DC.%26aulast%3DRauvala%26aufirst%3DH.%26atitle%3DReceptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528RAGE%2529-mediated%2520neurite%2520outgrowth%2520and%2520activation%2520of%2520NF-%25CE%25BAB%2520require%2520the%2520cytoplasmic%2520domain%2520of%2520the%2520receptor%2520but%2520different%2520downstream%2520signaling%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D19919%26epage%3D19924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">Recent reviews about ligands of RAGE and related diseases, see:</p></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">RAGE: A multi-ligand receptor unveiling novel insights in health and disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2232</span><span class="NLM_x">–</span> <span class="NLM_lpage">2252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.2174%2F092986710791331086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20459381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2232-2252&author=P.+Alexiouauthor=K.+Chatzopoulouauthor=K.+Pegklidouauthor=V.+J.+Demopoulos&title=RAGE%3A+A+multi-ligand+receptor+unveiling+novel+insights+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE: a multi-ligand receptor unveiling novel insights in health and disease</span></div><div class="casAuthors">Alexiou, P.; Chatzopoulou, M.; Pegklidou, K.; Demopoulos, V. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2232-2252</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor for advanced glycation end products (RAGE) is expressed in a range of cell types such as endothelial cells, smooth muscle cells, mesangial cells, mononuclear phagocytes and certain neurons.  It is a multi-ligand receptor and a member of the Ig superfamily of cell surface mols.  Its repertoire of ligands includes advanced glycation end products (AGEs), amyloid fibrils, amphoterin and S100/calgranulins.  This variety of ligands allows RAGE to be implicated in a wide spectrum of pathol. conditions such as diabetes and its complications, Alzheimer's disease, cancer and inflammation.  Addnl., genetic polymorphisms in the RAGE gene may have impact on the functional activity of the receptor.  It becomes obvious that RAGE pathway is a complicated one and the question of whether blockade of RAGE is a feasible and safe strategy for the prevention/treatment of chronic diseases is gradually gaining the attention of the pharmaceutical community.  In this review the biol. of RAGE and the triggered signaling cascades involved in health and disease will be presented.  Addnl., its potential as an attractive pharmacotherapeutic target will be explored by pointing out the pharmacotherapeutic agents that have been developed for RAGE blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Kmu1QNiF3LVg90H21EOLACvtfcHk0lg0f3imKlAwJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFeitb4%253D&md5=c8d2d2f33d37feb179f88f2abf09afcd</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F092986710791331086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791331086%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DChatzopoulou%26aufirst%3DK.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DRAGE%253A%2520A%2520multi-ligand%2520receptor%2520unveiling%2520novel%2520insights%2520in%2520health%2520and%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2232%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barlovic, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soro-Paavonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandeleit-Dahm, K. A.</span><span> </span><span class="NLM_article-title">RAGE biology, atherosclerosis and diabetes</span> <span class="citation_source-journal">Clin. Sci. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1042%2FCS20100501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=21457145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BC3MvgsVyruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=43-55&author=D.+P.+Barlovicauthor=A.+Soro-Paavonenauthor=K.+A.+Jandeleit-Dahm&title=RAGE+biology%2C+atherosclerosis+and+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE biology, atherosclerosis and diabetes</span></div><div class="casAuthors">Barlovic Drazenka Pongrac; Soro-Paavonen Aino; Jandeleit-Dahm Karin A M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical science (London, England : 1979)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">43-55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes is characterized by accelerated atherosclerosis with widely distributed vascular lesions.  An important mechanism by which hyperglycaemia contributes to vascular injury is through the extensive intracellular and extracellular formation of AGEs (advanced glycation end products).  AGEs represent a heterogeneous group of proteins, lipids and nucleic acids, irreversibly cross-linked with reducing sugars.  AGEs are implicated in the atherosclerotic process, either directly or via receptor-mediated mechanisms, the most extensively studied receptor being RAGE (receptor for AGEs).  The AGE-RAGE interaction alters cellular signalling, promotes gene expression and enhances the release of pro-inflammatory molecules.  It elicits the generation of oxidative stress in numerous cell types.  The importance of the AGE-RAGE interaction and downstream pathways leading to injurious effects as a result of chronic hyperglycaemia in the development, progression and instability of diabetic atherosclerotic lesions has been amply demonstrated in animal studies.  Moreover, the deleterious link of AGEs with diabetic vascular complications has been suggested in many human studies.  In the present review, our current understanding of their role as an important mediator of vascular injury through the various stages of atherosclerosis in diabetes will be reviewed and critically assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTm5pkAG-JAWiSm0e6ZOaemfW6udTcc2eauWiFTcKbz6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvgsVyruw%253D%253D&md5=9b477c777dbdd9739d6f47d1f3a9c752</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1042%2FCS20100501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20100501%26sid%3Dliteratum%253Aachs%26aulast%3DBarlovic%26aufirst%3DD.%2BP.%26aulast%3DSoro-Paavonen%26aufirst%3DA.%26aulast%3DJandeleit-Dahm%26aufirst%3DK.%2BA.%26atitle%3DRAGE%2520biology%252C%2520atherosclerosis%2520and%2520diabetes%26jtitle%3DClin.%2520Sci.%2520%2528London%2529%26date%3D2011%26volume%3D121%26spage%3D43%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sims, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rietdijk, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, A. J.</span><span> </span><span class="NLM_article-title">HMGB1 and RAGE in inflammation and cancer</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1146%2Fannurev.immunol.021908.132603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=20192808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=367-388&author=G.+P.+Simsauthor=D.+C.+Roweauthor=S.+T.+Rietdijkauthor=R.+Herbstauthor=A.+J.+Coyle&title=HMGB1+and+RAGE+in+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">HMGB1 and RAGE in inflammation and cancer</span></div><div class="casAuthors">Sims, Gary P.; Rowe, Daniel C.; Rietdijk, Svend T.; Herbst, Ronald; Coyle, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">367-388</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The immune system has evolved to respond not only to pathogens, but also to signals released from dying cells.  Cell death through necrosis induces inflammation, whereas apoptotic cell death provides an important signals for tolerance induction.  High mobility group box 1 (HMGB1) is a DNA-binding nuclear protein, released actively following cytokine stimulation as well as passively during cell death; it is the prototypic damage-assocd. mol. pattern (DAMP) mol. and has been implicated in several inflammatory disorders.  HMGB1 can assoc. with other mols., including TLR ligands and cytokines, and activates cells through the differential engagement of multiple surface receptors including TLR2, TLR4, and RAGE.  RAGE is a multiligand receptor that binds structurally diverse mols., including not only HMGB1, but also S100 family members and amyloid-β.  RAGE activation has been implicated in sterile inflammation as well as in cancer, diabetes, and Alzheimer's disease.  While HMGB1 through interactions with TLRs may also be important, this review focuses on the role of the HMGB1-RAGE axis in inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2HfiYhXSqSrVg90H21EOLACvtfcHk0lg0f3imKlAwJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSms7k%253D&md5=eb505a55bf44e06fbff2026629248be1</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132603%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DG.%2BP.%26aulast%3DRowe%26aufirst%3DD.%2BC.%26aulast%3DRietdijk%26aufirst%3DS.%2BT.%26aulast%3DHerbst%26aufirst%3DR.%26aulast%3DCoyle%26aufirst%3DA.%2BJ.%26atitle%3DHMGB1%2520and%2520RAGE%2520in%2520inflammation%2520and%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D367%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">T, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, C. Y.</span><span> </span><span class="NLM_article-title">RAGE and cardiovascular disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.2741%2F3700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=486-497&author=S.+Parkauthor=S.-J.+Yoonauthor=H.-J.+Tauthor=C.+Y.+Shim&title=RAGE+and+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and cardiovascular disease</span></div><div class="casAuthors">Park, Sungha; Yoon, Se-Jung; Tae, Hyun-Jin; Shim, Chi Young</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">486-497</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  RAGE is pattern recognizing receptors for diverse endogenous ligands.  RAGE activation by RAGE ligands is known to be assocd. with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells.  Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion mols.  Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis.  Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation.  RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathol. processes that result in various entities of cardiovascular disease.  Sol. RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo.  Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMHlUrKlArLVg90H21EOLACvtfcHk0ljRvVNcDL9-sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyltro%253D&md5=e3b9fdc26c996044b220313076546af2</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.2741%2F3700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3700%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DS.-J.%26aulast%3DT%26aufirst%3DH.-J.%26aulast%3DShim%26aufirst%3DC.%2BY.%26atitle%3DRAGE%2520and%2520cardiovascular%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2011%26volume%3D16%26spage%3D486%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bierhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiekofer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaninger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrassy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humpert, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloting, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritschler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haring, H.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleicher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span> </span><span class="NLM_article-title">Diabetes-associated sustained activation of the transcription factor nuclear factor-κB</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2792</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=2792-2808&author=A.+Bierhausauthor=S.+Schiekoferauthor=M.+Schwaningerauthor=M.+Andrassyauthor=P.+M.+Humpertauthor=J.+Chenauthor=M.+Hongauthor=T.+Lutherauthor=T.+Henleauthor=I.+Klotingauthor=M.+Morcosauthor=M.+Hofmannauthor=H.+Tritschlerauthor=B.+Weigleauthor=M.+Kasperauthor=M.+Smithauthor=G.+Perryauthor=A.-M.+Schmidtauthor=D.+M.+Sternauthor=H.-U.+Haringauthor=E.+Schleicherauthor=P.+P.+Nawroth&title=Diabetes-associated+sustained+activation+of+the+transcription+factor+nuclear+factor-%CE%BAB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DSchiekofer%26aufirst%3DS.%26aulast%3DSchwaninger%26aufirst%3DM.%26aulast%3DAndrassy%26aufirst%3DM.%26aulast%3DHumpert%26aufirst%3DP.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DM.%26aulast%3DLuther%26aufirst%3DT.%26aulast%3DHenle%26aufirst%3DT.%26aulast%3DKloting%26aufirst%3DI.%26aulast%3DMorcos%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DM.%26aulast%3DTritschler%26aufirst%3DH.%26aulast%3DWeigle%26aufirst%3DB.%26aulast%3DKasper%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.-M.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DHaring%26aufirst%3DH.-U.%26aulast%3DSchleicher%26aufirst%3DE.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26atitle%3DDiabetes-associated%2520sustained%2520activation%2520of%2520the%2520transcription%2520factor%2520nuclear%2520factor-%25CE%25BAB%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26spage%3D2792%26epage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span> </span><span class="NLM_article-title">Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">16498</span><span class="NLM_x">–</span> <span class="NLM_lpage">16506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=16498-16506&author=J.+Liauthor=A.+M.+Schmidt&title=Characterization+and+functional+analysis+of+the+promoter+of+RAGE%2C+the+receptor+for+advanced+glycation+end+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26atitle%3DCharacterization%2520and%2520functional%2520analysis%2520of%2520the%2520promoter%2520of%2520RAGE%252C%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D16498%26epage%3D16506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Deane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagare, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deane, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meenakshisundaram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarcone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlokovic, B. V.</span><span> </span><span class="NLM_article-title">A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=1377-1392&author=R.+Deaneauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+D.+Bellauthor=N.+T.+Rossauthor=B.+Larueauthor=R.+Loveauthor=S.+Perryauthor=N.+Paquetteauthor=R.+J.+Deaneauthor=T.+Meenakshisundaramauthor=T.+Zarconeauthor=G.+Fritzauthor=A.+E.+Friedmanauthor=B.+L.+Millerauthor=B.+V.+Zlokovic&title=A+multimodal+RAGE-specific+inhibitor+reduces+amyloid+%CE%B2-mediated+brain+disorder+in+a+mouse+model+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DLarue%26aufirst%3DB.%26aulast%3DLove%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DPaquette%26aufirst%3DN.%26aulast%3DDeane%26aufirst%3DR.%2BJ.%26aulast%3DMeenakshisundaram%26aufirst%3DT.%26aulast%3DZarcone%26aufirst%3DT.%26aulast%3DFritz%26aufirst%3DG.%26aulast%3DFriedman%26aufirst%3DA.%2BE.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DA%2520multimodal%2520RAGE-specific%2520inhibitor%2520reduces%2520amyloid%2520%25CE%25B2-mediated%2520brain%2520disorder%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D1377%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Men, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. G.</span><span> </span><span class="NLM_article-title">Nanoparticle and other metal chelation thetapeutics in Alzheimer disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1741</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1741&publication_year=2005&pages=246-252&author=G.+Liuauthor=M.+R.+Garrettauthor=P.+Menauthor=X.+Zhuauthor=G.+Perryauthor=M.+G.+Smith&title=Nanoparticle+and+other+metal+chelation+thetapeutics+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGarrett%26aufirst%3DM.%2BR.%26aulast%3DMen%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BG.%26atitle%3DNanoparticle%2520and%2520other%2520metal%2520chelation%2520thetapeutics%2520in%2520Alzheimer%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1741%26spage%3D246%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span> </span><span class="NLM_article-title">PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1097%2FWAD.0b013e318204b550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=21192237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=206-212&author=M.+N.+Sabbaghauthor=A.+Agroauthor=J.+Bellauthor=P.+S.+Aisenauthor=E.+Schweizerauthor=D.+Galasko&title=PF-04494700%2C+an+oral+inhibitor+of+receptor+for+advanced+glycation+end+products+%28RAGE%29%2C+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease</span></div><div class="casAuthors">Sabbagh, Marwan N.; Agro, Albert; Bell, Joanne; Aisen, Paul S.; Schweizer, Edward; Galasko, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-212</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the safety and tolerability of PF-04494700, an oral inhibitor of receptor for advanced glycation end products, in patients with mild-to-moderate dementia of the Alzheimer type.  Patients aged 50 years and older who met the National Institute of Neurol. and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Assocn. criteria for Alzheimer disease with an Mini-Mental State Examn. (MMSE) score between 12 and 26 (inclusive) were randomized to 10 wk of double-blind treatment with either a 10 mg "low dose" of PF-04494700 (after a 6-d loading dose of 30 mg/d), a 20 mg "high dose" of PF-04494700 (after a loading dose of 60 mg/d), or placebo.  Safety measures included adverse events, lab. tests, vital signs, and 12-lead ECG.  27 Patients received PF-04494700 30/co mg (female: 63%; mean age: 74.6 y; mean MMSE: 21.1), 28 patients received PF-04494700 60/20 mg (female: 57%; mean age: 76.6 y; mean MMSE: 21.6), and 12 patients received placebo (female: 67%; mean age: 74.1 y; mean MMSE: 19.2).  A higher proportion of patients completed 10 wk of double-blind treatment on both the "low-dose" regimen of PF-04494700 (88.9%) and the "high-dose" regimen (85.7%) than patients who were on placebo (66.7%).  Discontinuation owing to adverse events and incidence of severe adverse events, resp., were lower in the "low-dose" regimen (7.4%, 11.1%) and the "high-dose" regimen (3.6%, 10.7%) compared with placebo (25.0%, 16.7%).  There were no clin. meaningful differences in vital signs, lab. test results, or mean ECG parameters in patients treated with PF-04494700.  PF-04494700 had no consistent effect on plasma levels of β-amyloid, inflammatory biomarkers, or secondary cognitive outcomes.  Ten weeks of treatment with PF-04494700 was safe and well tolerated in patients with mild-to-moderate Alzheimer disease, indicating the feasibility of a larger long-term efficacy trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYOId4vbstBLVg90H21EOLACvtfcHk0lgi9FfT6PWOlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2hurfL&md5=99a792014511f247fe283378d8503ceb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1097%2FWAD.0b013e318204b550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWAD.0b013e318204b550%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DAgro%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DGalasko%26aufirst%3DD.%26atitle%3DPF-04494700%252C%2520an%2520oral%2520inhibitor%2520of%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528RAGE%2529%252C%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2011%26volume%3D25%26spage%3D206%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Srikanth, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maczurek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westcott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juskiw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Münch, G.</span><span> </span><span class="NLM_article-title">Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2Fj.neurobiolaging.2009.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19464758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVWmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=763-777&author=V.+Srikanthauthor=A.+Maczurekauthor=T.+Phanauthor=M.+Steeleauthor=B.+Westcottauthor=D.+Juskiwauthor=G.+M%C3%BCnch&title=Advanced+glycation+endproducts+and+their+receptor+RAGE+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease</span></div><div class="casAuthors">Srikanth, Velandai; Maczurek, Annette; Phan, Thanh; Steele, Megan; Westcott, Bernadette; Juskiw, Damian; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">763-777</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common dementing disorder of late life.  Although there might be various different triggering events in the early stages of the disease, they seem to converge on a few characteristic final pathways in the late stages, characterized by inflammation and neurodegeneration.  In this review, we revisit the hypothesis that advanced glycation endproducts (AGEs) and their receptor RAGE may play an important role in disease pathogenesis.  Accumulation of AGEs in cells and tissues is a normal feature of aging, but is accelerated in AD.  In AD, AGEs can be detected in pathol. deposits such as amyloid plaques and neurofibrillary tangles.  AGEs explain many of the neuropathol. and biochem. features of AD such as extensive protein crosslinking, glial induction of oxidative stress and neuronal cell death.  Oxidative stress and AGEs initiate a pos. feedback loop, where normal age-related changes develop into a pathophysiol. cascade.  RAGE and its decoy receptor sol. RAGE, may contribute to or protect against AD pathogenesis by influencing transport of β-amyloid into the brain or by manipulating inflammatory mechanisms.  Targeted pharmacol. interventions using AGE-inhibitors, RAGE-antagonists, RAGE-antibodies, sol. RAGE or RAGE signalling inhibitors such as membrane-permeable antioxidants may be promising therapeutic strategies to slow down the progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWteNhizjZprVg90H21EOLACvtfcHk0lgi9FfT6PWOlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVWmsrw%253D&md5=19e434013c3b1bf46e0ef57790eba26b</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSrikanth%26aufirst%3DV.%26aulast%3DMaczurek%26aufirst%3DA.%26aulast%3DPhan%26aufirst%3DT.%26aulast%3DSteele%26aufirst%3DM.%26aulast%3DWestcott%26aufirst%3DB.%26aulast%3DJuskiw%26aufirst%3DD.%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26atitle%3DAdvanced%2520glycation%2520endproducts%2520and%2520their%2520receptor%2520RAGE%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D763%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yammani, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresnick, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeser, R. F.</span><span> </span><span class="NLM_article-title">Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1002%2Fart.22042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=16948116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=2901-2911&author=R.+R.+Yammaniauthor=C.+S.+Carlsonauthor=A.+R.+Bresnickauthor=R.+F.+Loeser&title=Increase+in+production+of+matrix+metalloproteinase+13+by+human+articular+chondrocytes+due+to+stimulation+with+S100A4%3A+Role+of+the+receptor+for+advanced+glycation+end+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products</span></div><div class="casAuthors">Yammani, Raghunatha R.; Carlson, Cathy S.; Bresnick, Anne R.; Loeser, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2901-2911</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. S100 proteins have been implicated in various inflammatory conditions, including arthritis.  The aims of this study were to det. whether chondrocytes produce S100A4 and whether S100A4 can stimulate the prodn. of matrix metalloproteinase 13 (MMP-13) by articular chondrocytes via receptor for advanced glycation end products (RAGE)-mediated signaling.  Methods. The expression of chondrocyte S100A4 was analyzed by immunohistochem. using normal and osteoarthritic (OA) cartilage and by immunoblotting of chondrocyte cell lysates.  RAGE signaling was examd. by stimulating chondrocytes with S100A4 and monitoring for the activation of MAP kinases and NF-κB.  Prodn. of MMP-13 was detd. in the conditioned medium.  A pulldown assay using biotin-labeled S100A4 was used to demonstrate binding to RAGE.  Results. S100A4 expression was detected in human articular chondrocytes by immunoblotting and appeared to increase in the cell lysates from OA tissue.  Marked pos. immunostaining for S100A4 was also noted in sections of human cartilage with changes due to OA.  Stimulation of chondrocytes with S100A4 increased the phosphorylation of Pyk-2, MAP kinases, and activated NF-κB, followed by increased prodn. of MMP-13 in the conditioned medium.  This signaling was inhibited in cells pretreated with sol. RAGE, advanced glycation end product-bovine serum albumin, or the antioxidant Mn(III)tetrakis (4-benzoic acid) porphyrin, or by overexpression of a dominant-neg. RAGE construct.  A pulldown assay showed that S100A4 binds to RAGE in chondrocytes.  Conclusion. This is the first study to demonstrate that S100A4 binds to RAGE and stimulates a RAGE-mediated signaling cascade, leading to increased prodn. of MMP-13.  Since both S100A4 and RAGE are up-regulated in OA cartilage, this signaling pathway could contribute to cartilage degrdn. in OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXQ_IBJsrMbVg90H21EOLACvtfcHk0lgi9FfT6PWOlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksLnI&md5=5d3855a5814325255b26a41bd318c5f8</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1002%2Fart.22042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22042%26sid%3Dliteratum%253Aachs%26aulast%3DYammani%26aufirst%3DR.%2BR.%26aulast%3DCarlson%26aufirst%3DC.%2BS.%26aulast%3DBresnick%26aufirst%3DA.%2BR.%26aulast%3DLoeser%26aufirst%3DR.%2BF.%26atitle%3DIncrease%2520in%2520production%2520of%2520matrix%2520metalloproteinase%252013%2520by%2520human%2520articular%2520chondrocytes%2520due%2520to%2520stimulation%2520with%2520S100A4%253A%2520Role%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%26jtitle%3DArthritis%2520Rheum.%26date%3D2006%26volume%3D54%26spage%3D2901%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yan, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. M.</span><span> </span><span class="NLM_article-title">RAGE and Alzheimer’s disease: A progression factor for amyloid-β-induced cellular perturbation?</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=19387116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADC%252BD1M3psFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=833-843&author=S.+D.+Yanauthor=A.+Bierhausauthor=P.+P.+Nawrothauthor=D.+M.+Stern&title=RAGE+and+Alzheimer%E2%80%99s+disease%3A+A+progression+factor+for+amyloid-%CE%B2-induced+cellular+perturbation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?</span></div><div class="casAuthors">Yan Shi Du; Bierhaus Angelika; Nawroth Peter P; Stern David M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">833-43</span>
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    </div><div class="casAbstract">Receptor for Advanced Glycation Endproducts (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface molecules which serves as a receptor for amyloid-beta peptide (Abeta) on neurons, microglia, astrocytes, and cells of vessel wall.  Increased expression of RAGE is observed in regions of the brain affected by Alzheimer's disease (AD), and Abeta-RAGE interaction in vitro leads to cell stress with the generation of reactive oxygen species and activation of downstream signaling mechanisms including the MAP kinase pathway.  RAGE-mediated activation of p38 MAP kinase in neurons causes Abeta-induced inhibition of long-term potentiation in slices of entorhinal cortex.  Increased expression of RAGE in an Abeta-rich environment, using transgenic mouse models, accelerates and accentuates pathologic, biochemical, and behavioral abnormalities compared with mice overexpressing only mutant amyloid-beta protein precursor.  Interception of Abeta interaction with RAGE, by infusion of soluble RAGE, decreases Abeta content and amyloid load, as well as improving learning/memory and synaptic function, in a murine transgenic model of Abeta accumulation.  These data suggest that RAGE may be a therapeutic target for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwn01bLaXJ0SjiVMCqkKxVfW6udTcc2eYjJ71cBcerC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3psFGmug%253D%253D&md5=3d1c5b7bd492104e1915d264a7d0846e</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DBierhaus%26aufirst%3DA.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DStern%26aufirst%3DD.%2BM.%26atitle%3DRAGE%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520A%2520progression%2520factor%2520for%2520amyloid-%25CE%25B2-induced%2520cellular%2520perturbation%253F%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D833%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span> </span><span class="NLM_article-title">Solution structure of the variable-type domain of the receptor for advanced glycation end products: New insight into AGE-RAGE interaction</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">12299</span><span class="NLM_x">–</span> <span class="NLM_lpage">12311</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800910v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12299-12311&author=S.+Matsumotoauthor=T.+Yoshidaauthor=H.+Murataauthor=S.+Haradaauthor=N.+Fujitaauthor=S.+Nakamuraauthor=Y.+Yamamotoauthor=T.+Watanabeauthor=H.+Yonekuraauthor=H.+Yamamotoauthor=T.+Ohkuboauthor=Y.+Kobayashi&title=Solution+structure+of+the+variable-type+domain+of+the+receptor+for+advanced+glycation+end+products%3A+New+insight+into+AGE-RAGE+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi800910v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800910v%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYonekura%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DY.%26atitle%3DSolution%2520structure%2520of%2520the%2520variable-type%2520domain%2520of%2520the%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%253A%2520New%2520insight%2520into%2520AGE-RAGE%2520interaction%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12299%26epage%3D12311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Münch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thome, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Advanced glycation endproducts in ageing and Alzheimer’s disease</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2FS0165-0173%2896%2900016-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=9063589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A280%3ADyaK2s3hslKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=134-143&author=G.+M%C3%BCnchauthor=J.+Thomeauthor=P.+Foleyauthor=R.+Schinzelauthor=P.+Riederer&title=Advanced+glycation+endproducts+in+ageing+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Advanced glycation endproducts in ageing and Alzheimer's disease</span></div><div class="casAuthors">Munch G; Thome J; Foley P; Schinzel R; Riederer P</div><div class="citationInfo"><span class="NLM_cas:title">Brain research. Brain research reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">134-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Accumulation of advanced glycation endproducts (AGE) in the brain is a feature of ageing and degeneration, especially in Alzheimer's disease (AD).  Increased AGE levels explain many of the neuropathological and biochemical features of AD such as extensive protein crosslinking (beta-amyloid and MAP-tau), oxidative stress and neuronal cell death.  Oxidative stress and AGEs initiate a positive feedback loop, where normal age-related changes develop into a pathophysiological cascade.  Combined intervention using antioxidants, metal chelators, anti-inflammatory drugs and AGE-inhibitors may be a promising neuroprotective strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh5wFRQg1QoaqcneEtCi92fW6udTcc2eYjJ71cBcerC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3hslKhug%253D%253D&md5=82b683c67b8a6e3abe19bdb6029b8a97</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2896%2900016-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252896%252900016-1%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26aulast%3DThome%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DP.%26aulast%3DSchinzel%26aufirst%3DR.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAdvanced%2520glycation%2520endproducts%2520in%2520ageing%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D134%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reddy, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyaz, A.</span><span> </span><span class="NLM_article-title">Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1016%2Fj.drudis.2006.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=16793534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=646-654&author=V.+P.+Reddyauthor=A.+Beyaz&title=Inhibitors+of+the+Maillard+reaction+and+AGE+breakers+as+therapeutics+for+multiple+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases</span></div><div class="casAuthors">Reddy, V. Prakash; Beyaz, Ayse</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13 & 14</span>),
    <span class="NLM_cas:pages">646-654</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Maillard reaction is a complex series of reactions that involve reducing-sugars and proteins, giving a multitude of end-products that are known as advanced glycation end-products (AGEs).  AGEs can contribute to the pathogenesis of diabetes and neurol. diseases such as Alzheimer's disease.  AGEs also play a major role in vascular stiffening, atherosclerosis, osteoarthritis, inflammatory arthritis and cataracts.  Thus, AGE inhibitors and AGE breakers offer a potential strategy as therapeutics for diverse diseases.  Various AGE inhibitors have been developed in recent years, and their underlying mechanism is based on the attenuation of glycoxidn. and/or oxidative stress by the sequestration of metal ions, reactive 1,2-dicarbonyl compds., and reactive oxygen and reactive nitrogen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0eytO4rBcObVg90H21EOLACvtfcHk0liJjCa5y4fDkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGqtbw%253D&md5=6909c59fba12468b9663484a0a43907e</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DV.%2BP.%26aulast%3DBeyaz%26aufirst%3DA.%26atitle%3DInhibitors%2520of%2520the%2520Maillard%2520reaction%2520and%2520AGE%2520breakers%2520as%2520therapeutics%2520for%2520multiple%2520diseases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2006%26volume%3D11%26spage%3D646%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Roschek, B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rector, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillmore, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Punta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, N. A.</span><span> </span><span class="NLM_article-title">Peroxyl radical clocks</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">3527</span><span class="NLM_x">–</span> <span class="NLM_lpage">3532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0601462" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3527-3532&author=B.+Roschekauthor=K.+A.+Tallmanauthor=C.+L.+Rectorauthor=J.+G.+Gillmoreauthor=D.+A.+Prattauthor=C.+Puntaauthor=N.+A.+Porter&title=Peroxyl+radical+clocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo0601462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0601462%26sid%3Dliteratum%253Aachs%26aulast%3DRoschek%26aufirst%3DB.%26aulast%3DTallman%26aufirst%3DK.%2BA.%26aulast%3DRector%26aufirst%3DC.%2BL.%26aulast%3DGillmore%26aufirst%3DJ.%2BG.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DPunta%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26atitle%3DPeroxyl%2520radical%2520clocks%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3527%26epage%3D3532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliccho, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 1-heterocyclic-3-aminopyrrolidinones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1141-1145&author=I.+M.+Bellauthor=D.+C.+Beshoreauthor=S.+N.+Gallicchoauthor=T.+M.+Williams&title=Efficient+synthesis+of+1-heterocyclic-3-aminopyrrolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26aulast%3DGalliccho%26aufirst%3DS.%2BN.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DEfficient%2520synthesis%2520of%25201-heterocyclic-3-aminopyrrolidinones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1141%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Delia, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomaker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinda, A. S.</span><span> </span><span class="NLM_article-title">The synthesis of substituted phenylpyrimidines via Suzuki coupling reactions</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=127-131&author=T.+J.+Deliaauthor=J.+M.+Schomakerauthor=A.+S.+Kalinda&title=The+synthesis+of+substituted+phenylpyrimidines+via+Suzuki+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelia%26aufirst%3DT.%2BJ.%26aulast%3DSchomaker%26aufirst%3DJ.%2BM.%26aulast%3DKalinda%26aufirst%3DA.%2BS.%26atitle%3DThe%2520synthesis%2520of%2520substituted%2520phenylpyrimidines%2520via%2520Suzuki%2520coupling%2520reactions%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2006%26volume%3D43%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peng, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Journet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, G. A.</span><span> </span><span class="NLM_article-title">Highly regioselective amination of 6-aryl-2,4-dichloropyrimidine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/ol052578p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=395-398&author=Z.-H.+Pengauthor=M.+Journetauthor=G.+A.+Humphrey&title=Highly+regioselective+amination+of+6-aryl-2%2C4-dichloropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fol052578p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052578p%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.-H.%26aulast%3DJournet%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DG.%2BA.%26atitle%3DHighly%2520regioselective%2520amination%2520of%25206-aryl-2%252C4-dichloropyrimidine%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D395%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span> </span><span class="NLM_article-title">Preparation of esters of phosphoric acid by the reaction of trivalent phosphorus compounds with diethyl azodicarboxylate in the presence of alcohols</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1246%2Fbcsj.40.935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADyaF2sXksVegtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1967&pages=935-939&author=O.+Mitsunobuauthor=M.+Yamadaauthor=T.+Mukaiyama&title=Preparation+of+esters+of+phosphoric+acid+by+the+reaction+of+trivalent+phosphorus+compounds+with+diethyl+azodicarboxylate+in+the+presence+of+alcohols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of esters of phosphoric acid by the reaction of trivalent phosphorus compounds with diethyl azodicarboxylate in the presence of alcohols</span></div><div class="casAuthors">Mitsunobu, Oyo; Yamada, Masaaki; Mukaiyama, Teruaki</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Chemical Society of Japan</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">935-9</span>CODEN:
                <span class="NLM_cas:coden">BCSJA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2673</span>.
    </div><div class="casAbstract">Diethyl azodicarboxylate (I) (5.2 g.) in 20 ml. Et2O was added dropwise to 7.86 g. PPh3 and 3.24 g. PhCH2OH in 30 ml. of Et2O at room temp. with vigorous stirring.  After 2 days, 74.3% triphenylphosphine oxide (II), m. 148-50°, and 69.6% diethyl N-benzylhydrazodicarboxylate, b. 125-7° n22D 1.5066, was obtained.  Similarly prepd. was 91.4% tributyl phosphate, b. 103-12°.  II was also prepd. by treating 5.22 g. I in 10 ml. Et2O with 7.86 g. PPh3 and 2 ml. allyl alc. in 20 ml. Et2O at room temp.  I (1.74 g.) in 5 ml. Et2O was added dropwise to 1.78 g. allyl diethyl phosphite and 1 ml. EtOH in 10 ml. Et2O at room temp. with vigorous stirring to give 78.0% Et3PO4, b3-4 62-8°.  Similarly, PrEt2PO4, iso-PrEt2PO4, and Et2PhPO4, b4 137-9°, were prepd. in 74.5, 61.7, and 87% yields, resp.  I (1.74 g.) in 5 ml. Et2O was added dropwise to 1.93 g. diethyl N,N-diethylphosphoroamidite and 1.5 ml. allyl alc. in 10 ml. Et2O with vigorous stirring at room temp.  After the reaction mixt. was kept overnight at room temp., 75% diethyl N-(N,N-diethylethylamino)phosphoryl-N'-diethylhydrazodicarboxylate, b0.06 139-43°, was obtained by fractionation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16zjZHqGTd7Vg90H21EOLACvtfcHk0ljcVIW_cuHvag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXksVegtrc%253D&md5=83e58d59103e8cd0887c009903dc1d64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.40.935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.40.935%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMukaiyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520esters%2520of%2520phosphoric%2520acid%2520by%2520the%2520reaction%2520of%2520trivalent%2520phosphorus%2520compounds%2520with%2520diethyl%2520azodicarboxylate%2520in%2520the%2520presence%2520of%2520alcohols%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1967%26volume%3D40%26spage%3D935%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Evans, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, T. R.</span><span> </span><span class="NLM_article-title">Synthesis of diary ethers through the copper-promoted arylation of phenols with aryboronic acids. An expedient synthesis of thyroxine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2937</span><span class="NLM_x">–</span> <span class="NLM_lpage">2940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=2937-2940&author=D.+A.+Evansauthor=J.+L.+Katzauthor=T.+R.+West&title=Synthesis+of+diary+ethers+through+the+copper-promoted+arylation+of+phenols+with+aryboronic+acids.+An+expedient+synthesis+of+thyroxine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DWest%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520diary%2520ethers%2520through%2520the%2520copper-promoted%2520arylation%2520of%2520phenols%2520with%2520aryboronic%2520acids.%2520An%2520expedient%2520synthesis%2520of%2520thyroxine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D2937%26epage%3D2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fradera, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulfield, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinghorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitdehaag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vanZeeland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saniere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deronzier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorleans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span> </span><span class="NLM_article-title">Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1524-1527&author=Z.+Rankovicauthor=J.+Caiauthor=J.+Kerrauthor=X.+Fraderaauthor=J.+Robinsonauthor=A.+Mistryauthor=E.+Hamiltonauthor=G.+McGarryauthor=F.+Andrewsauthor=W.+Caulfieldauthor=I.+Cummingauthor=M.+Dempsterauthor=J.+Wallerauthor=P.+Scullionauthor=I.+Martinauthor=A.+Mitchellauthor=C.+Longauthor=M.+Baughauthor=P.+Westwoodauthor=E.+Kinghornauthor=J.+Bruinauthor=W.+Hamiltonauthor=J.+Uitdehaagauthor=M.+vanZeelandauthor=D.+Potinauthor=L.+Saniereauthor=A.+Fouquetauthor=F.+Chevallierauthor=H.+Deronzierauthor=C.+Dorleansauthor=E.+Nicolai&title=Design+and+optimization+of+a+series+of+novel+2-cyano-pyrimidines+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DJ.%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DE.%26aulast%3DMcGarry%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DF.%26aulast%3DCaulfield%26aufirst%3DW.%26aulast%3DCumming%26aufirst%3DI.%26aulast%3DDempster%26aufirst%3DM.%26aulast%3DWaller%26aufirst%3DJ.%26aulast%3DScullion%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DMitchell%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DC.%26aulast%3DBaugh%26aufirst%3DM.%26aulast%3DWestwood%26aufirst%3DP.%26aulast%3DKinghorn%26aufirst%3DE.%26aulast%3DBruin%26aufirst%3DJ.%26aulast%3DHamilton%26aufirst%3DW.%26aulast%3DUitdehaag%26aufirst%3DJ.%26aulast%3DvanZeeland%26aufirst%3DM.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DFouquet%26aufirst%3DA.%26aulast%3DChevallier%26aufirst%3DF.%26aulast%3DDeronzier%26aufirst%3DH.%26aulast%3DDorleans%26aufirst%3DC.%26aulast%3DNicolai%26aufirst%3DE.%26atitle%3DDesign%2520and%2520optimization%2520of%2520a%2520series%2520of%2520novel%25202-cyano-pyrimidines%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1524%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazerio, C. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span> </span><span class="NLM_article-title">Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinational kinase-directed heterocycle library</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2182</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0567485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2182-2183&author=Q.+Zhangauthor=Y.+Liuauthor=F.+Gaoauthor=Q.+Dingauthor=C.+Choauthor=W.+Hurauthor=Y.+Jinauthor=T.+Unoauthor=C.+A.+P.+Joazerioauthor=N.+Gray&title=Discovery+of+EGFR+selective+4%2C6-disubstituted+pyrimidines+from+a+combinational+kinase-directed+heterocycle+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja0567485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0567485%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DUno%26aufirst%3DT.%26aulast%3DJoazerio%26aufirst%3DC.%2BA.%2BP.%26aulast%3DGray%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520EGFR%2520selective%25204%252C6-disubstituted%2520pyrimidines%2520from%2520a%2520combinational%2520kinase-directed%2520heterocycle%2520library%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2182%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Deane, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Submamaryan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovanovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manness, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frangione, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liliensiek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlokovic, B.</span><span> </span><span class="NLM_article-title">RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1038%2Fnm890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=12808450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFOjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=907-913&author=R.+Deaneauthor=D.+S.+Yanauthor=R.+K.+Submamaryanauthor=B.+LaRueauthor=S.+Jovanovicauthor=E.+Hoggauthor=D.+Welchauthor=L+Mannessauthor=C.+Linauthor=J.+Yuauthor=H.+Zhuauthor=J.+Ghisoauthor=B.+Frangioneauthor=A.+Sternauthor=A.+M.+Schmidtauthor=D.+L.+Armstrongauthor=B.+Arnoldauthor=B.+Liliensiekauthor=P.+Nawrothauthor=F.+Hofmanauthor=M.+Kindyauthor=D.+Sternauthor=B.+Zlokovic&title=RAGE+mediates+amyloid-beta+peptide+transport+across+the+blood-brain+barrier+and+accumulation+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain</span></div><div class="casAuthors">Deane, Rashid; Yan, Shi Du; Submamaryan, Ram Kumar; LaRue, Barbara; Jovanovic, Suzana; Hogg, Elizabeth; Welch, Deborah; Manness, Lawrence; Lin, Chang; Yu, Jin; Zhu, Hong; Ghiso, Jorge; Frangione, Blas; Stern, Alan; Schmidt, Ann Marie; Armstrong, Don L.; Arnold, Bernd; Liliensiek, Birgit; Nawroth, Peter; Hofman, Florence; Kindy, Mark; Stern, David; Zlokovic, Berislav</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">907-913</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress underlying neuronal dysfunction and dementia.  Systemic Aβ infusion and studies in genetically manipulated mice show that Aβ interaction with receptor for advanced glycation end products (RAGE)-bearing cells in the vessel wall results in transport of Aβ across the blood-brain barrier (BBB) and expression of proinflammatory cytokines and endothelin-1 (ET-1), the latter mediating Aβ-induced vasoconstriction.  Inhibition of RAGE-ligand interaction suppresses accumulation of Aβ in brain parenchyma in a mouse transgenic model.  These findings suggest that vascular RAGE is a target for inhibiting pathogenic consequences of Aβ-vascular interactions, including development of cerebral amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzPBfBH_bYLLVg90H21EOLACvtfcHk0li54iW5Zpz8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFOjsL0%253D&md5=b27866af499c76d56d2ea585783863f6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm890%26sid%3Dliteratum%253Aachs%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DD.%2BS.%26aulast%3DSubmamaryan%26aufirst%3DR.%2BK.%26aulast%3DLaRue%26aufirst%3DB.%26aulast%3DJovanovic%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DD.%26aulast%3DManness%26aufirst%3DL%26aulast%3DLin%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DStern%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DArmstrong%26aufirst%3DD.%2BL.%26aulast%3DArnold%26aufirst%3DB.%26aulast%3DLiliensiek%26aufirst%3DB.%26aulast%3DNawroth%26aufirst%3DP.%26aulast%3DHofman%26aufirst%3DF.%26aulast%3DKindy%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DZlokovic%26aufirst%3DB.%26atitle%3DRAGE%2520mediates%2520amyloid-beta%2520peptide%2520transport%2520across%2520the%2520blood-brain%2520barrier%2520and%2520accumulation%2520in%2520brain%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D907%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Reviews about soluble Aβ toxicity, see:</p></div><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferreira, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Felice, F. G.</span><span> </span><span class="NLM_article-title">Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=332-345&author=S.+T.+Ferreiraauthor=M.+N.+Vieiraauthor=F.+G.+De+Felice&title=Soluble+protein+oligomers+as+emerging+toxins+in+Alzheimer%E2%80%99s+and+other+amyloid+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BT.%26aulast%3DVieira%26aufirst%3DM.%2BN.%26aulast%3DDe%2BFelice%26aufirst%3DF.%2BG.%26atitle%3DSoluble%2520protein%2520oligomers%2520as%2520emerging%2520toxins%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520amyloid%2520diseases%26jtitle%3DIUBMB%2520Life%26date%3D2007%26volume%3D59%26spage%3D332%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Akira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshi, K.</span><span> </span><span class="NLM_article-title">Amyloid oligomers: Dynamics and toxicity in the cytosol and nucleus</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2010&pages=1369-1379&author=K.+Akiraauthor=K.+Hiroshi&title=Amyloid+oligomers%3A+Dynamics+and+toxicity+in+the+cytosol+and+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DK.%26aulast%3DHiroshi%26aufirst%3DK.%26atitle%3DAmyloid%2520oligomers%253A%2520Dynamics%2520and%2520toxicity%2520in%2520the%2520cytosol%2520and%2520nucleus%26jtitle%3DFEBS%2520J.%26date%3D2010%26volume%3D277%26spage%3D1369%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyington, J. C.</span><span> </span><span class="NLM_article-title">The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">40762</span><span class="NLM_x">–</span> <span class="NLM_lpage">40770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=40762-40770&author=H.+Parkauthor=J.+C.+Boyington&title=The+1.5+%C3%85+crystal+structure+of+human+receptor+for+advanced+glycation+endproducts+%28RAGE%29+ectodomains+reveals+unique+features+determining+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DBoyington%26aufirst%3DJ.%2BC.%26atitle%3DThe%25201.5%2520%25C3%2585%2520crystal%2520structure%2520of%2520human%2520receptor%2520for%2520advanced%2520glycation%2520endproducts%2520%2528RAGE%2529%2520ectodomains%2520reveals%2520unique%2520features%2520determining%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D40762%26epage%3D40770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Stern, D.; Yan, S. D.; Schmidt, A. M.; Lamster, I.</span><span> </span><span class="NLM_article-title">Ligand binding site of RAGE and uses thereof</span>. US 2001/0053357 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+Stern&author=S.+D.+Yan&author=A.+M.+Schmidt&author=I.+Lamster&title=Ligand+binding+site+of+RAGE+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DD.%26atitle%3DLigand%2520binding%2520site%2520of%2520RAGE%2520and%2520uses%2520thereof%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>Sybyl, 7.0 ed.; SYBYL molecular modeling software, <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sybyl%2C+7.0+ed.%3B+SYBYL+molecular+modeling+software%2C+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26pub%3DTripos%2520Inc%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kumano-Kuramochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakakibara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekizawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, S.</span><span> </span><span class="NLM_article-title">Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in <i>Escherichia coli</i></span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1093%2Fjb%2Fmvm213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=18032414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2008&pages=229-236&author=M.+Kumano-Kuramochiauthor=Q.+Xieauthor=Y.+Sakakibaraauthor=S.+Niimiauthor=K.+Sekizawaauthor=S.+Kombaauthor=S.+Machida&title=Expression+and+characterization+of+recombinant+C-terminal+biotinylated+extracellular+domain+of+human+receptor+for+advanced+glycation+end+products+%28hsRAGE%29+in+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli</span></div><div class="casAuthors">Kumano-Kuramochi, Miyuki; Xie, Qiuhong; Sakakibara, Yoshikiyo; Niimi, Setsuko; Sekizawa, Kyoko; Komba, Shiro; Machida, Sachiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-236</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor involved in the development of diabetic complications.  Using an E. coli expression system, we have successfully expressed and purified the C-terminal biotinylated extracellular domain of human RAGE (hsRAGE), which consists of 3 Ig-like domains carrying 3 putative disulfide bonds.  Over 90% of hsRAGE was expressed in sol. form in trxB and gor mutant E. coli strain Origami (DE3).  Most hsRAGE was biotinylated with a C-terminal AviTag, and stably immobilized onto matrix via streptavidin without any treatment.  Immobilized hsRAGE without glycosylation recognized its ligands, such as AGEs.  Biotinylated hsRAGE was also able to apply in the detection of AGEs on microtiter wells like antibodies used in enzyme-linked immunoassay.  SPR anal. demonstrated that the dissocn. const. (Kd) of RAGE for AGE-BSA was 23.1 nM with the 2-state reaction model, and 13.5 nM with the 1:1 binding model, comparable to those of RAGEs on cell surface.  These results indicate that biotinylated hsRAGE must be useful not only in analyzing RAGE-ligand interactions but also detect AGEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotsFyd3rYTXrVg90H21EOLACvtfcHk0lhTJSPanH0_SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1KisLg%253D&md5=99b8ad08bd6f0eec6f31a881598b66e7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvm213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvm213%26sid%3Dliteratum%253Aachs%26aulast%3DKumano-Kuramochi%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DSakakibara%26aufirst%3DY.%26aulast%3DNiimi%26aufirst%3DS.%26aulast%3DSekizawa%26aufirst%3DK.%26aulast%3DKomba%26aufirst%3DS.%26aulast%3DMachida%26aufirst%3DS.%26atitle%3DExpression%2520and%2520characterization%2520of%2520recombinant%2520C-terminal%2520biotinylated%2520extracellular%2520domain%2520of%2520human%2520receptor%2520for%2520advanced%2520glycation%2520end%2520products%2520%2528hsRAGE%2529%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Biochem.%26date%3D2008%26volume%3D143%26spage%3D229%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chromy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacor, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span> </span><span class="NLM_article-title">Self-assembly of Abeta(1–42) into globular neurotoxins</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">12749</span><span class="NLM_x">–</span> <span class="NLM_lpage">12760</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi030029q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=12749-12760&author=B.+A.+Chromyauthor=R.+J.+Nowakauthor=M.+P.+Lambertauthor=K.+L.+Violaauthor=L.+Changauthor=P.+T.+Velascoauthor=B.+W.+Jonesauthor=S.+J.+Fernandezauthor=P.+N.+Lacorauthor=P.+Horowitzauthor=C.+E.+Finchauthor=G.+A.+Krafftauthor=W.+L.+Klein&title=Self-assembly+of+Abeta%281%E2%80%9342%29+into+globular+neurotoxins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fbi030029q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030029q%26sid%3Dliteratum%253Aachs%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DNowak%26aufirst%3DR.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BP.%26aulast%3DViola%26aufirst%3DK.%2BL.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DVelasco%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DB.%2BW.%26aulast%3DFernandez%26aufirst%3DS.%2BJ.%26aulast%3DLacor%26aufirst%3DP.%2BN.%26aulast%3DHorowitz%26aufirst%3DP.%26aulast%3DFinch%26aufirst%3DC.%2BE.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26atitle%3DSelf-assembly%2520of%2520Abeta%25281%25E2%2580%259342%2529%2520into%2520globular%2520neurotoxins%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D12749%26epage%3D12760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dahlgren, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stine, W. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaDu, M. J.</span><span> </span><span class="NLM_article-title">In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">32046</span><span class="NLM_x">–</span> <span class="NLM_lpage">32053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=32046-32053&author=K.+N.+Dahlgrenauthor=A.+M.+Manelliauthor=W.+B.+Stineauthor=L.+K.+Bakerauthor=G.+A.+Krafftauthor=M.+J.+LaDu&title=In+vitro+characterization+of+conditions+for+amyloid-beta+peptide+oligomerization+and+fibrillogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DK.%2BN.%26aulast%3DManelli%26aufirst%3DA.%2BM.%26aulast%3DStine%26aufirst%3DW.%2BB.%26aulast%3DBaker%26aufirst%3DL.%2BK.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520conditions%2520for%2520amyloid-beta%2520peptide%2520oligomerization%2520and%2520fibrillogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D32046%26epage%3D32053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokolov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonds, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntire, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span> </span><span class="NLM_article-title">Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46363</span><span class="NLM_x">–</span> <span class="NLM_lpage">46366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Fjm300172z&amp;key=10.1074%2Fjbc.C400260200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=15385542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46363-46366&author=R.+Kayedauthor=Y.+Sokolovauthor=B.+Edmondsauthor=T.+M.+McIntireauthor=S.+C.+Miltonauthor=J.+E.+Hallauthor=C.+G.+Glabe&title=Permeabilization+of+lipid+bilayers+is+a+common+conformation-dependent+activity+of+soluble+amyloid+oligomers+in+protein+misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</span></div><div class="casAuthors">Kayed, Rakez; Sokolov, Yuri; Edmonds, Brian; McIntire, Theresa M.; Milton, Saskia C.; Hall, James E.; Glabe, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">46363-46366</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Amyloid fibrillization is multistep process involving sol. oligomeric intermediates, including spherical oligomers and protofibrils.  Amyloid oligomers have a common, generic structure, and they are intrinsically toxic to cells, even when formed from non-disease related proteins, which implies they also share a common mechanism of pathogenesis and toxicity.  Here we report that sol. oligomers from several types of amyloids specifically increase lipid bilayer conductance regardless of the sequence, while fibrils and sol. low mol. wt. species have no effect.  The increase in membrane conductance occurs without any evidence of discrete channel or pore formation or ion selectivity.  The conductance is dependent on the concn. of oligomers and can be reversed by anti-oligomer antibody.  These results indicate that sol. oligomers from many types of amyloidogenic proteins and peptides increase membrane conductance in a conformation-specific fashion and suggest that this may represent the common primary mechanism of pathogenesis in amyloid-related degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZv4RcRRTY7Vg90H21EOLACvtfcHk0lhhFGpRzCmxig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaqtr8%253D&md5=ef1f794bf39581185bb3cbadb9091045</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400260200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400260200%26sid%3Dliteratum%253Aachs%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DSokolov%26aufirst%3DY.%26aulast%3DEdmonds%26aufirst%3DB.%26aulast%3DMcIntire%26aufirst%3DT.%2BM.%26aulast%3DMilton%26aufirst%3DS.%2BC.%26aulast%3DHall%26aufirst%3DJ.%2BE.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26atitle%3DPermeabilization%2520of%2520lipid%2520bilayers%2520is%2520a%2520common%2520conformation-dependent%2520activity%2520of%2520soluble%2520amyloid%2520oligomers%2520in%2520protein%2520misfolding%2520diseases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46363%26epage%3D46366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savonenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vehmas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K. I.</span><span> </span><span class="NLM_article-title">Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2006&pages=1149-1162&author=T.+Melnikovaauthor=A.+Savonenkoauthor=Q.+Wangauthor=X.+Liangauthor=T.+Handauthor=L.+Wuauthor=W.+E.+Kaufmannauthor=A.+Vehmasauthor=K.+I.+Andreasson&title=Cycloxygenase-2+activity+promotes+cognitive+deficits+but+not+increased+amyloid+burden+in+a+model+of+Alzheimer%E2%80%99s+disease+in+a+sex-dimorphic+pattern"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DSavonenko%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKaufmann%26aufirst%3DW.%2BE.%26aulast%3DVehmas%26aufirst%3DA.%26aulast%3DAndreasson%26aufirst%3DK.%2BI.%26atitle%3DCycloxygenase-2%2520activity%2520promotes%2520cognitive%2520deficits%2520but%2520not%2520increased%2520amyloid%2520burden%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520a%2520sex-dimorphic%2520pattern%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D141%26spage%3D1149%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Maezawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laferla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L. W.</span><span> </span><span class="NLM_article-title">Congo red and thioflavin-T analogs detect Abeta oligomers</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300172z&amp;key=17953662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300172z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=457-468&author=I.+Maezawaauthor=H.+S.+Hongauthor=R.+Liuauthor=C.+Y.+Wuauthor=R.+H.+Chengauthor=M.+P.+Kungauthor=H.+F.+Kungauthor=K.+S.+Lamauthor=S.+Oddoauthor=F.+M.+Laferlaauthor=L.+W.+Jin&title=Congo+red+and+thioflavin-T+analogs+detect+Abeta+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Congo red and thioflavin-T analogs detect Aβ oligomers</span></div><div class="casAuthors">Maezawa, Izumi; Hong, Hyun-Seok; Liu, Ruiwu; Wu, Chun-Yi; Cheng, R. Holland; Kung, Mei-Ping; Kung, Hank F.; Lam, Kit S.; Oddo, Salvatore; LaFerla, Frank M.; Jin, Lee-Way</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Several small mol. ligands for amyloid-β (Aβ) fibrils deposited in brain have been developed to facilitate radiol. diagnosis of Alzheimer's disease (AD).  Recently, the build-up of Aβ oligomers (AβO) in brain has been recognized as an addnl. hallmark of AD and may play a more significant role in early stages.  Evidence suggests that quant. assessment of AβO would provide a more accurate index of therapeutic effect of drug trials.  Therefore, there is an urgent need to develop methods for efficient identification as well as structural anal. of AβO.  We found that some well established amyloid ligands, analogs of Congo red and thioflavin-T (ThT), bind AβO with high affinity and detect AβO in vitro and in vivo.  Binding studies revealed the presence of binding sites for Congo red- and thioflavin-T-analogs on AβO.  Furthermore, these ligands can be used for imaging intracellular AβO in living cells and animals and as pos. contrast agent for ultrastructural imaging of AβO, two applications useful for structural anal. of AβO in cells.  We propose that by improving the binding affinity of current ligands, in vivo imaging of AβO is feasible by a 'signal subtraction' procedure.  This approach may facilitate the identification of individuals with early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLlAZIbpn1T7Vg90H21EOLACvtfcHk0lhhFGpRzCmxig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqs70%253D&md5=0bc56e05072d219bfbafee42e418982d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaezawa%26aufirst%3DI.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DR.%2BH.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DLaferla%26aufirst%3DF.%2BM.%26aulast%3DJin%26aufirst%3DL.%2BW.%26atitle%3DCongo%2520red%2520and%2520thioflavin-T%2520analogs%2520detect%2520Abeta%2520oligomers%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D457%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O3U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O3U','PDB','3O3U'); return false;">PDB: 3O3U</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i108"><a href="/doi/suppl/10.1021/jm300172z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53285"></div></div></div></div></div><hr /></hr><p class="last">Validation data for ELISA assay, FSB staining of coronal section of AD model, NF-κB reporter assay on the C6 glioma cell, and purity data of the tested compounds. This material is available free charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300172z/suppl_file/jm300172z_si_001.pdf">jm300172z_si_001.pdf (392.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300172z&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm300172z%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300172z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ca29bd163d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
